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SUMMARY 
Analysis of non-Hodgkin's lymphomas by conventional cytogenetics and 
fluorescence in-situ hybridisation 
David William Hammond 
Cytogenetic analysis was performed on 40 non-Hodgkin's lymphoma (NHQ node 
biopsies. Chromosomes X, 3 and 12 were the most frequently gained; of the much 
rarer monosomies, loss of chromosome 13 was most common. Structural 
abnormalities primarily involved chromosomes 14,1,18,6 and 17. A markedly 
greater number of chromosome gains were associated with low-grade disease 
when compared to high-grade. 
In order to obtain further information from the cytogenetic analysis of the NHL 
karyotypes, the fluorescence in-situ hybridisation (FISH) technique was applied 
to the series. 
The activation state of additional X-chromosomes was examined and evidence 
that more than one X-chromosome was present in the active state in 4/9 cases 
was obtained. Further, in an apparent case of monosomy X, a marker was 
identified as an abnormal X-chromosome by chromosome painting. 
Interphase FISH was applied to NHL cells and numeri cal chromosome changes 
were identified; this approach was also attempted on aged bone marrow smears 
from acute lymphocytic leukaemia patients, in order to test the utility of the 
technique on archival material. 
Dual chromosome painting was used to elucidate the origins of add(14) 
chromosomes in 8 of the cases. In the control and two other cases the translocated 
material was demonstrated to be from chromosome 18, in two cases it was from 
chromosome 3 and in one case them was an insertion of chromosome 11 material. 
it was not possible to identify the origins of the translocated material in one NHL 
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and in the final case the apparent add(14) was demonstrated not to contain 
chromosome 14 material. 
Structural abnormalities of chromosome 6 were investigated both by chromosome 
painting and by hybridisation of the MYB gene. The latter, which was initially 
mapped to 6q23 before hybridisation to NHL cells revealed previously 
unsuspected rearrangements. 
One case contained extrachromosomal chromatin bodies that appeared to be 
double minute chromosomes (dmin), which FISH analysis demonstrated to be 
derived from the X-chromosome and contain centromere-associated DNA. 
The significance of these results is discussed with reference to previously 
published series of NHL karyotypes. 
4 
TABLE OF CONTENTS 
Page 
DEDICATION 
DECLARATION 2 
SUMMARY 
TABLE OF CONTENTS 5 
ABBREVIATIONS 12 
LIST OF TABLES 14 
LIST OF FIGURES 15 
CHAPTER ONE INTRODUCTION 
1.1) CANCER AND CHROMOSOMES 20 
1.1.1) Historical background 20 
1.1.2) The nature of chromosome change 21 
1.1.3) Chromosomes and genes 22 
1.2) MALIGNANT LYMPHOMAS 24 
1.2.1) Introduction 24 
1.2.2) Lymphocyte ontogeny 25 
1.2.3) Classification of non-Hodgkin's lymphomas 26 
1.2.4) Incidence 27 
1.3) GENETICS OF NON-HODGKIN'S LYMPHOMA 28 
1.3.1) Introduction 28 
1.3.2) Cytogenetics of non-Hodgkin's lymphomas 28 
1.3.3) Molecular biology of non-Hodgkin's Lymphoma 32 
1.3.4) Histological associations with karyotype. 33 
1.3.5) Clinical implications of genetic abnormalities in NHL 34 
1.4) MOLECULAR CYTOGENETICS 34 
1.4.1) Introduction 34 
5 
1.4.2) The origins of in-situ hybridisation 36 
1.4.3) Probes and vectors 37 
1.4.3.1) Single copy probes 37 
1.4-3-2) Chromosome-specific repetitive probes 38 
1.4-3-3) Chromosome painting probes 38 
1.4.4) Probe labelling and detection 39 
1.4-5) FISH imaging 40 
1-5) THE APPLICATION OF FISH TO THE STUDY 
OFMALIGNANCY 42 
1.5.1) Introduction 42 
1.5.2) FISH mapping techniques 42 
1.5.2.1) Metaphase mapping 42 
1.5.2.2) Interphase mapping 43 
1.5-3) Identification of derived chromosomes 44 
1.5.3.1) Chromosome painting 44 
1.5.3.2) Ratio-labelling and reverse chromosome painting 44 
1.5.3.3) Micro-FISH 45 
1.5.4) Interphase cytogenetics 46 
1.5.4.1) Detection of structural abnormalities in interphase cells 46 
1.5.4.2) Detection of numerical chromosome abnormalities 47 
1.5.4.3) Correlation of chromosome abnormalities with cell type 47 
1.5.5) Comparative genomic hybridisation (CGH) 48 
1.6) AIMS OF THE STUDY 49 
CHAPTER TWO MATERIALS AND METHODS 
2.1) MATERIALS 51 
2.1.1 Clinical samples 51 
2.1.1.1) Lymph node biopsies 51 
2.1.1.2) Peripheral blood 51 
2.1.2) Tissue culture 51 
2.1.2.1) Culture media 51 
2.1.2.2) Phytohaemagglutinin(PHA) 54 
2.1.2.3) Human serum 54 
2.1.2.4) Thymidine 54 
2.1.2.5) Phosphate buffered saline(PBS) 54 
2.1.2.6) Deoxycytidine 54 
6 
2.1.3) Cytogenetics 55 
2.1.3.1) Colcemid 55 
2.1-3-2) Hypotonic solutions 55 
2.1.33) Fixative 55 
2.1.3.4) Slides 55 
2.1.3.5) Blotting paper 55 
2.1.3.6) Gurrs buffer 55 
2.1.3.7) Sorensens buffer 56 
2.1.3.8) Leishmans stain 56 
2.1.3.9) Trypsin solution 56 
2.1.3.10) Lipsol solution 56 
2.1.3.11) Borate buffer 56 
2.1.3.12) Wrights giemsa stain 56 
2.1.3.13) Immersion lens oil 57 
2.1.4) Molecular biology 57 
2.1.4.1) Strains of Escherichia Coli 57 
2.1.4.2) DNA clones 57 
2.1.4.3) Gene libraries 57 
2.1.4.4 Antibiotics 57 
2.1.4.5) Luria-Bertani (LB) medium 59 
2.1.4.6) Calcium Chloride solution 
(For preparation of competent cells) 59 
2.1.4.7) Glycerol solution (For preparation of E. Coli stocks) 59 
2.1.4.8) STET buffer 59 
2.1.4.9) 1M Tris stock 59 
2.1.4.10) 0.5M EDTA stock 60 
2.1.4.11) TE buffer 60 
2.1.4.12) Lysozyme 60 
2.1.4.13) DNAase free RNAase 60 
2.1.4.14) Materials for Maxi preparations of plasmid DNA 60 
2.1.4.15) Phenol: chlorofonn: isoamyl alcohol (25: 24: 1) 61 
2.1.4.16) Restriction enzymes and molecular size markers 61 
2.1.4.17) 5x Tris-borate (TBE) 61 
2.1.4.18) lOx Loading buffer 62 
2.1.4.19) Electrophoresis, tanks and power packs 62 
2.1.4.20) Ethidium Bromide (EtBr) 62 
2.1.4.2 1) DNA purification kit 
62 
2.1.4.22) Sephadex G-50 62 
2.1.4.23) Gel photography 
63 
7 
2.1.5) In-situ hybridisation 63 
2.1.5.1) Nick translation 63 
2.1.5.2) Hybridisation mix 64 
2.1.5.3) Rubber solution 64 
2.1.5.4) 20x SSC stock solution 64 
2.1.5.5) SSCT 64 
2.1.5.6) SSCTM 65 
2.1.5.7) Detection reagents 65 
2.1.5.8) Slide mountant 65 
2.1.5.9) Borate buffer 65 
2.1.5.10) Competitor DNA 65 
2.1.5.11) Pepsin stock solution 65 
2.1.5.12) Transfer RNA 65 
2.1.5.13) Salmon sperm DNA 66 
2.1.5.14) Dot blot assays 66 
2.1.6) General chen-ticals 66 
2.1.6.1) Water 66 
2.1.6.2) Reagents 66 
2.1.7) General laboratory consumables 67 
2.1.7.3) Automatic pipettes and tips 67 
2.1.7.4) Disposable plastics 67 
2.1.7.5) Glassware 67 
2.1.8) Equipment 67 
2.1.8.1) Centrifuges 67 
2.1.8.2) Heating equipment 67 
2.1.8.3 Sterilising equipment 68 
2.1.8.4) Surgical scissors 68 
2.1.8.5) Measurement of absorbance 68 
2.1.8.6) Transilluminator 68 
2.1.9 ) Microscopy 66 
2.1.9.1) Photomicroscopy 68 
2.1.9.2) Digital imaging microscopy 69 
2.1.9.3) Photographic papers 69 
2.1.9.4) Processing 69 
2.1.9.5) Enlarger 69 
2.2) METHODS 70 
2.2.1) Tissue culture 
70 
2.2.1.1) Peripheral blood 70 
8 
2.2.1.2) Lymph node 70 
2.2.2) Cytogenetics 71 
2.2.2.1) Slide making 71 
2.2.2.2) G-banding 72 
2.2.3) Molecular biology 72 
2.2.3.1) Preparation of competent cells 72 
2.2.3.2) Transformation of competent cells 73 
2.2.3.3) Growth of clones in plasmid vectors 73 
2.2.3.4) Preparation of plasmid DNA 74 
2.2.3.5) Quantification of DNA. 75 
2.2.3.6) Digestion of DNA by restriction enzymes. 75 
2.2.3.7) Gel electrophoresis, of DNA. 75 
2.2.3.8) Recovery of DNA from electrophoresis gels 76 
2.2.4) Photography 77 
2.2.4.1) Development of PAN AHU film 77 
2.2.4.2) Printing from PAN AHU film 77 
2.2.4.3) Photography of electrophoresis gels 77 
2.2.5) Fluorescence in-situ hybridisation 77 
CHAPTER THREE TECHNICAL DEVELOPMENT OF 
FLUORESCENCE IN-SITU HYBRIDISATION 
3.1) INTRODUMON 79 
3.2) SLIDE PREPARATION 79 
3.2.1 Slide making 79 
3.2.2 Ageing and storage of preparations 80 
3.2.3 Pre-treatment of preparations 80 
3.2.4 Evaluation 81 
3.3) PROBE LABELLING 81 
3.3.1 Introduction 81 
3.3.2 Labelling protocol 84 
3.3.3 Dot blot assay of probe labelling 84 
3.4) DENATURATION AND HYBRIDISATION 86 
3.4.1 Introduction 86 
3.4.2 Probe mixtures 86 
3.4.3) Denaturation and hybridisation methods 88 
9 
3.5) DETEMON 88 
3.5.1) Post hybridisation washes 88 
3.5.2) Immuno-cytochemistry 89 
3.6) CHROMOSOME BANDING AND FISH 91 
3.7) PHYSICAL MAPPING 91 
3.8) PHOTOGRAPHY 93 
CHAPTER FOUR RESULTS OF CYTOGENETIC STUDIES 
4.1) INTRODUCTION 97 
4.2) KARYOTYPES OF INDIVIDUAL BIOPSIES 97 
4.3) OVERALL ANALYSIS OF THE SERIES 147 
4.3.1) Introduction 147 
4.3.2) Numerical analysis 147 
4.3.3) Structural analysis 150 
CHAPTER FIVE RESULTS OF FISH STUDIES 
5.1) INTRODUCTION 154 
5.2 NUMERICAL CHANGES 154 
5.2.1) Investigation of X activation 154 
5.2.2) Investigation of monosomy X 162 
5.2.3) Interphase analysis 163 
5.2.3.1) Interphase analysis of NHL 163 
5.2.3.2) Interphase analysis of archival material 163 
5.3) STRUCTURAL CHANGES 168 
5.3.1) Investigation of add(14)(q) chromosomes 168 
5.3.2) Investigation of abnormalities of chromosome 6.175 
5.3.2.1) Painting of chromosome 6 175 
5.3.2.2) FISH analysis of the MYB proto-oncogehe 175 
5.3.4) Analysis of double minutes in NHL 180 
10 
CHAIqER SIX DISCUSSION 
6.1) CYTOGENETICS 185 
6.1.1) General considerations 185 
6.1.2) Numerical changes 186 
6.1.3) Structural changes 188 
6.2) MOLECULAR CYTOGENETICS 190 
6.2.1) Numerical studies 190 
6.2.1.1) Activation of chromosome X 190 
6.2.1.2) Interphase cytogenetics 192 
6.2.2) Structural studies 193 
6.2.2.1) Abnormalities of chromosome 14 193 
6.2.2.2) Abnormalities of chromosome 6 196 
6.2.2.3) Analysis of double minutes 197 
6.3) CONCLUSIONS 198 
BIBLIOGRAPHY 201 
PUBLICATIONS ARISING FROM THE WORK PRESENTED 
IN THIS THESIS. 229 
ACKNOWLEDGEMENTS 231 
11 
ABBREVIATIONS 
AMCA aminomethylcoumarin acetic acid 
AML acute myeloid leukaemia 
APAP alkaline phosphatase anti allcaline phosphatase 
BCIP 5-bromo-4-chloro-3-indolylphosphate 
BrdU 5-bromodeoxyuridine 
CCD charge coupled device 
CGH comparative genomic hybridisation 
CISSH chromosome in-situ suppression hybridisation 
CLL chronic lymphocytic leukaemia 
DAPI diaminoPhenylindole 
DNA deoxyribonucleic acid 
DOP degenerate oligonucleotide primed 
EDTA disodium ethylenediaminetetraacetate 
FISH fluorescence in-situ hybridisation 
FITC fluorescein isothiocyanate 
Ig immunoglobulin 
IRS interspersed repetitive sequences 
ISCN International System for Human CYtogenetic Nomenclature 
LB Luria-Bertani 
LOH loss of heterozygosity 
NBT nitroblue tetrazolium 
NHL non-Hodgkin's lymphoma 
PBS phosphate buffered aline 
PCR polymerase chain reaction 
PHA phytohaemagglutinin 
RHH Royal Hallamshire Hospital 
RNA ribonucleic acid 
12 
TCR T-cellreceptor 
TR texas red 
TRITC tetramethy1rhodamine isothiocyanate 
TSG tumour suppressor gene 
VNTR variable number tandem repeat 
WPH Weston Park Hospital 
YAC yeast artificial chromosome 
13 
GLOSSARY OF CYTOGENETIC TERMS 
add Additional material of unknown origin 
brackets, square Used to indicate clone size and number of cells 
comma Separates chromosome numbers, sex chromosomes and 
chromosome abnormalities 
cp Composite karyotype 
del Deletion 
der Derivative chromosome 
dmin Double minute chromosome 
dup Duplication 
i Isochromosome 
idem Used to denote the stemline karyotype in subclones 
ins Insertion 
inv Inversion 
mar Marker chromosome 
P Short arm of the chromosome 
plo Short arm part of the centromere 
parenthesis Surrounds structurally altered chromosome(s) and 
breakpoints 
plus Gain 
q Long arm of chromosome 
qlO Long arm part of the centromere 
question mark Questionable identification of a chromosome, 
chromosome arm or chromosome breakpoint 
semicolon Separates chromosomes and bands in structural 
rearrangements involving more than one chromosome 
t Translocation 
13 
LIST OF TABLES 
Page 
Table 1.1 Relationship of B-Cell Development to 
Lymphoid Malignancy 26 
Table 1.2 Incidence of recurring abnormalities 
in large series of NHL 30 
Table 1.3 Translocations which activate oncogenes 
in B-cell NHL 31 
Table 1.4 Correlations Between Cytogenetic Abnormalities 
and Clinical Outcome in NHL 35 
Table 2.1 Patient Details 
Table 2.2 DNA Probes and Libraries 
52 
58 
Table 4.1 Karyotypes of cells from NHL node biopsies 98 
Table 5.1 Analysis of X Activation in NHL 160 
Table 5.2 FISH with an X Centromere Probe applied to Stored 
Bone Marrow Smears taken from Patients with ALL 
in Remission 168 
Table 5.3 Interphase FISH Analysis of Eight Children with ALL 169 
Table 5.4 Mapping of the MYB Proto-oncogene onto 
Metaphase Chromosomes 177 
14 
LIST OF FIGURES 
Page 
Figure 3.1 Metaphase spread from peripheral blood lymphocytes, 
hybridised with probes for the X centromere and the MYB 
proto-oncogene and untreated with RNase. 82 
Figure 3.2 Metaphase spreads from peripheral blood lymphocytes, 
pretreated with RNase. 83 
Figure 3.3 Male metaphase spread from peripheral blood 
lymphocytes, hybridised with a painting probe for 
the X chromosome. 87 
Figure 3.4 Metaphase spreads from peripheral blood lymphocytes, 
hybridised with a centromere probe specific for the 
X chromosome and a probe for the MYB proto-oncogene. 90 
Figure 3.5 Examples of pre- and post-banding on metaphase 
spreads from peripheral blood lymphocytes. 92 
Figure 3.6 A metaphase spread from peripheral blood lymphocytes 
before and after post-banding, hybridised with probes for the 
chromosome 6 centromere and the MYB proto-oncogene. 94 
Figure 4.1 Representative karyotype from case LOOI. 105 
Figure 4.2 Representative karyotype from case L002.106 
Figure 4.3 Representative karyotype from case L003.107 
Figure 4.4 Representative karyotype from case L004.108 
Figure 4.5 Representative karyotype from case L005. * 110 
Figure 4.6 Representative karyotype from case L006. III 
Figure 4.7 Representative karyotype from case L007.112 
15 
Figure 4.8 Representative karyotype from case L008.113 
Figure 4.9 Representative karyotype from case L009.114 
Figure 4.10 Representative karyotype from case L010A. 115 
Figure 4.11 Representative karyotype from case L010B. - 116 
Figure 4.12 Representative karyotype from case LO II- 118 
Figure 4.13 Representative karyotype from case L012.119 
Figure 4.14 Representative karyotype from case L013.120 
Figure 4.15 Representative karyotype from case L014.121 
Figure, 4.16 Representative karyotype from case L015.122 
Figure, 4.17 Representative karyotype from case L016.123 
Figure 4.18 Representative karyotype from case L017.125 
Figure 4.19 Representative karyotype from case L019. 126 
Figure 4.20 Representative karyotype from case L020A. 127 
Figure 4.21 Representative karyotype from case L020B. 128 
Figure 4.22 Representative karyotype from case L02 1. 129 
Figure 4.23 Representativ6-karyotype from case L022. 130 
Figure 4.24 Representative karyotype from case L023.132 
Figure 4.25 Representative karyotype from case L024.133 
Figure 4.26 Representative karyotype from case L025.134 
Figure 4.27 Representative karyotype from case L026A. 135 
16 
Figure 4.28 Representative karyotype from case L026B. 136 
Figure 4.29 Representative karyotype from case L027.137 
Figure 4.30 Representative karyotype from case L028.138 
Figure 4.31 Representative karyotype from case L029.140 
Figure 4.32 Representative karyotype from case L030.141 
Figure 4.33 Representative karyotype from case L031.142 
Figure 4.34 Representative karyotype from case L032.143 
Figure 4.35 Representative karyotype from case L034.144 
Figure 4.36 Representative karyotype from case L036.145 
Figure 4.37 Representative karyotype from case L037.146 
Figure 4.38 Numerical chromosome changes in NHL. 148 
Figure 4.39 Chromosome gains in high and low grade NHL 149 
Figure 4.40 Chromosome gains in treated and untreated NHL. 150 
Figure 4.41 Structural chromosome changes in NHL. 151 
Figure 4.42 Structural chromosome changes in high 
and low grade NHL. 152 
Figure 4.43 Structural chromosome changes in treated 
and untreated NHL. 152 
Figure 5.1 Interphase nuclei of normal peripheral blood 
lymphocytes, hybridised with a centromeric probe 
for the X-chromosome. 157 
17 
Figure 5.2 Centromeric probe for the X-chromosome 
hybridised to interphase nuclei from abnormal 
peripheral blood lymphocytes. 158 
Figure 5.3 FISH analysis of X-chromosome centromeres 
in interphase nuclei from a series of NHL cells. 159 
Figure 5.4 Representativekaryotype of case L109.162 
Figure 5.5 Metaphase spread from case L109 that had apparently 
exhibited monosomy of the X chromosome, hybridised with a 
painting probe specific for the X-chromosome. 164 
Figure 5.6 FISH analysis of the X chromosome in peripheral blood 
lymphocytes by the use of a centromeric alphoid 
repeat probe in metaphase and interphase cells. 166 
Figure 5.7 Hybridisation of X centromere probes to interphase 
nuclei from Romanowsky stained bone marrow smears. 167 
Figure 5.8 Partial karyotypes of non-Hodgkin's lymphomas 
showing normal and derivative chromosomes 14.171 
Figure 5.9 Analysis of non-Hodgkin's lymphoma metaphases 
by dual chromosome painting. 172 
Figure 5.10 Analysis of NHL metaphases with chromosome 
6 painting. 176 
Figure 5.11 FISH analysis of the MYB gene on normal metaphases. 178 
Figure 5.12 FISH analysis of the MYB gene on NHL 
metaphase spreads. 179 
Figure 5.13 Cytogenetic and FISH analysis of cells from 
a NHL node biopsy. 181 
Figure 5.14 FISH analysis of the presence of centromere-associated 
DNA sequences in dmin in malignant cells. 182 
18 
CHAPTER ONE 
INTRODUCTION 
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1.1) CANCER AND CHROMOSOMES 
1.1.1) Historical background 
It is now over 100 years since the observations first linking chromosome 
abnormalities and cancer cells were recorded by von Hansemann, (reviewed in 
Chaganti, 1983). Theodor Boveri, writing in the early years of this century, 
proposed the earliest hypothesis that related the development of tumours to 
cellular genetics (reviewed in Hsu, 1987). He suggested that malignant cells were 
derived from normal cells and that the malignant phenotype was caused by 
factors within the cell rather than the environment. Furthermore, he proposed that 
each tumour originated from a single cell and that the tumour cell had an 
abnormal chromatin content. However, it was not possible to test these prophetic 
ideas for some decades. It was not until techniques using colcemid, a spindle 
poison, to collect mitotic cells and hypotonic treatment to swell those cells and 
therefore allow chromosome spreading to be devised (Hsu, 1952), that it became 
possible to analyse chromosomes in mammalian cells accurately. 
Following the establishment of the normal diploid human chromosome number 
(Tjio and Levan, 1956), a critical assessment of numerical chromosome 
abnormalities in cancer cells became possible for the first time. The identification 
of the first specific cancer associated chromosome change soon followed, with 
the discovery of an abnormally small karyotypic marker in patients with chronic 
myeloid leukaemia, the Philadelphia chromosome (Nowell and Hungerford, 
1960). A confusing richness of chromosomal abnormalities in other malignancies 
initially deried further analysis, although patterns of association, in which 
particular chromosome types increased or decreased were discerned. (Levan, 
1966; van Steenis, 1966). The invention of chromosome banding (Caspersson et 
al, 1970) provided a powerful tool for a more discriminatory quantification of 
karyotypic change. It was now possible to accurately identify individual 
chromosomes and therefore to detect and characterise structural rearrangements. 
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The Philadelphia chromosome was revealed as an exchange of material (a 
translocation) between chromosomes 9 and 22. (Rowley, 1973) and allowed the 
detection of other rearrangements specific to particular malignancies, for example 
the t(8; 14) which is found in the majority of Burkitt lymphomas. (Zech et al, 
1976). 
1.1.2) The Nature of chromosome change 
It had been clear to workers in the field that a fundamental genetic instability 
underlay the karyotypic changes they were observing in cancer cells. However, 
whether these anomalies were the result (and therefore random) or the cause (and 
therefore specific) of the malignancy was uncertain. As data has accumulated, 
increasing numbers of associations between particular cytogenetic changes and 
specific malignancies have been found (Sandberg, 1980; Yunis, 1983). 
Chromosomal abnormalities have now been detected in all tumour types (Heim 
and Mitelman, 1987a) and the conclusion that these changes are non-random is 
inescapable. 
Although many specific associations between karyotype and cancer are now 
catalogued, the overall pattern of change remains very heterogeneous. A further 
classification, that may well reflect the biological reality, into primary and 
secondary aberrations, has been proposed (Heim and Mitelman, 1987a). Primary 
changes often occur as sole abnormalities and are frequently associated with 
particular tumour types. Secondary changes do not occur alone, are found more 
commonly in more advanced disease and may appear in a wider range of 
malignancies. It is noteworthy that these secondary abnormalities also appear to 
show a non random distribution (Heim and Mitelman, 1986). It may 
be inferred 
that secondary aberrations provide a pool of genetic changes in the context of 
which cells are tested for "fitness" in terms of their proliferative capacity within a 
particular environment, thus leading to tumour progression. The selective 
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pressures will vary, being dependent on the primary changes, the particular 
malignancy and the type of tissue involved. 
An already highly complex pattern of cytogenetic change is further exacerbated 
by a geographic heterogeneity affecting a range of neoplasia- associated 
chromosome abnormalities. In a recent study (Johansson et al, 1991), the authors 
found highly significant differences in the frequency of characteristic aberrations 
in consecutive series of patients with the same diagnosis. Most of the results were 
for haematological malignancies, for example, in cases of chronic myeloid 
leukaemia an additional Philadelphia chromosome was found at a frequency of 
9% in Eastern Europe but at 43% in Japan. Some differences were also noted in 
the frequency of some solid tumour associated cytogenetic changes, monosomy 
22 in meningioma being one example. Some of this variation may be due to 
differences in technique, as has been shown when direct preparations were 
compared to short term culture for example (Atkin and Baker, 1990). However, 
the external environment and variations in genetic background must also be 
considered. 
1.1.3) Chromosomes and genes 
Evidently, chromosomes are structures that carry genes.. A natural corollary to the 
study of chromosome abnormalities in cancer is an investigation of those 
molecular changes mediated by large scale cytogenetic alterations. 
Different categories of chromosome abnormality will effect a variety of events at 
the molecular level. Numerical changes, involving whole chromosomes, lead to a 
change of gene dosage, either positive or negative, at all gene loci present on the 
chromosomes involved. Structural changes can involve exchange of material at 
particular loci through translocations or inversions, a loss of specific genetic 
material through deletion or a gain of material through duplication. Small circular 
extra-chromosomal DNAs, termed double minutes and chromosome structures 
not amenable to normal banding procedures (homogeneously staining regions) 
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have also been observed in human tumour cell lines and direct preparations 
(Barker, 1982). Further examination has revealed these structures as sites of 
amplification of specific genes, such as MYCN in neuroblastoma (Schwab et al, 
1983). 
Intensive investigation of the molecular genetics of cancer has revealed several 
classes of oncogenes (cancer causing genes). Although originally discovered by 
retroviral transduction (Stehelin et al, 1976), these genes are not indigenous to 
viral genomes, but are present in the cells of mammals (and many other phyla) 
playing important roles in the control of cellular growth and proliferation. A first 
class, proto- or cellular oncogenes, typically gain in function when genetically 
damaged by point mutation, amplification or translocation (Bishop, 1991). This 
group appears to act in a dominant fashion, in that these genes may directly 
contribute to malignant transformation. A second class, that of tumour suppressor 
genes (TSG), were discovered following the proposal by Knudson of a "two hit" 
hypothesis as an explanation of the different actiological patterns of 
retinoblastoma, an inherited childhood cancer (Knudson, 1971). In the familial 
form of the disease, one defective copy of a gene was inherited and only a single 
somatic mutation of the other allele was required to engender malignancy. In the 
sporadic form, which has a later age of onset, two separate inactivating events are 
needed. After the discovery of occasional interstitial deletions at chromosome 
l3q14 in retinoblastoma cells, the RB I gene was found to be the target for this 
dual inactivation (Cavenee et al, 1983). TSG regulate cell proliferation by 
actuating temporary withdrawal from the cell cycle, differentiation or apoptosis 
(programmed cell death). Genetic lesions that inactivate these genes liberate the 
cell from the constraints they impose on growth. 
The non-random nature of chromosome changes in human malignancy has been 
further emphasised by the realisation that many of the oncogenes so far identified 
are situated at cancer specific chromosomal breakpoints. (Heim and Mitelman, 
1987b). Furthermore, of those aberrations found as the sole anomalies in at least 
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two neoplasms of the same morphology, only 83 bands, one fourth of the 
standard human karyotype, were involved (Mitelman, 1986). This intimate 
relationship, between cytogenetic and molecular levels of genetic change in 
cancer, provides an additional justification for the continuation of cytogenetic 
studies in neoplastic: disease. A fuller discussion of the significance of specific 
chromosome changes and associated oncogenes, will be found in section 1.3 
below. 
1.2) MALIGNANT LYMPHOMAS 
1.2.1) Introduction 
Lymphocytes are those immunologically competent cells which assist the 
phagocytes both in the defence of the body against infection and other foreign 
invasion and add specificity to the attack. In lymphoid malignancy, an 
uncontrolled proliferation of lymphocytes or their precursor cells arises. When 
this (usually) monoclonal population of abnormal cells infiltrates or replaces 
normal lymphoid tissue the resulting disease is usually diagnosed as a lymphoma. 
However, involvement of the bone marrow and consequently of the peripheral 
blood, may also occur. This latter condition is considered diagnostic of leukaemia 
and therefore uncertainty may arise as to the exact definition of the disease. 
Although a very heterogeneous group of cancers, the lymphomas may be broadly 
divided, firstly into Hodgkin's disease, which is characterised by the presence of 
Reed-Sternberg cells and secondly into non-Hodgkin's lymphomas (NHL). This 
latter category embraces a spectrum of disease, presenting with diverse 
histopathology and described by several systems of classification. The remainder 
of this section explores this complexity in greater detail. 
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1.2.2) Lymphocyte ontogeny 
A vital feature of cells of the immune system is their ability to recognise foreign 
antigens through their possession of antigen receptor genes. In the case of 
B-lymphocytes, derived from the bone marrow, which mediate humoral 
(circulatory) immunity, the immunoglobulins (1g) fulfil this function. The cellular 
component is provided by T-lymphocytes, derived from the thymus, which utilise 
T-cell receptors (TCR). Each of these cellular compartments consists of precursor 
cells and a variety of mature cell types which subserve different functions. The 
antigen receptor genes have evolved mechanisms whereby, through the 
differential assembly of variable and constant components, each cell possesses 
receptors containing unique variable regions (Wall and Kuel, 1983; Staudt and 
Ixnardo, 1991). Thus each receptor molecule has the ability to react specifically 
with one antigen amongst the huge number to which the cell may be exposed. It 
is noteworthy that the genes that code for the constant and variable regions of the 
receptors are separated in the genome and therefore, during their assembly, are 
particularly likely to become involved in chromosome translocations. This has 
implications for the activation of certain oncogenes implicated in the genesis of 
malignant lymphoma and is discussed further below. 
This process of rearrangement takes place in a series of discrete steps and thereby 
allows the developmental stage of a cell to be identified by antibodies to specific 
cell surface markers. Until antigenic activation, lymphoid cells are maintained in 
a resting state and rearrangements occurring up to this point are known as antigen 
independent. After encountering the specific antigen with which they react, 
lymphocytes undergo proliferation, during which further identifiable stages of 
differentiation, which are antigen dependant, commence. An outline of this 
development in B cells is shown below in table 1.1, indicating the relationship of 
different phenotypes to lymphoid malignancy. 
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1.2.3) Classification of non-Hodgkin's lymphomas 
NHLs range from highly proliferative, rapidly fatal diseases to indolent and well 
tolerated malignancies. Practically all follicular and most diffuse lymphomas are 
derived from B-lymphocytes, with less than 10% carrying membrane features of 
T cells. NHL apparently retain the characteristics of their normal counterpart cells 
and so attempts have been made to classify them on that basis. Changes in the 
cyto-architecture of the lymph node are also seen and have 
Table 1.1 Relationship of B-Cell Development to Lymphoid Malignancy 
Leukaenda or NHL subtype B-cell counterpart B-cell 
differentiation 
pathway 
CLL, Low grade lymphocytic Mature immuno- Primary, antigen 
NHL competent B-cell. independent 
CLL, Low grade lymphocytic Memory B-cell Secondary, antigen 
NHL independent 
Burkitt's lymphoma Pre B-cell Primary, antigen 
independent 
Low grade follicular NHL and Follicular centre Secondary, antigen 
High grade diffuse counterparts cells: centroblasts dependent 
and centrocysts 
High grade immunoblastic NHL Immunoblasts Secondary, antigen 
dependent 
High grade lymphoblastic NHL Lymphoblasts Secondary, antigen 
dependent 
High grade lymphoblastic NHL Pre B-cell Primary, antigen 
deDendent 
great importance in some systems. Among widely employed schemes is the 
Rappaport classification, which divides NHL by pattern (nodular vs diffuse) and 
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by cytologic cell type (Nathwani et al, 1976). Other major systems are the Lukes, 
and Collins (Lukes and Collins, 1974) and Kiel (Stansfeld et al, 1988) 
classifications, which attempt to predict immunologic phenotype and function 
from morphology. 
In 1980, an attempt was made to unify the six major classifications in use at the 
time and to provide a means of translation between systems. This Working 
Formulation (The Non-Hodgkin's Lymphoma Pathologic Classification Project, 
1982) has since become a classification scheme in its. own right, although this 
was not the original intention and may now be used to compare data compiled 
under the various classification systems. The updated Kiel classification 
(Stansfeld et al, 1988) was used to describe the cases discussed in this thesis. 
Very recently, proposals were made by an international group of pathologists to 
completely revise the classification of lymphoid neoplasms (Harris et al, 1994). It 
is too soon to predict how far this new classification will supplant existing 
systems. 
1.2.4) Incidence 
NHL account for approximately 3-5% of the deaths from all malignant neoplasms 
in the developed world, but a more variable percentage elsewhere (Magrath, 
1990). However, because of the many available classification systems for NHL 
there is great difficulty in comparing the frequency or incidence of different 
subtypes. This problem not withstanding, there appears to have been a dramatic 
and ongoing increase in the incidence of NHL, that cannot be attributed to 
changes in diagnostic criteria (Banks, 1992). One study from the USA estimated 
that there has been an increase in risk of 10.3% for females and 9.2 % for males 
every five years since 1965 (Holford et al, 1992). In Britain, the incidence rate of 
NHL has increased annually in recent years by approximately 4% (Cartwright, 
1992). At present no clear explanation is available for this phenomenon. 
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1.3) GENETICS OF NON-HODGKIN'S LYMPHOMA 
1.3.1) Introduction 
Genetic studies of NHL have produced a picture of complex and often 
contradictory changes. Data has been gathered from a large number of different 
centres (see below), which have employed a variety of classification systems 
when codifying their results. The situation is further exascerpated by the finding 
of chromosome abnormalities in reactive lymph nodes (Grace et al, 1989; Zhand 
et al, 1993). This has in turn made assessing the relationship of genetic changes to 
histological grade and the value of such changes as prognostic indicators a matter 
of some difficulty. Large numbers of samples must be studied, in order that the 
variation in local methods and reporting procedures has a minimal effect on the 
analysis of the data as a whole. Cytogenetic studies will be discussed first, 
followed by a consideration of specific molecular changes in NHL, which in this 
disease are often intimately related to chromosome abnormalities. 
1.3.2) Cytogenetics of non-Hodgkin's Jymphomas 
The majority of information on chromosome changes in NHL has been derived 
from the short term culture of lymph node biopsies, although some data has been 
obtained from fine needle aspirates (Kristoffersson, 1985). The fourth edition of 
the "Catalog of chromosome aberrations in cancer" (Mitelman, 1991) described 
some 1500 cytogenetically abnormal cases and the literature to date contains over 
2000 cases. The majority of these are of B-cell immnophenotype, by far the most 
common form of NHL in the UK, and most of the information considered 
in this 
section was gained from the study of B-cell disease. 
Although many different chromosome changes have been observed in NHL, only 
a limited number have been consistently found at an incidence of greater than 
2%. Even in these cases, the rate of occurrence has varied widely from study to 
study. Table 1.2 (adapted from Offit and Chaganti, 1991) compares the incidence 
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rates of the most commonly occurring abnormalities in a range of large series. 
These recurring abnormalities fall into three groups. Aneuploidy of whole 
chromosomes, structural abnormalities of a single chromosome, such as deletions 
and inversions and finally translocations. 
The significance of aneuploidy in malignancy is difficult to determine for several 
reasons. It seems unlikely that every gene on an extra chromosome is aberrantly 
active; it is also uncertain whether these are primary or secondary changes, 
playing either an active role in the genesis of NHL, by conferring a selective 
advantage on cells in which they occur, or resulting from a general genetic 
instability in the tumour. It may be that these abnormalities fulfil both these roles 
at different times in neoplastic development, since additional chromosomes 3,7 
and 12 have each been found as the sole aberration in small numbers of NHL 
(Mitelman et al, 1991b). 
Structural abnormalities of single chromosomes, particularly deletions, may point 
to the possible presence of tumour suppressor genes (Jonveaux and Berger, 
1990), whilst a chromosomal region consistently involved in rearrangements may 
be the site of an oncogene. Chromosome 6 in particular has been closely 
investigated in NHL (Barletta et a], 1987; Offit et al, 1993; Menasce et al, 1994) 
and data from these studies are considered below. 
The t(8; 14)(q24; q32) was the first recurring translocation to be associated with a 
lymphoproliferative disease (Manolov and Manolova, 1972). This translocation 
or one of its variant forms, the t(8; 22)(q24; ql D or t(2; 8)(pI2; q24), has been 
found in nearly 100% of Burkitt lymphomas (Heim and Mitelman, 1987a) and 
rearrangements such as these have provided fundamental insights 
into the role 
that chromosome translocations play in malignant transformation. B 
(and T) cell 
tumours have large numbers of well characterised chromosome abnormalities that 
involve the "rearranging" genes (immunoglobulins and T cell receptors) and there 
is general agreement that errors in normal V-D-J joining result in the formation of 
this type of aberrant arrangement (Rabbits and Boehm, 1991). 
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The recombinase enzyme involved in class switching recognises 8 or 9 base 
signal sequences and it has been established that in some cases these sequences 
are involved on the chromosome not carrying the rearranging gene. However, in 
other examples, alternative mechanisms appear to be involved (Wyatt et a], 1992; 
Seite et al, 1993). Whatever the mechanism, a model in which chromosomal 
rearrangement at one of the rearranging genes erroneously involves a second 
chromosome, carrying a proto-oncogene at the breakage junction and which Iatter 
is activated to become an oncogene, seems generally valid. Chromosome studies 
of NHL have revealed a variety of examples, which are shown in table 1.3 
Table 1.3 Translocations which activate oncogenes in B-cell NHL 
Translocation Oncogene Reference 
t(8; 14)(q24; q32) MYC 
t(14; 18)(q32; q2t) BCL-2 
t(11; 14)(ql3; q32) 
CCN-DI 
(BCL-1) 
t(10; 14)(q24; q32) LYT-10 
t(14; 19)(q32; q24) BCL-3 
t(3; 22)(q27; q 11) BCL-5 
DaHa-Favera et al, 1982 
Tsujimoto et al, 1985 
Motakura et al, 1991 
Ned et al, 1991 
McKeithan et al, 1987 
Miki et al, 1994a 
t(3; 14)(q27; q32) BCL-6 Ye et al. 1993 
Although most of these oncogenes are activated by being positioned adjacent to 
the immunoglobulin heavy chain locus (IgH) on chromosome 14q32, variant 
arrangements are also found, as described above for Burkitt lymphoma. The BCL- 
2 gene, for example, has also been detected in rearrangements with both the 
immunoglobulin kappa and lambda light chain loci, at 2p12 and 22qll 
respectively (Hillion et al, 1991; Leroux et al, 1990). It should also be noted that 
BCL-3 is only rarely found rearranged in NHL (vanKrieken, 1990). 
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1.3.3) Molecular biology of non-Hodgkin's Lymphoma 
Those genes activated in the translocation events described above, have been 
studied, to determine what part their protein products may play in malignant 
transformation. The myc protein has several functional domains, including a 
binding region for DNA and two protein dimerization motifs. It functions in the 
context of a transcriptional network involving at least three other proteins and 
must dimerize with the max protein to become transcriptionally active. When this 
occurs, target genes downstream are activated (Rabbits, 1994). It is currently 
thought that MYC mediates the transfer of cells from Go into either GI or 
programmed cell death (apoptosis) (Wyllie et al. 1987; Askew et al, 1991; Evan 
et al, 1992). 
BCL-2 had no sequence homology to any other known gene when first cloned 
(Tsujimoto, 1984a), but two related genes, BAX and BCL-X have since been 
identified (Oltvai et al, 1993; Boise et al, 1993). The gene product is mostly 
located on the inner mitochondrial membrane and acts to prevent the passage of 
cells into apoptosis, including that induced by MYC. It can thus act synergistically 
with MYC to prevent cell death and allow continuous cell cycling to take place 
(Vaux et al, 1988; Bissonnette et al, 1992). In NHL, high levels of the BCL-2 
protein are normally found only in neoplastic germinal centre cells (Hockenberry 
et al, 1990). 
Although the BCL-1 region was first cloned in 1984 (Tsujimoto et al, 1984b), 
there has been considerable debate about which particular gene or genes were 
activated, since none were found to be close to the translocation 
breakpoint. 
However, it now seems likely that PRAD-1, a gene identical to human cyclin 
D I, 
is the one activated by the rearrangement (Withers et al. 1991). 
Functionally, it 
appears to be involved in the G1 to S phase transition in the cell cycle 
(Motokura 
and Arnold, 1993). 
The LYT-10 gene, now named NFKB-2 (Chang et al, 1994), is a member of a 
family of transcription factors implicated in the transcriptional control of a wide 
range of genes, including those controlling B and T cell activation. The BCL-3 
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gene shares some sequence homology to NFKB-2 (Nolan et al, 1993) and 
probably also acts as a transcription factor. 
The final two genes in Table 1.3, BCL-5 and BCL-6, probably represent the 
independent discovery of the same entity. Cloned only recently, molecular 
analysis has revealed an identical structure, including an homology with zinc 
finger transcription factors. Expression of the gene has been found in 33% of 
diffuse large cell lymphomas (Ye et al, 1993) and in Burkitt Iymphoma cell lines 
(Miki et al, 1994b). 
Deletions and other alterations of chromosome 6q and chromosome 17p are 
common in NHL and have provoked interest in the possible involvement of 
oncogenes mapped to these locations. The MYB proto-oncogene has now been 
localised to 6q23 (See section 5.3.2.2) and the P53 tumour suppressor gene maps 
to l7p13 (McBride et al, 1986). However, there is limited evidence to support the 
involvement of these genes (Barletta et al, 1987; Rodriguez et al, 199 1). 
1.3.4) Histological associations with karyotype. 
In spite of considerable efforts from different centres, very few cytogenetic 
abnormalities have proved to be associated with a particular histologic sub-group 
of NHL. In one recent study, although 16 associations between karyotypic 
aberrations and a particular histologic subtype NHL were found, in none of the 
cases was the abnormality found in more than 30% of cases (Juneja et al, 1990). 
Even the t(14; 18), which has a universally close association with follicular 
lymphoma, is found in different frequencies from study to study (see Table 1.2). 
Furthermore, it has also been found in other sub-types at quite high rates; 18% in 
diffuse large cell lymphomas (Offit et al, 1991b) and in 54% of reactive lymph 
nodes by a sensitive molecular method (Limpens et al, 1991). 
Possibly the only translocation with an invariable association with only one 
disease type in NHL is the t(2; 5)(p23; q35), which occurs in most anaplastic large 
cell lymphomas arising from activated T lymphocytes (Ki-1 lymphoma) and is 
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not found elsewhere (Kaneko et al, 1989). Interestingly, a novel putative 
oncogene (ALK), has recently been identified at 2p23 in this rearrangement. 
(Morris et al, 1994) 
1.3.5) Clinical implications of genetic abnormalities in NHL 
A major aim in studying the genetics of malignancy has always been the hope of 
identifying changes that have prognostic significance for the course of the 
disease. In NHL for example, the ability to predict which patients with low grade 
disease were likely to transform to high grade, would have important implications 
for treatment. Table 1.4 summarises those correlations which have been found 
between chromosome abnormalities and prognosis in those centres at which 
adequate follow up data was available. In five out of the eight studies 
documented, abnormalities of chromosome 17 carried a poor prognosis. Four 
studies found changes in lp carried a worse prognosis. 
Three studies have analysed serial changes in the observed karyotypes with time 
(Sanger et al, 1987; Levine et al, 1990; Whang-Peng et al, 1995). In one case, the 
acquisition of trisomy 7 accompanied transformation of histologic grade. When 
taken together with the observation that trisomy 7 is found significantly more 
frequently in t(14; 18)-bearing intermediate and high grade NHL when compared 
to low grade NHL (Yunis et al, 1987), the possibility that acquisition of trisomy 7 
is associated with transformation to a higher grade must be considered. 
1.4) MOLECULAR CYTOGENETICS 
1.4.1) Introduction 
Even when high resolution banding techniques visualising up to 1000 bands per 
human genome are employed, there is a huge disparity in resolution between 
cytogenetic and molecular methodology. Although the study of chromosomes can 
provide information on numerical abnormalities, structural aberrations are only 
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detectable down to a limit of approximately 5 megabases of DNA. The 
advantages of being able to investigate both genetic changes in the whole cell 
simultaneously and gathering data on the degree of heterogeneity in the 
population of cells under investigation maybe be out-weighed by the necessity of 
obtaining good quality mitotic figures, which can often be difficult in the study of 
neoplastic cells. 
Molecular techniques such as Southern blotting (Southern, 1975) and polymerase 
chain reaction amplification (PCR) (Saiki et al, 1988) provide sensitive and 
specific methods for the investigation of defined structural and numerical genetic 
changes. However, it is not possible either to differentiate between the normal 
and malignant cells in a population or to derive specific relationships between 
phenotype and genotype. 
In-situ hybridisation techniques, since they involve the annealing of nucleic: acid 
probes to target sequences in which the morphology is preserved, provide a 
bridge between cytogenetic and molecular genetic methods. It is possible to apply 
this approach both to interphase nuclei and metaphase chromosomes, giving rise 
to the general description of molecular cytogenetics. A review of in situ 
technology and development is given in the following sections, accompanied by a 
consideration of ways in which the technique may be applied. 
1.4.2) The origins of in-situ hybridisation 
If the two strands of the DNA double helix are broken apart by treatment with 
heat or alkali, it is possible, under appropriate conditions, to anneal another 
complementary single DNA strand to a homologous sequence. Although this 
technique was developed by studying nucleic acids in solution, 
it has proved 
possible to hybridise DNA in solution (the probe) to DNA fixed on a supportive 
matrix (the target). When the hybridisation is performed in-situ, the target 
remains mostly within the tissue of origin. This is in contrast to a technique such 
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as Southern blotting, in which DNA is extracted from the tissue before 
hybridisation. 
The early workers in this field labelled probes isotopically and detected the 
results with autoradiography (Pardue and Gall, 1969; John et al, 1969; 
Buongiorno-Nardelli and Amaldi, 1969). Although sensitive, this system has 
several disadvantages. Experiments are time consuming, mainly due to the long 
autoradiographic exposures required. Resolution is poor, since isotopic particles 
may travel in any direction through the photographic emulsion coating the slides 
before encountering a silver grain and the level of background is generally high, 
necessitating a lengthy statistical analysis of the results. 
Since the early 1980's, novel methods of probe labelling, detection and imaging 
have been developed and a huge expansion in the use of non-radioactive in situ 
hybridisation has followed. 
1.4.3) Probes and vectors 
1.4.3.1) Single copy probes 
Unique sequences are available as probes cloned into a variety of different 
vectors. Plasmids carry inserts of up to about 10 kb. Bacteriophage vectors take 
up to 24 kb and cosmids 35-45 kb although in the case of the former, vector 
sequences may make up the greatest part of the construct. Yeast artificial 
chromosomes (YACs) may contain between 200 - 1000 kb of cloned human 
DNA 
Although all these vectors may be used to carry probes for in-situ hybridisation, 
those with larger inserts are more likely to contain interspersed repetitive 
sequences (IRS) which are found throughout the human genome (Korenberg and 
Rykowski, 1988). During in-situ hybridisation these are likely to anneal non- 
specifically, obscuring the signal at the target sequence. The introduction of 
chromosome in-situ suppression hybridisation (CISSH) has allowed the 
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localisation of unique sequences contained within phage, cosmid and YAC 
vectors as well as in whole chromosome libraries (Landgent et al, 1987; Pinkel et 
al, 1988; Lichter et al, 1988). The technique involves the annealing of the labelled 
probe to unlabelled competitor DNA before hybridisation. The competitor is 
either total human DNA, sheared or sonicated to 50 - 500 bp in length, or human 
Cot 1 DNA. The latter is obtained by denaturing and then reannealing total 
human DNA under conditions which enrich highly repetitive sequences. Pre- 
annealing with either competitor results in the blocking of IRS within the probe 
and also, since excess unlabelled competitor is added to the reaction, within the 
target material. 
1.4.3.2) Chromosome-specific repetitive probes 
Chromosome-specific repetitive probes are now available for each human 
chromosome. DNA at or near the centromere of human chromosomes consists of 
one or more families of satellite DNA, of which of the alpha satellite DNA is the 
most common (Willard and Waye, 1987). These sequences consist of tandem 
arrays of repeated DNA motifs and therefore a probe for a particular consensus 
sequence will detect a multiplicity of hybridisation sites. When hybridised at the 
appropriate stringency, these centromere-specific probes produce discrete 
hybridisation signals either on chromosome homologues in metaphase 
preparations, or in interphase nuclei. They may therefore be used both as an aid to 
the identification of a specific chromosome and also io establish chromosome 
ploidy. 
1.4.3.3) Chromosome painting probes 
Complex mixtures of probes specific to a single chromosome type can be used to 
delineate that chromosome in metaphase and interphase. This has given rise to the 
term "chromosome painting". Collections of such probes have been derived from 
both somatic cell hybrids containing a single human chromosome and from flow 
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sorted whole chromosome specific libraries (Lichter et al, 1988; Cremer et al, 
1988; Pinkel et, al, 1988; Kievits et al, 1990). 
1.4.4 Probe labelling and detection 
Probes may be detected either by direct labelling with a reporter molecule or 
indirectly, by labelling with a low molecular weight compound (a hapten), which 
is then detected using a variety of reporter molecules. 
Although the earliest direct chemical coupling of fluorochromes to nucleic acids 
was achieved some 15 years ago (Bauman et al, 1980), this approach has not been 
easily employed until more recently, when fluorochrome-conjugated nucleotides 
became commercially available. Probes may now be labelled directly with 
fluorochromes and although this does not give such sensitivity as indirect 
methods, there are gains in speed, lower background and the potential of 
accurately quantifying the signal. Recent studies have reported the localisation of 
directly labelled probes of 50-100 kb (Wiegant et al, 1991; 1993). 
For indirect techniques, the most commonly used haptens are biotin (Langer et al, 
1980) and digoxigenin (Heiles et al, 1988). The latter has the advantage of being 
derived from plant material (Digitalis sp) and is therefore not indigenous to 
animal tissues. Both these haptens are available covalently linked to dNTPs via a 
flexible linker arm and may be incorporated into the probe by established 
enzymatic labelling methods such as nick translation, oligonucleotide primed 
synthesis or PCR. Nick translation is particularly appropriate for in-situ 
hybridisation, since the size of the labelled fragment may be controlled by the 
amount of DNasel used in the reaction. Probe size has been found to be a critical 
factor in successful in-situ hybridisation, with an average of 300 bp being optimal 
(Lawrence and Singer, 1985). Other haptens have been incorporated into probe 
DNA by chemical modification. Examples are acetylaminofluorene (Landgent et 
al, 1984), sulphone (Viscidi et al, 1986) and mercury (Hopman et al, 1986). 
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However, since the advent of fluorochrome-conjugated nucleotides these 
techniques are rarely used. 
A variety of reagents have been employed for the detection of haptenised probes. 
For biotin, either avidin or streptavidin (both of which possess a high affinity for 
biotin) have been used, conjugated either to enzymes such as peroxidase or 
alkaline phosphatase (Garson et al, 1987; Habeebu et al, 1990), or to 
fluorochromes (Pinkel et al, 1986). The enzyme conjugates are visualised by 
chemical reactions which generate a coloured precipitate; a brown 
diaminobenzidine product with peroxidase and a blue indole-formazan product 
with alkaline phosphatase. Both products are detected with conventional light 
microscopy. Fluorescent detection of biotin labelled probes is by the use of 
sequential layers of avidin-fluorochrome, biotinylated anti-avidin antibodies and 
avidin-fluorochrome (Pinkel et al, 1986). Digoxigenin is detected by specific 
antisera followed by a layer of fluorescently conjugated anti-immunoglobulins 
against the primary antibody (Lichter et al, 1990) The most widely employed 
fluorochromes are fluorescein isothiocyanate (FITC) emitting in the green, 
tetramethy1rhodamine isothiocyanate (TRITC) and texas red (TR) both emitting 
in the red and aminomethylcournarin acetic acid (AMCA) which emits in the 
blue. Newly available fluorophores include Cy 5 which, although emitting in the 
infra red, is visible to a CCD camera equipped with the appropriate filters (see 
below). As fluorescent detection systems have become more widely employed, 
the acronym FISH (fluorescence in-situ hybridisation) has become synonymous 
with the use of the technique. 
1.4.5) FISH imaging 
For many uses of FISH, an epifluorescence microscope equipped with 
appropriate filter sets is adequate. Modern instruments may be equipped with 
double and triple filter blocks, which enable more than one fluorochrome to be 
viewed simultaneously. Where only single filters are available, it is necessary to 
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make multiple exposures, employing each filter in turn, thus overlaying the 
different images onto the same section of film. This may introduce registration 
problems as a consequence of altering the optical pathway, since the dichroic 
mirror in each filter block will not be at exactly the same angle to the camera light 
beam. Errors in localising the signal may thus be produced. 
More recently, confocal laser scanning microscopes and charge coupled device 
(CCD) cameras have been used for detecting FISH signals. 
The principal of confocal microscopy is the point illumination of the specimen by 
a focused laser beam, combined with point detection using an aperture the size of 
the illuminated spot. By then scanning across the specimen in a controlled 
pattern, a high resolution image of a thin layer (an optical section) can be 
recorded (Brakenhoff et al, 1985). Originally designed to facilitate the acquisition 
of a three dimensional image of a specimen, confocal. microscopy has been used 
to successfully map single copy probes to chromosome bands (Albertson et al, 
1991). The confocal microscope is about as sensitive as a conventional 
epifluorescence microscope, but the ability to detect signal present at different 
levels within a specimen may provide an enhanced capacity to detect low level 
fluorescence. Accurate registration of different fluorescent images from the same 
specimen is achieved by the simultaneous detection of signal from two separate 
filter channels. The two images are exactly merged by computer software and 
stored in memory until required for further analysis, providing a considerable 
advantage over conventional photography. 
The cooled CCD camera is many times more sensitive than the two instruments 
described above. Originally devised for astronomical use, it is extremely sensitive 
to photons over a wide range of wavelengths (400-1000 nm), using an array of 
light sensitive CCDs to collect the fluorescent image (Hiraoka et al, 1989). 
Photons striking the array are proportionately transduced to electrons for as long 
as the shutter remains open and the resulting image information stored by 
computer in digital form. An image for each fluorophore is collected separately 
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via the appropriate filter and a complete pseudocolour picture is produced by 
software. Registration problems may be avoided by mounting the exitation filters 
on a wheel between the lamp and the microscope, eliminating the need to move 
filters through the light path of the camera. 
1.5) THE APPLICATION OF FISH TO THE STUDY OF MALIGNANCY 
1.5.1) Introduction 
FISH technology is now widely employed to investigate many aspects of tumour 
genetics. In the context of cytogenetic studies perhaps the most important are: - 
the characterisation of derived (der) chromosomes, in which only part of the 
material is identifiable; the mapping and ordering of cloned DNA sequences; the 
detection of numerical and structural chromosome abnormalities; and the analysis 
of non-dividing cells, now termed interphase cytogenetics (Cremer et al, 1986). 
In many turnours, including NHL, this latter technique is proving very valuable, 
since it is often difficult to obtain metaphase preparations. Numerical and 
structural abnormalities are detectable and it is now possible to correlate 
cytogenetic abnormalities with cell phenotype in some cases (Price et al, 1992). 
The application of these technologies is discussed below. 
1.5.2) FISH Mapping Techniques 
1.5.2.1) Metaphase mapping 
Previously, hybridised probes were localised by comparing their position either 
with G- or R-bands generated before or after the hybridisation experiment, 
(Cannizzaro and Emanuel, 1984) or with a standard karyograrn (Lichter et al, 
1990). DNA sequences can now be mapped directly onto metaphase 
chromosomes using simultaneous fluorescent banding techniques. Several 
methods for producing fluorescent banding are available, most of which involve 
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the incorporation of 5-bromodeoxyuridine (BrdU) into lymphocyte cultures 
before subsequent treatment with other chemicals (Albertson et al, 1991; Fan et 
al, 1990). Human DNA amplified with primers for the ALU or LINES repetitive 
sequences, labelled and used as a probe, results in R- or G-banding respectively 
(Baldini and Ward, 1991). More recently, the use of image processing software 
has allowed the production of G-bands from simple DAPI staining (Carter, 1994). 
The resolution of metaphase mapping appears to be limited to sequences 
separated by more than I Mb (Trask et al, 1991; Lawrence et al, 1990; 1992). 
1.5.2.2) Interphase mapping 
The use of chromosomes in interphase has increased the sensitivity of mapping 
and ordering probes. Hybridisation to Go interphase nuclei from fibroblast cell 
lines has increased the resolution to 50-1000 kb. Sequences from the large and 
well characterised dystrophin gene have been used to demonstrate that there is a 
strong correlation between the interphase distance of pairs of hybridised probes 
and the linear distance within the 100-1000 kb range (Lawrence et al, 1990). 
Other recent work, using 13 probes from a 4-megabase pair region of the 
Huntington disease locus, supports these findings (van den Engh et al, 1992). 
Other methods have been used to obtain finer resolution for interphase mapping. 
In one technique, drugs or alkaline treatment are utilised to release strands of 
chromatin from nuclei (Heng et al, 1992). A resolution of 21 kb was obtained 
using five cosmids from the cystic fibrosis transmembrane regulator gene and 
gave a good correlation with the physical map. Another approach employs 
detergent and high salt extraction to create nuclear halos. Hybridisation signals 
appeared as "beads on a string" and it was possible to detect overlaps 
between 
cosmid clones within the range 10-200 kb (Wiegant et al, 1992). 
The two most 
recent techniques are less complex to carry out. In one method, 
detergent was 
used to produce long strands of linear DNA down a tilted microscope slide (Parra 
and Windle, 1993). In the other method, either alkali or formamide were applied 
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to previously fixed material and the DNA was linearized by pulling a coverslip 
along the slide (Fidlerova et al, 1994). In both cases a good correlation with the 
expected physical distances was obtained. 
1.5.3) Identification of Derived Chromosomes 
1.5.3.1) Chromosome painting 
FISH with whole chromosome paint probes allows the accurate identification of 
structural chromosome abnormalities in metaphase cells. Several methods of 
constructing such libraries are now available. Those originally used for painting 
were flow sorted from hybrid cell lines containing small numbers of human 
chromosomes. Each paint consisted of many sub-clones representing a specific 
sorted chromosome (Fuscoe et al, 1989; Collins, 1991). Chromosome paints 
derived in this way are now commercially available for each human chromosome 
and have made the use of the technique widely available. Many groups of 
workers have combined G-banding and chromosome painting to characterise 
derived chromosomes in a variety of tumour material. Some recent applications 
have been in prostatic cancer (Brothman and Patel, 1992), NHL (Bajalica et al, 
1993) and ovarian carcinoma (Xu and Wang, 1994). 
1.5.3.2) Ratio-labelling and reverse chromosome painting 
The application of chromosome paints can be laborious and time consuming 
because of the numerous combinations of probes required. However, recent 
developments in ratio-labelling, in which probes are labelled with varying ratios 
of different haptens and detected using combinations of fluorescent affinity 
reagents, may make this less tedious in future. One group used this approach to 
simultaneously paint half the human chromosome complement in twelve different 
colours (Dauwerse et al, 1992). 
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An alternative strategy has been to flow sort the abnormal chromosome, which is 
then amplified by PCR and hybridised to normal metaphase spreads. Degenerate 
oligonucleotide primed (DOP) PCR (Telenius et al, 1992a) is used for the 
amplification step. This method randomly amplifies -any DNA and therefore 
requires relatively few chromosomes (200-500) to produce a whole chromosome 
paint which is representative of the abnormal chromosome. When this is labelled 
and painted back onto normal human chromosomes, the cytogenetic origins of the 
abnormal chromosome will be revealed. This method is thus "reverse" 
chromosome painting (Carter et al, 1992). The technique requires both the 
availability of a cell line containing the abnormal chromosome and skilled flow 
sorting. Reverse painting has been used to characterise translocations involving 
the locus for multiple endocrine neoplasia type 2A (Telenius et al, 1992b) and for 
the analysis of constitutional karyotypes (Carteret al, 1992; Rack et al, 1993). 
1.5.3.3) Micro-FISH 
Although multicolour FISH analysis has made significant advances, simultaneous 
detection of 24 colours, required to delineate the whole human karyotype is still 
not possible. Additionally, painting probes give no information with regard to 
which specific region of a particular chromosome is involved. A recent 
development makes it possible to obtain region-specific probes for any part of the 
human genome. 
The technique combines microdissection of human chromosomes with direct 
enzymatic amplification of the micro-dissected DNA fragments (Meltzer et al, 
1992). Although other groups have used micro- dissection to generate 
chromosome specific libraries (Lengauer et al, 1991; Trautman et al, 1991), they 
directly cloned the fragments using a difficult microcloping method (Ludecke et 
al, 1989). The micro-FISH procedure of Meltzer and colleagues is simpler and 
faster. 25-30 micro-dissected fragments are cut from the region of interest and 
DOP-PCR amplification is carried out. After purification, the PCR products are 
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labelled with biotin and hybridised to normal human metaphases, revealing the 
chromosome location(s) of the region of interest. The technique has been used to 
identify a translocation and deletion chromosome in a melanoma cell line 
(Meltzer et al, 1992) and more recently to demonstrate that terminal deletions of 
6q are telomeric translocations (Meltzer et al, 1993) and to detect variant 
Philadelphia translocations, in chronic myeloid leukaemia (Zhang et al, 1993). 
1.5.4) Interphase cytogenetics 
1.5.4.1) Detection of structural abnormalities in interphase cells 
Although the detection of structural abnormalities in interphase nuclei is possible 
by chromosome painting, problems of interpretation are possible due to the 
overlap of extended chromosome domains (Pinkel et al, 1988). Detection of 
specific chromosome translocations in interphase cells is more accurately 
achieved by the use of locus specific probes, but this is only possible in cases 
where the translocation has been characterised at a molecular level. 
Dual colour FISH, using probes which flank specific translocation breakpoints, 
has been successfully employed in the interphase cells of haematological 
malignancies to detect the Philadelphia translocation in chronic myeloid 
leukaemia (CML) (Arnoldus et al, 1990; Tkachuk et al, 1990) and to investigate 
rearrangements of the CCNDI, BCL-2 and BCL-3 genes in CLL (Amiel et al, 
1994). Translocations were detected by the presence of a coalesced "orange" (red 
+ green) signal. 
In the solid tumour field, several groups have examined the breakpoint of the 
t(11; 22)(q24; qll. 2) associated with Ewing's sarcoma (Giovanni et al, 1992; 
Taylor et al, 1992). Giovanni and colleagues employed single colour FISH with 
cosmids from either side of the 11 q24 breakpoint. When the translocation was 
present, the hybridisation pattern showed two signals widely separated and two 
signals very close together. Taylor and co-workers used two colour FISH with 
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cosmids that flanked the 22q 11 breakpoint. Although dual colour is theoretically 
more accurate, since it ensures that the distance between two different probes is 
measured, both groups found approximately 50% of nuclei to be evaluable, with 
no false positives. 
1.5.4.2) Detection of numerical chromosome abnormalities 
Labelled chromosome -specific centromere probes are now available for all 
human chromosomes. Since individual chromosomes occupy discrete and 
relatively compact domains within interphase nuclei (Haaf and Schmid, 1991), 
these alphoid satellite sequences generate strong and discrete hybridisation 
signals within interphase nuclei. Such probes have now been used successfully to 
enumerate chromosome copy number in a range of solid turnours and 
haematological malignancies. Ilose solid tumours investigated include breast 
tumours (Devilee et al, 1988), ovarian carcinoma (Nederloff et al, 1989) and 
brain tumours (Amoldus et al, 1991). Amongst the haernatological malignancies 
that have been studied, chronic lymphocytic leukaemia (CLL) was investigated 
for the presence of trisomy 12 (Anastasi et al, 1992). Tlie abnormality was 
detected in 30% of cases, including those which were unsuccessful or had shown 
a normal karyotype by conventional cytogenetics. 
1.5.4.3) Correlation of chromosome abnormalities with cell type 
It has recently proved possible to identify the specific cell type in which 
particular chromosome abnormalities are occurring. One approach has used 
previously stained and morphologically classified peripheral blood or bone 
marrow cells. After photography, the cells were subjected to FISH, relocated and 
re-photographed (Anastasi et al, 199 1). 
In many cases, however, immunophenotyping is necessary to classify the cells of 
interest. A new method for the simultaneous detection of immunophenotype and 
karyotypic: abnormalities employed the finding that the alkaline phosphatase anti 
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alkaline phosphatase (APAP) technique is resistant to the harsh pretreatment 
required for FISH. When Fast Red was used as a chromogen in the APAP 
procedure, both immunophenotype and chromosome copy number were 
detectable in the same cell (Price et al, 1992). Using this method to study 
polycythaemia vera, Price and colleagues established that myeloid and erythroid 
cells were trisomy 8 positive but not B- and T-lymphocytes. More recently, this 
approach has been applied to studies of acute myeloid leukaemia (AML) 
(Baurmann et al, 1993) and CLL (Garcia-Marco et al, 1994). 
1.5.5) Comparative Genomic Hybridisation (CGH) 
A completely novel approach to the global identification of chromosome copy 
number has recently been described, which requires no previous knowledge of the 
tumour karyotype. The CGH technique (Kallioniemi et al, 1992; du Manoir et a], 
1993) is carried out with DNA extracted from tumour cells and normal reference 
DNA. Tumour DNA is labelled with biotin and normal DNA with digoxigenin; 
after mixing with unlabelled Cot I DNA, hybridisation is carried out to normal 
human metaphase cells. Biotinylated probe is detected with avidin-FITC (green) 
and digoxigeninylated probe with anti-digoxigenin-rhodamine (red). Gene 
amplification in the tumour generates a relative increase in the green to red ratio 
at the appropriate locus on the target metaphase. Similarly, a deletion in the 
tumour will be indicated by an increase in the red to green ratio, since each DNA 
has an equal chance of hybridising to each locus of the target chromosomes. The 
signals are quantitated by a digital image analysis system, which generates a 
fluorescence ratio profile for each target chromosome examined. 
At present, the system will detect a change in copy number of DNA from 10-20 
Mb in length, about the size of a chromosome band (Kallioniemi et al, 1994). 
Contamination of the tumour DNA by normal tissue is a potential problem, 
because if this exceeds 50% the results cannot be considered reliable (Kallioniemi 
et al, 1994). It is also noteworthy that balanced translocations; are not detectable 
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by this method, since this does not lead to a relative difference in DNA content 
between the tumour and the normal reference. 
Several solid tumours have now been evaluated by CGH. These include 
liposarcoma (Suijkerbuijk et al, 1994), small cell lung cancer (Reid et al, 1994), 
malignant glioma (Schr6ck et al, 1994), prostate cancer (Cher et al, 1994) and 
uveal melanoma (Speicher et al, 1994). Extrachromosomal gene amplification in 
AML has also been characterised by CGH (Mohamed et al, 1993). This technique 
also has potential for the analysis of archival material, since it has proved 
possible to use material from paraffin embedded solid turnours for CGH 
experiments, in which DNA was extracted from tissue sections and amplified 
using DOP-PCR (Speicher et al, 1993). 
1.6) AIMS OF THE STUDY 
The primary task of the project was to analyse the malignant cell chromosomes in 
a series of NHL lymph node biopsy samples from the United Kingdom. Initially, 
this was carried out by conventional G-banding. By collating data on numerical 
and structural chromosome changes, it was hoped to establish a relationship 
between these changes and the genetic aetiology of NHL. 
It was envisaged, however, that conventional cytogenetic analysis would not be 
adequate for the complete characterisation of all chromosome changes detected 
in 
the series. The FISH technique was therefore adopted for the further analysis of 
cytogenetic aberrations, which involved the optimisation of the technique 
for 
application to NHL material. 
Numerical aberrations were studied by interpha§e cytogenetics, using 
chromosome specific centromere probes. Structural abnormalities were 
investigated by the application of both unique sequence and chromosome 
painting probes. Dual colour hybridisation was carried out whenever possible, 
in 
order to increase the information obtained from individual NHL cells 
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CHAPTER TWO 
MATERIALS AND METHODS 
50 
HEALTH AND SAFTEY 
All biological specimens were processed in saftey cabinets. Laboratory coats and 
gloves were worn both when handling biological specimens and during all 
molecular biology procedures. 
All practical work followed the health and saftey requirements for the laboratory 
recommended by COSHH (Control of Substarices Hazardous to Health). 
Before conducting any procedure involving recombinant DNA, a genetic 
manipulation medical was attended 
2.1) MATERIALS 
2.1.1 Clinical samples 
2.1.1.1) Lymph node biopsies 
Samples from lymph node biopsies were made available from both Weston Park 
Hospital (WPH) and the Royal Hallamshire Hospital (RHH). After a pathologist 
had made an initial assessment of the biopsy, a piece of tissue was placed in 
culture medium and kept at 4*C until taken to the Centre for Human Genetics for 
processing, which took place within two hours of surgery. 
Details of diagnosis were obtained after the samples were processed. A 
pathologist at either WPH or RHH examined stained paraffin sections of the 
biopsy microscopically, in order to determine the lymph node architecture and the 
nature of the cells involved. In some 10-15% of cases, immunohistochemistry 
was also applied, particularly to distinguish between B and T-cell lymphomas. 
Those samples classified as NHL were analysed cytogenetically and the patient 
details obtained for each case. This information is summarised in Table 2.1. 
2.1.1.2) Peripheral blood 
Samples of peripheral blood from volunteers were collected into lithium-heparin 
tubes and processed as described below. 
2.1.2) Tissue culture 
Solutions were stored at 4*C unless otherwise stated. 
2.1.2.1) Culture media 
Both TC199 and HAM-FIO media were from GIBCO Life Technologies Ltd. 
Supplements were added to the media and these are listed below. 
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Human serum (Blood Transfusion Service; see section 2.1.2.3) 
Penicillin (Glaxo) 
Streptomycin (Glaxo) 
L-Glutamine (Sigma) 
25mM Hepes, buffer (Gibco) 
2.1.2.2) Phytohaemaggludnin(PHA) 
PHA from Gibco was prepared by adding 10ml sterile distilled water to the 
Iyophilised M form of the chemicaL 
2.1.2.3) Human serum 
Pooled human serum was obtained from Sheffield blood donation centre and 
sterilised with a 0.2g filter. 20ml aliquots were stored at -20 
. C. 
2.1.2.4) Thymidine 
Tbymidine was prepared by dissolving 300mg in loml sterile distilled water with 
occasional stirring and was then filter sterilised. 
2.1.2.5) Phosphate buffered saline(PBS) 
One PBS tablet (Oxoid Ltd) was dissolved in 100ml distilled water, aliquoted and 
sterilised by autoclaving. 
2.1.2.6) Deoxycytidine 
A solution of 22.7mg/ml in sterile PBS was stored in I ml aliquots at -20 
C. 
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2.1.3) Cytogenetics 
Stock solutions were stored at 4*C unless otherwise stated. 
2.1.3.1) Colcemid 
A stock solution of colcemid (Gibco) was prepared by reconstituting 100pg of 
sterile Iyophilised Powder with 10ml sterile distilled water. 
2.1.3.2) Hypotonic solutions 
Stock hypotonic solutions were prepared by adding 5.59g or 3.19g KCI each to 11 
distilled water to give 0.075M and 0.0375M solutions respectively. The former 
was used in lymph node culture and the latter in blood cell culture. 
2.1.3.3) Fixative 
Methanol and glacial acetic acid were freshly mixed 3: 1 when required. 
2.1.3.4) Slides 
One side double frosted slides (Horwell Ltd) were soaked overnight in Decon at 
4*C and then washed under hot and cold tap water. Once clean, slides were kept at 
4'C in distilled water until required, which was usually the same day. 
2.1.3.5) Blotting paper 
Fibre free Postlip papers (HoRingsworth and Vose) were used. 
2.1.3.6) Gurrs buffer 
One Gurrs buffer tablet pH6.8 (BDH) was dissolved in 100ml sterile deionised 
water with constant stirring and stored at room temperature. 
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2.1.3.7) Sorensens buffer 
9.47g disodium hydrogen phosphate and 9.08g potassium dihydrogen phosphate 
were dissolved in 11 deionised distilled water, and stored at room temperature. 
2.1.3.8) Leishmans stain 
Stock solutions were prepared by adding 2.4g Leishmans powder (BDH) to 1.61 
methanol. The mixture was stirred constantly on a hot plate until boiling, then 
removed from the heat and stirred for a further two hours at room temperature. 
The solution was then filtered through Whatman N2 I filter paper into a glass 
beaker and stored at room temperature until use. For staining, the stock solution 
was diluted 1: 4 with Gurrs Buffer. 
2.1.3.9) Trypsin solution 
Trypsin for G-banding was prepared by dissolving 0.6g Trypsin 1: 250 powder 
(Difco) in 500ml Sorensens buffer with constant stirring. The stock solution was 
dispensed into 10ml aliquots and stored at -20*C. 
2.1.3.10) Lipsol solution 
Lipsol liquid concentrate (Lip Ltd) was diluted to 1% with Normal Saline (4.38g 
NaCI in 500ml distilled water) when required. 
2.1.3.11) Borate buffer 
3.55g 50mM Na2SO4 and 0.48g Na2B407 were dissolved in distilled, deionised 
water and the pH adjusted to 9.2. The stock was stored at room temperature. 
2.1.3.12) Wrights giemsa stain 
Wrights Stain was obtained ready prepared from Sigma and stored at room 
temperature in the dark. Immediately before use, the stock solution was diluted 
1: 2 in Borate Buffer. 
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2.1.3.13) Immersion lens oil 
Lenzol immersion oil was obtained from BDH 
2.1.4) Molecular biology 
2.1.4.1) Strains of Escherichia Coli 
E. coli JMI09 (Yanisch-Perron et al. 1985) was used for plasmid work. E. coli 
LF. 392 (Murray et al, 1977) was used with Lambda phage. Glycerol stocks of the 
strains (Promega) were stored at -20 C. 
2.1.4.2) DNA clones 
Details of the DNA clones used are given in Table 2.2 below. All inserts were of 
genomic DNA. 
2.1-4.3) Gene libraries 
In addition to those libraries detailed in Table 2.2, commercially available 
chromosome paints were obtained (Cambio, Cambridge) for chromosomes X, 3, 
6,8,10 and 11. These consisted of PCR products with biotin label already 
incorporated. A pan-centromere probe also labelled with- biotin was obtained from 
Alpha Lab. 
2.1.4.4 Antibiotics 
Ampicillin stock (50mg1ml) was made up in deionised water and filter sterilised. 
Tetracyclin stock (5mg/ml) was made up in ethanol. Both antibiotics were 
obtained from Glaxo. Stocks were stored in light-proof containers at -20'C. 
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2.1.4.5) Luria-Bertani (LB) medium 
For one litre, lOg Bacto-Tryptone (Difco), 5g Bacto Yeast extract (Difco) and 5g 
NaCI were added to 950ml deionised water. 7be pH was then adjusted to 7.0 and 
the solution was made up to IL with deionised water before finally being 
autoclaved. If solid media was required, 15g Agar (Difco) was added before 
autoclaving. 
2.1.4.6) Calcium Chloride solution (For preparation of competent cells) 
4.41g CaC12,1.51g PIPES and 75ml glycerol were made up to 500ml with 
deionised H20 and the pH was adjusted to 7.0. The solution was filter sterilised 
and then stored at room temperature. 
2.1.4.7) Glycerol solution (For preparation of E. Coli stocks) 
0.2g MgS04 and 0.3g Tris were dissolved in 100ml 65ml Glycerol/35ml 
deionised H20. The solution was filter sterilised and stored at room temperature. 
2.1.4.8) STET buffer 
5.8g NaCl, 1.21g Tris and 0.34g EDTA were added to 995ml distilled H20 and 
the solution was autoclaved. 5ml Triton X-100 was added after the other 
constituents had cooled from autoclaving. 
2.1.4.9) 1M Tris stock 
121. lg Tris base was dissolved in 800ml H20, adjusted to pH 8.0 with 
concentrated HCI and the volume made up to I litre with H20. 
The solution was 
autoclaved and stored at room temperature. 
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2.1.4.10) 0.5M EDTA stock 
186.1 g disodiurn ethylenediaminetetraacetate. 2H20 (EDTA) was added to 800ml 
H20. While stirring on a magnetic stirrcr the pH was adjusted to 8.0 with NaOH. 
When all the EDTA was dissolved, the solution was autoclaved and stored at 
room temperature. 
2.1.4.11) TE buffer 
10ml of IM Tris stock and 2ml 0.5M EDTA stock were added to 988ml dH20 
2.1.4.12) Lysozyme 
A stock solution was prepared at a concentration of 50 mg/ml in sterile deionised 
H20, dispensed into aliquots and stored at -20*C. Aliquots were discarded after 
use. 
2.1.4.13) DNAase free RNAase 
Pancreatic RNAase (RNAase A) was dissolved to a concentration of 10mg/ml in 
I OmM Tris (pH 7.5), 15mM NaCl, heated at I 00*C for 15 minutes and allowed to 
cool slowly to room temperature. IOOW aliquots were stored at -20 C. 
2.1.4.14) Materials for Maxi preparations of plasmid DNA 
For large scale preparation of plasmid DNA, a Qiagen-tip 500 column was used 
with the buffers supplied in the Qiagen kit. The composition of these 
buffers is 
shown below. 
Buffer PI :- loogg/ml RNAase A, 5OmM Tris-Cl. JOmM EDTA pH 8.0, stored at 
40C. 
Buffer P2: - 200mM NaOH, I %SDS. 
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Buffer P3 :-2.55M potassium acetate pH 4.8 
Buffer QBT: - 750mM NaCl, 50mM MOPS, 15% ethanol pH 7.0,0.15% Triton 
X-100. 
Buffer QC: - LOM NaCl, 50mM MOPS, 15% ethanol pH 7.0. 
Buffer QF: - 1.25M NaCl, 50mM MOPS, 15% ethanol pH 8.2. 
2.1.4.15) Phenol: chloroform: isoamyl alcohol (25: 24: 1) 
Liquefied phenol was stored at -20 
0 C. For equilibration, the solution was allowed 
to warm to room temperature and then melted at 650C. An equal volume of 0.5M 
Tris was added, the solution stirred for 15 minutes and the phases allowed to 
separate. Ile upper (aqueous) phase was removed and the procedure repeated 
with 0.1 M Tris The equilibrated phenol was then mixed with an equal volume of 
chloroforin: isoamyl alcohol (24: 1) and stored under O. IM Tris in a light proof 
bottle at 40C. 
2.1.4.16) Restriction enzymes and molecular size markers 
Enzymes, lambda ladder and kilobase ladder were supplied by Gibco-BRL and 
stored at -200C. Restriction enzymes were used 
in the recommended 
manufacturers buffers. 
2.1.4.17) 5x Tris-borate (TBE) 
54g Tris base, 27.5g boric acid and 20ml 0.5M EDTA (pH 8.0) were added to 800 
ml distilled water, stirred well and made up to one litre with distilled water. 
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2.1.4.18) IN Loading buffer 
20% Ficoll 400, OAM Na2EDTA, 1% SDS and 0.25% bromophenol blue. 10ml 
was made up and stored in I ml aliquots at room temperature. 
2.1.4.19) Electrophoresis tanks and power packs 
Standard and midi tanks were from BRL. Mini tanks and power packs were from 
Bio-rad. 
2.1.4.20) Ethidium Bromide (EtBr) 
A stock solution of lmg/ml was prepared by adding one EtBr tablet (Bio-rad) to 
11 ml distilled H20 and was then stored at 40C. 
2.1.4.21) DNA purification kit 
A Prep-A-Gene kit from Bio-Rad was used to purify DNA from agarose gel 
electrophoresis. In addition to the binding matrix, the contents of which were 
unspecified by the manufacturers, the kit contained the following buffers, 
described below. 
Binding buffer: - 50mm Tris, ImM EDTA, 6M NaCIO4, pH 7.5 
Wash buffer. - 4OmM Tris, 4mM EDTA, 0.8M NaCl, pH 
7.4 
Elution buffer: - lOmM Tris, ImM EDTA, pH 
8.0 
2.1.4.22) Sephadex G-50 
lOg Sephadex beads were slowly added to 160ml distilled H20. The swollen 
resin was then washed twice with fresh water and then equilibrated in TE (pH 
7.6), autoclaved and stored at room temperature. 
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2.1.4.23) Gel photography 
Electrophoresis gels were photographed with a Polaroid MP4 Land Camera using 
667 ASA 300 film (Polaroid) 
2.1.5) In-situ hybridisation 
2.1.5.1) Nick translation 
Two kits, both supplied by BRL, were used to label DNA probes with haptens. 
For biotin labelling, the "Bionick" kit was employed. For labelling with 
digoxigenin the Nick Translation System (8160SB) was used. Appropriate 
components of each kit are listed below. 
8160SB 
Solution A4, (10x nucleotide mix) 0.2mM dATP, dCTP and dGTP, 500mM Tris 
(pH 7.8), 5OmM M9CI2, IOOmM 2-mercaptoethanol and 100 pg/ml nuclease free 
BSA. 
Solution C (IOx enzyme mix) 0.4 U/gl DNA Polymerase 1,40 pg/gl DNAse 1, 
50mM Tris (pH 7.5), 5mM magnesium-acetate. ImM 2-mercaptoethanol, O. ImM 
phenylmethylsulfonyl fluoride, 50% (v/v) glycerol and 100 pg/mI nuclease free 
BSA. 
Soludon D- stop buffer) 300mM Na2 EDTA (pH 8-0) 
Bionick 
I Ox dNTP mix 0.2mM dCTP, dGTP and dTTP, 0. ImM dATP, 0. ImM biotin- 14 
-dATP, 500mM Tris (pH 7.8), 50mM 
M902, IOOmM 2-mercaptoethanol and 
100 pg/ml nuclease free BSA. 
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IN enzyme mix 0.5 U/gl DNA Polymerase 1,0.0075 U/gl DNAse 1,50mM Tris 
(pH 7.5), 5mM magnesium -acetate. ImM 2-mcrcaptoethanol, O. ImM 
phenylmethylsulfonyl fluoride, 50% (v/v) glycerol and 100 pg/ml nuclease free 
BSA. 
SiQp-buffer 300mM Na2EDTA (pH 8.0) 
20x Digoxig * 
For labelling with digoxigenin, a 50gl stock, containing 0.1 mM digoxigenin- II 
-dUTP (51il of a ImM stock, Boehringer) and 0.3mM dTTP (1.5gl of a lOmM 
stock, Sigma) was made in sterile distilled water and stored at -200C. 
2.1.5.2) Hybridisation mix 
One gram dextran sulphate was dissolved in a solution which comprised Iml 20x 
SSC, 5ml formamide, Iml 10% Tween 20 (Pierce) and 3nil H20. All solutions 
were filter sterilised before mixing. The pH was adjusted to 7.0 and 10041 
aliquots were stored at -200C. 
2.1.5.3) Rubber soludon 
Cover slips were sealed during hybridisation with Neoprene (Phillips, 
Manchester). 
2.1.5.4) 20x SSC stock solution 
175.3g NaCl and 88.2g sodium citrate made up to IL with distilled H20 and the 
pH was adjusted to 7.0. The solution was then autoclaved. 
2.1.5.5) SSCT 
4x SSC containing 0.05% Tween 20, adjusted to pH 7.0. 
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2.1.5.6) SSCrM 
SSCT containing 5% non-fat dried milk (Marvel, Cadburys). 
2.1.5.7) Detection reagents 
Tle following chemicals were used to visualise hybridisations. Fluorescein- 
labelled Avidin DCS and Biotinylated anti-Avidin D (both from Vector) and Anti 
-digoxigenin-rhodamine Fab fragments (Boehringer Mannheim). 
2.1.5.8) Slide mountant 
Citifluor AFI (Citifluor, London) was used, with either propidium iodide 
(0.5pg/ml) or DAPI (0.1 pg/ml) (both from Sigma) as a counter stain. 
2.1.5.9) B orate buffer 
A 500 ml batch of buffer containing 50mM Na2SO4 (3.55g) and 2.5mM 
Na2B407 (0.48g) was made with distilled water, adjusted to pH 9.2, and stored at 
room temperature. 
2.1.5.10) Competitor DNA 
Human placental DNA sonicated to -500bp in length or human COT-I DNA 
sonicated to between 70 and 300bp (GibcoBRL) were used. 
2.1.5.11) Pepsin stock solution 
One gram of pepsin (Sigma) was dissolved in 10ml dH20 and stored at -20 
C in 
100gl aliquots. 
2.1.5.12) Transfer RNA 
25mg E Coli transfer RNA (Sigma) were dissolved in 2ml distilled H20 and 50gl 
aliquots stored at -20*C. 
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2.1.5.13) Salmon sperm DNA 
50gl aliquots of sonicated salmon sperm DNA at 10mg/ml were stored at -20*C. 
2.1.5.14) Dot blot assays 
A BluGENE non radioactive nucleic acid detection system (BRL) was used. The 
kit contained the following reagents. 
SAAP conjugat- lmg/ml streptavidin-alkaline phosphatase in 3M NaCl, ImM 
M902,0.1 mM ZnC12,30mM triethanolamine (pH 7.6) 
M 75mg/ml nitroblue tetrazolium in 70% dimethylformamide 
B-M 50mgtml 5-bromo-4-chloro-3-indolylphosphate in dimethylformamide 
Biotinylated DNA 0.2pg/gl biotinylated lambda DNA, 0.2gg/gl sheared herring 
spenn DNA in 6x SSC. 
DNA dilution buffe O. Igg/gl sheared herring spenn DNA in 6x SSC. 
2.1.6) General chemicals 
2.1.6.1) Water 
All aqueous solutions were prepared using either deionised or distilled water. 
Deionised water was prepared by passing tap water through two PWT Permutit 
250 deionisers. Double distilled water was from an Aquatron Bibby still. 
2.1.6.2) Reagents 
All chemicals were of at least analar grade. Unless otherwise stated, reagents 
were supplied by Sigma Chemical Company, BDH Chemicals Ltd or Fisons 
Scientific. Storage followed the manufacturers recommendations. 
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2.1-7) General laboratory consumables 
2.1.7.3) Automatic pipettes and tips 
Gilson "Pipetman" pipettes and Treff tips were used. 
2.1.7.4) Disposable plastics 
Syringes and hypodermic needles were from Becton-Dickinson, capped test-tubes 
and universals were from Falcon Plastics. Petri dishes and plastic pasteur pipettes 
were from Sterilin and microfuge tubes were from Sarstedt. 
2.1.7.5) Glassware 
Pyrex glassware was washed with detergent, rinsed twice with tap water, once 
with deionised water and then dried in a hot air cabinet. Glassware required for 
microbiological work was then autoclaved. 
2.1.8) Equipment 
2.1.8.1) Centrifuges 
An MSE Centaur 2 was used for tissue culture and cytogenetics procedures. For 
molecular biology techniques either an IEC Centra or a Beckman J2 were used. 
Microcentrifugation was carried out with an Eppendorf microcentrifuge. 
2.1.8.2) Heating equipment 
Heating blocks and water baths were from Techne. The shaking incubator was 
from New Brunswick Scientific Co., and the incubator from Harvard/LTE. A 
Memmert high temperature oven and a Tricity microwave were also used. 
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2.1.8.3 Sterilising equipment 
For autoclaving, a Rodwell series 32 was used for 20 mins at 121 C, 15 psi. For 
filter sterilisation, antipyrogenic 0.22 micron disposable syringe filters (Millipore) 
were used. 
2.1.8.4) Surgical scissors 
Curved scissors from Gallencampf were sealed in aluminium foil, autoclaved and 
stored wrapped until required 
2.1.8.5) Measurement of absorbance 
A Jcnway 6050 colorimeter was used for monitoring the growth of E. Coli 
cultures. 
A Cecil series 2 spectrophotometer was used for DNA estimation. 
2.1.8.6) Transilluminator 
A model IM20 was used, obtained from UVP inc, Cambridge, UK. 
2.1.9 ) Microscopy 
2.1.9.1) Photomicroscopy 
For standard cytogenetics, an Olympus BH2 microscope and automatic camera 
system was used, with Agfa Copex PAN AHU 35mm film (Agfa Gevaert). 
For 
fluorescence in-situ hybridisation (FISH) a Leitz Laborlux 12 equipped for 
epifluorescence and fitted with filters for FITC, rhodamine and 
DAPI was 
utilised. Photographs were taken with an MPS 46/52 camera system, using 
640T 
colour slide film (Scotch). Film was stored at 4oC until use and 
developed within 
48 hours of exposure. 
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2.1.9.2) Digital imaging microscopy 
A KAF 1400 cooled CCD camera (Photometrics) attached to an Axioskop 
microscope (Zeiss) equipped for epifluorescence and fitted with both a multi- 
bandpass transmission filter and an external filter wheel carrying excitation filters 
for FITC, Rhodamine and DAPI was used. Images were captured and recorded 
using Smartcapture software (Digital Scientific Instruments, Cambridge, UK) 
running on a Quadra 840AV computer (Apple Macintosh). 
2.1.9.3) Photographic papers 
Kodakrome 11 RC monochrome FIM, F2M, F3M and RM papers (Eastman 
Kodak), sizes R8 in. and 8xlO in., were used. 
2.1.9.4) Processing 
Developers. For films, G141C (Agfa Gevaert) was stored at 4*C and diluted 1: 4 
in warm tap water for use. For papers, Dektol powder (Kodak) was dissolved in 
800ml water at 38*C with constant stirring and made up to I litre. In use, the 
solution was diluted 1: 2 in water at 20 C. 
Fjzgr. Kodak Unifix solution was diluted with water 1: 4 for film and 1: 9 for 
papers. 
Colour film was processed commercially (Propix, Sheffield, UK). 
2.1.9.5) Enlarger 
An Autofocus Focomate V35 (Leitz) was used for exposing negatives to paper. 
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2.2) METHODS 
2.2.1) Tissue culture 
2.2.1.1) Peripheral blood 
A 0.5 ml aliquot of heparinized venous blood was added to 10ml TC199 medium, 
(which contained 2% PHA and 20% Human serum and was supplemented with 
L-glutamine, sodium carbonate, penicillin and streptomycin) and incubated at 
37 0 C. After 48 hours, thymidine was added to a final concentration of 0.3mg/ml 
and this block released 18 hours later by the addition of deoxycytidine to a final 
concentration of 0.3gg/ml. 4 hours later, colcemid was added to a final 
concentration of 0.1 gg/ml and after 20 mins the culture harvested. 
The cell suspension was centrifuged at 1000 rpm at room temperature. The 
supernatant was discarded and the pellet resuspended in 0.075M KCI, prewarmed 
to 370C and added dropwise, whilst continuously shaking the tube. The 
suspension immediately centrifuged and the supernatant removed. Tlie cells were 
fixed by the dropwise addition of 5ml 3: 1 methanol: glacial acetic acid whilst the 
tube was agitated. The suspension was pelleted and the procedure repeated until 
the fixative remained clear. After a final fixation the cell suspension was stored at 
-200C until slides were prepared. 
2.2.1.2) Lymph node 
Biopsy material was transported to the laboratory in culture medium and four 
10ml aliquots of FIO medium (containing 10% human serum and supplemented 
with 25mM Hepes buffer and L-glutamine) in universals were prewarmed at 
370C. The tissue sample was removed from the transport medium, placed in the 
lid of a petrie dish and moistened with pre-warmed FIO. Curved scissors were 
used to cut up the specimen, which was then transferred with a pasteur pipette to 
10ml FIO at 370C. 
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If the sample was small, the transport medium was spun down, any pelleted cells 
were resuspended in FIO medium and added to the main suspension. If the 
specimen was large (greater than lcm3), part of the material was removed with a 
scalpel and stored at -20*C before setting up the remainder. 
An aliquot of the main suspension was used to set up three cultures (1,2 and 3). 
Material sufficient to just produce a hazy appearance was added to each of the 
remaining universals. Culture 1 had colcemid added t6 a final concentration of 
0.1 gg/ml and was then incubated at 37 C for 30 min before harvesting. Culture 2 
had colcemid added to a final concentration of 0.0 1 gg/ml and was then incubated 
at 37 C overnight. Culture 3 was incubated overnight and then had colcemid 
added to a final concentration of 0.1 gg/ml for I hour, at which time cultures I and 
2 were harvested. 
The cell suspension was centrifuged at 1200 rpm for 10 min at room temperature. 
The supernatant was discarded and the pellet resuspended in 0.075M KCI, 
prewarmed to 37 0C and added dropwise, whilst continuously shaking the tube. 
After a 10 min incubation at 37*C the suspension was spun down for 5 min, the 
supernatant removed and the cells fixed by the dropwise addition of 5ml 3: 1 
methanol/glacial acetic acid as the tube was agitated. The suspension was pelleted 
and the procedure repeated twice. The cell suspension was then stored at -200C 
until slides were prepared. 
2.2.2) Cytogenetics 
2.2.2.1) Slide making 
Each cell suspension was centrifuged at 1200 rpm for 10 min and then 
resuspended in a small quantity of fixative until it was slightly opaque. Using a 
pasteur pipette, one drop of suspension was dropped onto the centre of cold wet 
grease free slides. Excess fixative was blotted off and the slides allowed to dry at 
room temperature. 
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2.2.2.2) G-banding 
Slides were stained with freshly made Uishmans stain for 90 seconds, rinsed 
with Gurr's buffer and blotted dry. They were then examined under the 
microscope to assess the number and quality of mitotic figures present. Slides 
were then aged by leaving them at room temperature for at least two days or by 
incubating them at 800C for two hours. Immersion lens oil was removed with 
ethanol, the slides were destained with fixative and air-dried. 
A modified version of Seabright's method (Seabright 1971) was used for 
chromosome banding. Trypsin solution was spread over the slides for 5-30 
seconds and then rinsed off with Sorensen's buffer. Leishman's stain was then 
applied for 90 seconds, the slides rinsed with Gurr's buffer and then blotted dry. 
Banded metaphases were examined under the microscope and their karyotypes 
recorded according to the International System for Cytogenetic Nomenclature 
(ISCN) (ISCN, 1991). Cells were then photographed and representative photo- 
karyotypes constructed for each specimen. 
2.2.3. ) Molecular biology 
Gloves were wom for all laboratory work involving nucleic acids. All solutions 
and disposable items were sterilised before use. 
2.2.3.1) Preparation of competent cells 
A single colony of E. Coli JM109 was inoculated into 50ml 
LB medium and 
grown overnight with moderate shaking (250 rpm). 4ml of the culture was 
inoculated into 400ml LB medium in a 2-litre flask and grown at 37*C with 
shaking to an OD590 of 0.375. The culture was then aliquoted into 16 pre-chilled 
polypropylene tubes which were left on ice for 10 min. The cells were kept cold 
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for all subsequent steps. The tubes were centrifuged at 2500rpm for 7 min at 4C 
in the IEC centrifuge. The supernatant was poured off and each pellet was 
resuspended in 5ml ice-cold CaC12 solution. The contents of each pair of tubes 
were pooled into one and then centrifuged at 2500rpm for 5 min at 4 C. The 
supernatant was discarded, each pellet was resuspended in 10ml cold CaC12 and 
kept on ice for 30 min. The cells were again centrifuged at 2500rpm for 5 min at 
4C and finally resuspended in 2ml cold CaC12.250ýfl aliquots were dispensed 0 
into chilled microfuge tubes and frozen immediately at -70 C (Ausubel et al, 
1991). 
2.2.3.2) Transformation of competent cells 
Where clones were provided as plasmid stocks, it was necessary to use them to 
transform E. coli cells in order to replicate a sufficient quantity for further use. 
Aliquots of lOng DNA in a volume of 10-25gl were added to a round- bottom 
15ml test tube and placed on ice. A tube of competent cells was warmed rapidly 
between the hands and 100gl dispensed immediately into the tubes containing the 
DNA. The contents were mixed gently and placed on ice for 10 min. The cells 
were then heat shocked by placing the tubes in a water bath at 420C for 2 min. 
lml LB medium was added to each tube and they were then shaken at 250 rpm 
for 1 hr at 370C (Ausubel et al, 1991). Aliquots were placed on LB agar plates 
containing the appropriate antibiotic (ampicillin at 50-10099/ml or tetracyclin at 
lOgg/ml). The remainder of the mixture was stored at 40C for subsequent 
platings. 
2.2.3.3) Growth of clones in plasmid vectors 
A single colony of ECQILJM109 containing the DNA clone of 
interest was 
inoculated into 50ml LB in a 250ml flask containing the appropriate antibiotic 
(see above) and grown overnight at 37*C with moderate shaking (250 rpm). The 
culture was left at room temperature the following day and was then added to 
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500ml LB (also containing antibiotic) in a2 litre flask and incubated overnight at 
37*C with moderate shaking (250 rpm). Plasmid DNA was prepared from the 
culture the next day. 
If required, glycerol stocks were also prepared at this stage by mixing 50041 of 
culture with 500gl glycerol solution and storing in a sealed microfuge tube at 
-200C. 
2.2.3.4) Preparation of plasmid DNA 
Extraction and purification of plasmid DNA was by alkaline lysis 
(Bimboim, 1983) using the Qiagen kit for maxi preparations. The composition of 
the buffers is given in section 2.1.4.14. 
Alkaline lysis. 71be 500ml culture from 2.2.3.3 above was centrifuged at 4000 rpm 
for 10 min at 40C in two 250ml bottles. The pellets were resuspended in a total of 
10ml buffer PI and transferred to a high speed centrifuge tube. 10ml buffer P2 
was then added, mixed in by tube inversion and incubated at room temperature 
for 5 min. 10ml Buffer P3 was added, mixed thoroughly by inverting the tube 6 
times and the suspension was centrifuged at >20,000 g for 30 min at 40C. The 
supernatant was removed to a fresh tube as carefully as possible and re- 
centrifuged at >20,000 g for 10 min at 40C (Bimboim, 1983). 
Column purification. A Qiagen tip-500 column was equilibrated with 10ml 
buffer 
QBT and allowed to empty completely by gravity flow. The supernatant was then 
applied and allowed to enter the column, which was then washed three times with 
buffer QC. The purified DNA was eluted with 15ml buffer QF into a clean tube, 
allowing the column to drain completely. 
Precipitation- The DNA was precipitated with 0.7 vol (10.5ml) isopropanol at 
room temperature for 10 min and then centrifuged at high speed for 30 min at 
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40C. The supematant was carefully removed and the pellet was washed with 70% 
ethanol. The DNA was re-centrifuged for 15 min, dried briefly but not completely 
and resuspended in 20OW TE. 
2.2.3.5) Quantification of DNA. 
Purified DNA was measured to estimate the quality and quantity obtained. An 
aliquot was diluted 100 times in TE and absorbance readings were taken at 260 
nni and 280 nm. The OD260 x 50 x0 equals the approximate concentration of 
DNA in gg /ml. The ratio between the readings at 260 nni and 280 nin. 
(OD260/OD280) gives an estimate of purity. ( Pure preparations of DNA have an 
OD2601OD280 Of 1.8 ) If this ratio is significantly lower than 1.8 (less than 1.4) 
the sample is contaminated and accurate quantitation will not be possible. 
2.2.3.6) Digestion of DNA by restriction enzymes. 
DNA from purified vectors was cut with appropriate enzymes in order to confirm 
their identity and to recover cloned inserts. To a microfuge tube, the below were 
added sequentially to a total volume of 20gl 
x gI DNA solution (usually approximately Igg) 
2 gI appropriate enzyme buffer 
y gl sterile distilled water to 20 gl 
z gi enzyme (approximately I unit/gg) 
0 The tube was incubated in a water bath at 37 C for 2 hours, after which the 
digested DNA was subjected to gel electrophoresis. 
2.2.3.7) Gel electrophoresis of DNA. 
0.5g or lg agarose was added to 50ml (minigel) or 100ml (midigel) 
Ix TBE in a 
conical flask and melted in a microwave oven. A gel casting platform was sealed 
at both ends with tape and a gel comb inserted. The melted agarose was then 
poured into the platform and allowed to set at room temperature. When 
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completely set the comb was carefully removed from the gel and the platform 
placed in an electrophoresis tank. The gel was covered to a depth of Imm with Ix 
TBE, containing ethidium bromide at a final concentration of Igg/ml. 2ttl of 
loading buffer was added to each sample, which were then loaded into individual 
slots. 5gl size marker was loaded into a free slot after mixing with 2AI loading 
buffer. The lid of the tank was fitted and the power pack connected, making 
certain the DNA would migrate into the gel toward -the anode. Voltage was 
applied at between 1-10 V/cm until the dye from the loading buffer had migrated 
a distance judged suitable for the separation of the appropriate DNA fragments. 
The apparatus was disconnected and the platform containing the gel was 
positioned over a UV transilluminator for examination and photography. 
2.2.3.8) Recovery of DNA from electrophoresis gels 
A Prep-A-Gene kit (see section 2.1.4.21) was used to extract DNA from agarose 
gels. The piece of gel containing the DNA of interest was excised with a sterile 
scalpel and cut into 2mm pieces which were added to a microcentrifuge tube. The 
tube was -spun briefly and the volume of the contents estimated by measuring 
water into a similar tube and comparing their appearance. Three volumes of 
binding buffer were added to the agarose pieces, the tube was vortexed and then 
incubated at 500C, vortexing intermittently. For each gg of DNA thought to be 
present, 5pl of matrix was added. After mixing, the tube was incubated at room 
temperature for 10 minutes and then microfuged for 30 seconds. The pellet was 
then resuspended in 50 matrix volumes of binding buffer and spun down for 30 
seconds. This step was repeated once. The pellet was then resuspended in 50 
matrix volumes of wash buffer, spun down for 30 seconds and the step repeated 
twice more. The resulting pellet was resuspended in one matrix volume of elution 
buffer and incubated at 500C for 5 minutes. The suspension was spun down for 2 
minutes to obtain a solid pellet and the supernatant, which contained the DNA, 
was carefully removed. The elution step was repeated once more and the 
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supernatants were pooled. The total supernatant was microfuged briefly to remove 
any trace of matrix and transferred to a fresh tube for storage at -20 
0 C. 
2.2.4. ) Photography 
2.2.4.1) Development of PAN AHU film . 
In absolute darkness, film was removed from the cassette, wound onto a spool 
and placed in a developing canister. Under safety light, developer was added to 
the canister, which was constantly shaken for 2-3 minutes After a brief wash with 
tap water, fixer was added to the canister, followed by constant shaking for 10 
minutes. The film was washed with running tap water for 10 minutes, removed 
from the spool and hung up to dry. 
2.2.4.2) Printing from PAN AHU film 
Under safety light, film was exposed onto photographic paper with the enlarger. 
The paper was developed for 1-4 minutes and then stopped with tap water, 
slightly acidified with acetic acid. After fixing for 5 minutes, prints were washed 
under running tap water for 10-20 minutes before air drying. Adjustments to the 
exposure time, aperture and choice of paper were necessary to obtain good prints. 
2.2.4.3) Photography of electrophoresis, gels 
Gels were photographed in the tray, whilst excited by the transilluminator. A red 
filter, an aperture of f5.6 and an exposure time of 1/30 second were used. 
2.2.5) Fluorescence in-situ hybridisation 
This technique and associated methods underwent a considerable degree of 
modification and development in the course of this work. The methodology is 
therefore presented separately in the following chapter. 
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CHAPTER THREE 
TECHNICAL DEVELOPMENT OF FLUORESCENCE IN- 
SITU HYBRIDISATION 
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3.1) INTRODUCTION 
In-situ hybridisation is the annealing of a nucleic acid probe to a target in which 
the morphology is preserved. Early workers in this field labelled probes 
isotopically (Pardue and Gall, 1969), but since the 1980s non-isotopic labelling 
has been used with increasing frequency (Langer et al, 1981). There are a number 
of reasons for this: - experiments take less time to perform, the techniques are 
safer to carry out, there are improvements in resolution and with the use of 
multiple fluorescence detection systems (Nederlof et al, 1989), it is possible to 
visualise several target regions simultaneously in the same specimen (Reid et al, 
1992). 
In the work presented here, FISH was applied to human metaphase chromosomes 
and interphase nuclei. In each case, the same series of steps were undertaken: - 
slide preparation, probe labelling, denaturation of probe and target, hybridisation, 
detection and photography. Optimisation of each step was attempted in order to 
maximise the success of individual experiments. The number of cells in which 
signals were observed (the hybridisation efficiency), the intensity of those signals 
and the signal to noise ratio, were taken into account when comparing differences 
between protocols. The effect of different treatments on target morphology was 
also noted. In the following sections, individual steps will be considered and the 
methods found to give the best results will be described. 
3.2) SLIDE PREPARATION 
3.2.1 Slide making 
Cell suspensions of material for FISH were droPped'onto slides as described 
above (Methods 2.2.1). If the suspensions had been stored for more than a 
few 
weeks, at least two re-fixations were required in order to produce good 
preparations. Quality was most easily determined by inspection with phase 
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contrast microscopy. A phase dark appearance and lack of cytoplasm were the 
best indicators of a good preparation (Donlon, 1986). 
3.2.2 Ageing and storage of preparations 
Slides aged at room temperature for one to two weeks gave the best results. If the 
slides were then stored in 70% ethanol at 40C, good FISH results could be 
obtained for about another two months. 
3.2.3 Pre-treatment of preparations 
Slides were subjected to the following protocol prior to FISH. 
Those slides previously stored in 70% ethanol at 40C were air dried and 
equilibrated in 2xSSC for 5 minutes. Slides at room temperature were used 
directly. 
An incubation with 100gg RNaseA/mI in 2xSSC (1: 100 dilution of the stock 
solution) was carried out at 370C for one hour. 150gl were applied to a 22x5O 
mm coverslip. A slide was touched to the coverslip and hung upside down in a 
slide holder placed on its side in a humid chamber (a plastic sandwich box 
containing paper towels moistened with water). The coverslip was pulled off and 
the slide washed 3x5 min in 2xSSC at room temperature, in a Coplin jar on a 
shaking platform. 
A 0.01M solution of HCI was made by adding Iml IN HCI to 99ml distilled 
H20. After warming to 370C, 5091 pepsin stock was added and the slide then 
incubated at 370C for 10 min. After 2x 5min washes in IxPBS and Ix 5min 
wash in IxPBS, 50MM M902 in a Coplin jar on a shaking platform at room 
temperature, the slide was post-fixed. 
A 1% formaldehyde solution was freshly made by adding 2.7ml formaldehyde 
(37%) to 97.3ml IxPBS, 50mM M902. The slide was incubated for 10 min at 
room temperature and then washed for 5 min in IxPBS at room temperature, in a 
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Coplin jar on a shaking platform. After dehydration in a 70%, 95% and 100% 
ethanol series, the slide was air dried. 
32.4 Evaluation 
At the inception of the FISH work, no pre-treatment other than dehydration was 
employed. Subsequent additions to the protocol were evaluated individually. 
Treatment with RNase A was found to reduce background signal; a factor of 
major importance when working with small single copy probes (Figure 3.1). 
Pepsin digestion increased hybridisation efficiency and signal strength but 
chromosome morphology was adversely affected (Figure 3.2). Digestion with 
Proteinase K was also tested (0.4gg/ml in 20mM Tris-HCI, 2mM CaC12; 5-10 
min, 370C). This gave a similar but less effective result to Pepsin (data not 
shown). The addition of a post-fixation step maintained target integrity, whilst 
allowing the benefits of protease digestion to be maintained. 
3.3) PROBE LABELLING 
3.3.1 Introduction 
Probes were labelled with one of two reporter molecules in the course of this 
work. Nucleotides, modiflied with either biotin or digoxigenin, were incorporated 
into probe DNA by a nick translation reaction (Langer et al, 1981). This was 
considered preferable to random priming (Feinberg and Vogelstein, 1984), since 
the size of the labelled probe fragments has been found to be important for 
effective FISH (Lawrence and Singer, 1985). This optimum range (100 - 500 bp) 
can be obtained for a probe of any size by adjusting the DNAse concentration in 
the nick translation reaction. 
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Figure 3.1 
Metaphase spread from peripheral blood lymphocytes, hybridised with probes for 
the X centromere and the MYB proto-oncogene. 
Pre-treatment with RNase was not applied and a high level of background signal 
is visible. 
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Figure 3.2 
Metaphase spreads from peripheral blood lymphocytes. Pre-treatment with RNase 
was applied in each case. 
a) Male metaphase hybridised with probes for the X-chromosome centromere and 
the MYB proto-oncogene. No pepsin pre-treatment was applied. No signals from 
the MYB probe are visible. 
b) Metaphase hybridised with probes for the chromosome 6 centromere and the 
MYB proto-oncogene. Pepsin pre-treatment was applied. Clear signals from the 
MYB probe are visible on one chromosome 6, indicated by the arrow. 
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3.3.2 Labelling protcocol 
For labelling with biotin, the Bionick kit (Section 2.1.5.1) was used. Igg probe 
DNA, 5[tl dNTP mix and sterile distilled water were added to an Eppendorf tube, 
to a total volume of 45gl. Following the addition of 5[tl Bionick enzyme mix, the 
tube was incubated at 150C for I hour. The tube was then transferred to an ice 
bath and 5gl stop buffer added. 
During the incubation period, a separation column was prepared. A pasteur 
pipette was plugged with glass wool and filled to within Icni of the top with 
Sephadex G50. The incubation mixture was loaded onto the column and then 
eluted with TE (pH7.0). The second 600gl of eluate, which contained the probe, 
was collected. 
50jig E. Coli tRNA (4gl of the stock) and 50gg salmon sperm DNA (5gl of the 
stock) were added as carrier. After the addition of 0.1 volumes (6041) 3M Sodium 
acetate pH5.6, the mixture was vortexed briefly and split equally into two tubes. 
Two volumes ethanol (660gl) were added and the tubes placed at -700C for I 
hour. The precipitated probe was pelleted by microfugation at full speed for 15 
minutes, dried completely in a speedvac and resuspended in 50gi TE. Storage was 
at -200C. 
A similar procedure was followed for labelling with digoxigenin. However, the 
Nick Translation System (Section 2.1.5.1) was used and the reaction mixture 
consisted of Igg DNA, 5gl solution A4,2.5gl digoxigenin mix, sterile 
distilled 
water to a final volume of 45gl and 5gl solution C (the enzyme mix). 
The 
incubation was for 90 minutes at 150C. 
3.3.3 Dot blot assay of probe labelling 
When necessary, a colourimetric assay was employed to assess the quality of 
the 
hapten labelling. This was indicated when, for example, a newly labelled probe 
failed to give an adequate result. A Blu-gene kit (Section 
2.1.5.14) was used to 
perform the assay. 
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The following buffers were made up. 
B uffer I containing 0.1 M Tris-HCl (pH7.5), 0.15M NaCl 
Buffer 2 containing 3% bovine serum albumin (fraction V) in buffer 1 
Buffer 3 containing 0.1 M Tris-HCl (pH9.5), 0.1 NaCl, 50mM MgC12 
Stop buffer containing 20mM Tris (pH7.5), 0.5mM Na2EDTA. 
All solutions were then filtered through 0.45gm filters. 
Serial dilutions were made in the kit DNA dilution buffer from both the labelled 
probes under test and from the labelled control DNA provided with the kit, such 
that 5gl aliquots would contain 20,10,5,2 or 0 pg. These were spotted onto a 
nylon membrane which was then dried at 800C for 1.5 hours. 
The filter was rehydrated for I minute in sufficient buffer I to cover it and then 
incubated in sufficient buffer 2 to cover for I hour at 650C. Immediately prior to 
use, the SAAP conjugate was diluted to Igg/ml by adding 4gl of stock to 4ml 
buffer 1. The filter was then incubated in diluted SAAP conjugate for 10 minutes 
with gentle agitation, occasionally pipetting the solution over the filter. The 
conjugate was decanted off and the filter washed 2xlO minutes with buffer 1, 
using 20-40x the volume of conjugate previously employed. The filter was then 
washed in buffer 3 for 10 minutes and approximately 7.5ml dye solution was 
prepared by adding 33gl NBT solution to buffer 3, mixing gently and then adding 
25gl BCIP solution followed by gentle mixing. The filter was then incubated in 
the dye solution within a sealed hybridisation bag for 30 minutes to 3 hours 
in the 
dark, to allow colour development. The reaction was terminated 
by washing in 
stop buffer and the filter was dried between sheets of blotting paper at 
800C for 2 
minutes. 
When probe labelling had been successful, a coloured spot was visible at the site 
of the appropriate 2pg aliquot, of approximately the same 
intensity as that seen in 
the 2pg spot of the control DNA. 
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3.4) DENATURATION AND HYBRIDISATION 
3.4.1 Introduction 
The strategy that was followed in bringing target and probe together depended 
both on the size and copy number of the target and on the nature of the probe. For 
example, a small target that was present in a high copy number could be 
sucessfully detected with less probe than a larger but unique target. Some of the 
probes used in this work contained interspersed repetitive sequences (IRS) that 
are scattered throughout the human genome (Korenberg and Rykowski, 1988). If 
such probes were hybridised directly, non-specific signal would be detected. To 
overcome this problem, probes were pre-hybridised with unlabelled human DNA. 
This approach (Lichter et al, 1988) is termed chromosomal in situ suppression 
(CISS). Figure 3.3 shows an example of this technique in practice. The following 
sections describe the general protocols used for denaturation and hybridisation 
and the variations required for different probeltarget combinations. 
3.4.2 Probe mixtures 
Each hybridisation event occupied half a slide and took. place in an II gI volume. 
Amounts of probe appropriate to each type are given below. 
Chromosome specific repeat 10-20ng 
Single copy 50-100ng 
Total DNA from an individual human 
chromosome (chromosome paint) 150-500ng 
Labelled probes were added to an Eppendorf tube as required. 
When a 
chromosome paint was part of the probe mixture, a 
10-25x excess of unlabelled 
human DNA was included. A 2x volume of ethanol was added to the tube, mixed 
well and then Iyophilised. The pellet was resuspended 
in II gl hybridisation mix. 
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Figure 3.3 
Male metaphase spread from peripheral blood lymphocytes, hybridised with a 
painting probe for the X chromosome. Signal is visible both on the whole of the X 
chromosome (arrow) and on the pseudo-autosomal region of the Y chromosome 
(arrow head). 
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3.4.3) Denaturation and hybridisation methods 
If no IRS were present in the probe(s) used, it was possible to denature probe and 
target simultaneously. The hybridisation mixture was pipetted onto the target area 
of the slide and covered with a 22x22mm coverslip. The slide was placed in an 
oven at 800C for 3-5 minutes and then transferred to an incubator at 370C in a 
humid chamber where hybridisation took place overnight. 
When denaturation of probe and target took place separately, the tube containing 
the hybridisation mixture was heated at 750C for 5 minutes in a heating block. At 
the end of that time, if IRS were present, the tube was transferred to a 370C water 
bath for at least 30 minutes. If no pre-annealing was required, the tube was placed 
on ice immediately after denaturation. 
Target slides were pre-warmed to approximately 500C and then denatured in 70% 
formamide, 2xSSC, pH 7.0 at 700C for 2 minutes. They were then immediately 
dehydrated in an ice cold ethanol series of 70%, 95 % and 100% and air dried. The 
denatured hybridisation mixture was pipetted onto the target area of the slide and 
covered with a 22x22mm coverslip which was then sealed with rubber solution. 
Hybridisation then took place overnight in a humid chamber at 370C. 
It was noted that separate denaturation appeared to give more consistent results 
and this method was adopted for all subsequent experiments. 
3.5) DETECTION 
3.5.1) Post hybridisation washes 
After hybridisation, usually overnight, the rubber solution was carefully removed 
with tweezers and the coverslip gently pulled off. Slides were then washed R5 
minutes in 50% formamide, 2x SSC, pH7.0 at 420C. This temperature was used 
for most experiments, but occasional variations were employed to either lower the 
stringency (370C) or to raise it (600C). Slides were then washed 3x5 minutes in 
2x SSC, pH7.0 at 420C. 
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3.5.2) Immuno-eytochernistry 
Biotin labelled probes were detected with a layer of FTtC-conjugated avidin. An 
amplification step was usually applied, consisting of an additional layer of 
biotinylated anti-avidin followed by another layer of FITC-conjugated avidin 
(Pinkel et al, 1986). If necessary, further layers could be added, but this often 
resulted in a poor signal to noise ratio (Figure 3.4). 
Immediately following the post hybridisation washes, slides were washed for 3 
minutes in SSCT at room temperature. A blocking incubation with SSCTM was 
then carried out. Iml SSCTM was centrifuged for 1.5 minutes to remove solids 
and I 00gl applied to a 22x5Omm coverslip. A slide was touched to the liquid and 
hung upside down in a slide holder placed on its side in a humid chamber at room 
temperature. (Subsequent incubations were carried out in the same manner). After 
10 minutes the coverslips were allowed to slip off and the slides washed in SSCT 
for 3 minutes. 
2pl FITC-avidin stock were mixed with lml SSCTM and 100gl loaded onto each 
slide as above. A 20 minute incubation in a humid chamber was then carried out 
in the dark at room temperature. 3x3 minute washes with SSCT were followed by 
a 20 minute incubation with biotinylated anti-avidin. 1041 stock were dissolved in 
Iml SSCTM, the solids were spun out and 100gl applied to each slide. After a 
further 3x3 minute washes with SSCT, a final incubation with FITC-avidin was 
carried out exactly as above. 
A final wash in SSCT for 3 minutes was followed by 2x5 minute washes in PBS. 
Slides were then dehydrated through a series of 70%, 95% and 100% ethanol, 
allowed to air dry and mounted in 2591 AM containing 0.5gg/ml propidium 
iodide counterstain. 
When digoxigenin labelled probes were to be simultaneously detected, the 
following changes were made to the protocol described above. 12gl of anti- 
digoxigenin-rhodamine stock were added to the solution for the second 
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Figure 3.4 
Metaphase spreads from peripheral blood lymphocytes, hybridised with a 
centromere probe specific for the X chromosome and a probe for the MYB proto- 
oncogene. 
a) Preparation with one layer of amplification. The signals on the X centromere 
are indicated by arrows; each pair of MYB signals is indicated by an arrow head. 
b) Preparation with two layers of amplification, hybridised under identical 
conditions to a). Although the signals are stronger, the increase in background 
makes interprrtation prac6cally impossible. 
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Figure 3.5 
Example of pre- and post-banding on metaphase spreads from peripheral blood 
lymphocytes. 
a) Metaphase pre-banded with a low trypsin concentration. (Smit et al, 1990). 
b) Metaphase banded after FISH with the borate buffer method. (Cannizzaro and 
Emanuel, 1984). 
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preparations from peripheral blood lymphocytes. Successful hybridisations; were 
photographed and their co-ordinates were recorded. 
If all single signals had been taken into account, large numbers of cells would 
have had to be assessed, in order to determine the target site statistically, since 
some background signals were invariably present. To avoid this, only those 
signals occurring as symmetrical pairs, one on each chromatid, were considered 
as true hits. The probability of paired signals occurring by chance at the same 
chromosome locus in more than one or two cells was extremely low. 
Following FISH, slides were post-banded as described above. Cells that had been 
successfully hybridised were located and re-photographed. Photographic slides 
were projected onto a screen to enable measurements to be taken. 
The distance from the centromere to the probe and from the centromere to the 
telomere were measured. The ratio of cen-probe/cen-telomere was calculated to 
give the fractional length (FL) relative to the distance from centromere to 
telomere on the target chromosome arm (Lichter et al, 1990). Some workers have 
applied the FL to standard karyograms (ISCN, 1985) to determine a 
corresponding band location (Williams et al, 1991). This might lead to 
inaccuracies, since such diagrams cannot reflect differing states of chromosomal 
condensation. In this protocol, the FL was applied to the corresponding post- 
banded chromosome. The cen-telomere distance was determined and multiplied 
by the FL. This measurement was then used to determine a band location on the 
post-banded chromosome (Figure 3.6). 
3.8) PHOTOGRAPHY 
Microscopic inspection was carried out in a darkened room. If only 
FITC 
detection and propidium iodide counterstain had been used, slides were scanned 
with the rhodamine filter to reduce photo-bleaching of the signal. 
Photographs 
were taken with the FITC filter, which allowed co-visualisation of the 
counterstain. The camera controller was set to darkfield and the automatic 
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Figure 3.6 
a) A metaphase spread from peripheral blood lymphocytes, hybridised with 
probes for the chromosome 6 centromere (arrow) and the MYB proto-oncogene 
(arrow head). In this case the hybridisation of MYB could only be seen on one of 
the chromosomes 6. 
b) the same metaphase after post-banding. 
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exposure control was set one or two stops faster than the film rating, in order to 
reduce exposure times. 
When both FITC and rhodamine were used, the material was counterstained with 
DAPI. Slides were then scanned with the DAPI filter and photographed by 
exposing them independently through the rhodamine, FITC and DAPI filters, in 
that order, without activating the film transport. The camera controller was set up 
as above. This produced a single multiple exposure, in which all three colours 
were represented. 
In the latter part of this work, a CCD camera and associated software were used 
to capture digitised images of the preparations. The slide was automatically 
exposed through the rhodamine, FITC and DAPI filters and a composite 
pseudocolour image was stored in the computer memory. The stored images 
could then be manipulated and printed as required. 
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CHAPTER FOUR 
RESULTS OF CYTOGENETIC STUDIES 
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4.1) INTRODUCTION 
A total of 43 lymph node biopsies from 39 cases were cultured and metaphase 
chromosomes analysed by Giemsa banding. (See Chapter 2, sections 2.2.1.2 and 
2.2.2. ) The quality of the karyotypes varied. This was due in part to differences in 
the amount of original biopsy material available, which in turn depended on the 
size of the excised node and the requirements of the pathologist. The other major 
source of variation was the degree to which individual samples grew in culture. 
Overall, successful cytogenetic analyses were obtained from 40/43 samples. The 
results of these analyses are shown in table 4.1. Information on individual cases 
may be found in table 2.1, (section 2.1). 
4.2) KARYOTYPES OF INDIVIDUAL BIOPSIES 
L001- This case was diagnosed as B-cell high-grade centroblastic lymphoma. 
Cytogenetic analysis was carried out on 25 cells, of which 100% exhibited an 
abnormal karyotype, shown in figure 4.1. 
L002- This case was diagnosed as B-cell low-grade follicular lymphoma. 
Cytogenetic analysis was carried out on 29 cells, of which 100% exhibited an 
abnonnal karyotype, shown in figure 4.2. 
L003- This case was diagnosed as B-cell high-grade'Centroblastic lymphoma. 
Cytogenetic analysis was carried out on 34 cells, of which 100% exhibited an 
abnormal karyotype, shown in figure 4.3. 
L004- This case was diagnosed as B-cell low-grade follicular 
lymphoma. 
Cytogenetic analysis was carried out on 40 cells, of which 75% exhibited an 
abnormal karyotype, shown in figure 4.4. 
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L001 
B-ceU high-grade centroblastic 
47, XY, dup(l)(ql lq44), del(2)(q2l), +3, del(9)(q2 1), add(l 1)(q23) 
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L002 
B-ceU low-gmde foWcular 
46, XX, inv(9)(pl3q22), t(14; 18)(q32; q2l), add(16)(pl3.3) 
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BgREL-4.42 Representative karyotype from case L(X)2 
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L003 
B-ceU high-grade centroblastic 
46, XY, +X, add(3)(q 13), add(6)(q 13), -8, del(14)(q22q24), add(17)(p 13) 
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Figure 4.3 Representative karyotype from case L(H)3 
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L004 
B-cell low-gmde foRicular 
46, XY, del(5)(pl4), add(12)(pl 1), add(15)(q22) 
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Eilg. gre 4.4 Representative karyotype from case L(H)4 
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L005- This case was diagnosed as B-cell low-grade follicular lymphoma. 
Cytogenetic analysis was carried out on 49 cells, of which 73% exhibited an 
abnormal karyotype. The most common clone is shown in figure 4.5. Another 
clone (represented by 5 cells) did not show a trisomy X. 
L006- This case was diagnosed as B-cell high-grade centroblastic lymphorna. 
Cytogenetic analysis was carried out on 22 cells, of which 100% exhibited an 
abnormal karyotype, shown in figure 4.6. 
1,007- This case was diagnosed as B-cell low-grade follicular lymphoma. 
Cytogenetic analysis was carried out on 28 cells, of which 82% exhibited an 
abnormal karyotype, shown in figure 4.7. 
1,008- This case was diagnosed as B-cell low-grade follicular lymphoma. 
Cytogenetic analysis was carried out on 28 cells, of which 82% exhibited an 
abnormal karyotype, shown in figure 4.8. 
1,009- This case was diagnosed as B-cell low-grade follicular lymphorna. 
Cytogenetic analysis was carried out on 24 cells, of which 88% exhibited an 
abnormal karyotype, shown in figure 4.9. 
LOIO- This case was initially diagnosed as a B-cell low-grade 
follicular 
Iymphoma. Cytogenetic analysis of the first sample (LOIOA), was carried out on 
25 cells, of which 100% exhibited an abnormal karyotype, shown 
in figure 4.10. 
A second biopsy was obtained two years after the first. This sample 
(LOIOB) was 
diagnosed as B-cell high-grade centroblastic lymphoma. Cytogenetic analysis was 
carried out on 18 cells, of which 100% exhibited an abnormal karyotype, shown 
in figure 4.11. 
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L005 
B-cell low-grade foUicular 
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Figure 4.5 Representative karyotype from case L005 
L006 
B-cell high-grade centroblastic 
46, XX, add(14)(q32), del(14)(q3 1), t(20; 22)(q 13.3; ql2) 
f add(14q)(q32) revised to der(14)t(3; 14)(?; q32), following FISH) 
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Figure 4. Representative karyotype from case L(X)6 
L007 
B-ceH low-gmde follicular 
91-94, XXYY, +X, +X, add(I)(p13), add(2)(p21) x2, ädd(3)(p13), -4, 
del(6)(ql6q22), -7, +12, +12, t(14; 18)(q32; q21) x2, -17, -22 [cpl8l 
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FiCUU-41,17 Representative karyotype from case L(W 
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L008 
B-ceH low-gmde foUicular 
48, XX, +3, del(6)(p2l), +del(6)(q2l), t(10; 13)(q22; ql2), del(14)(q3l), 
del(I 7)(p 11), add(22)(q 13) 
W&I 
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17 Is 
Fi=re 4.8 Representative karyotype from case L008 
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L009 
B-ceH low-gmde follicular 
62, XX, +X, +add(l)(pl 1), +2, +ins(3;? )(q2l;? ) x2, +del(5)(q31), del(7)(q32), 
+del(7)(q32), +8, +9, del(10)(q22), +add(10)(q23), +11, +12, +13, 
t(14; 18)(q32; q2l), +add(14)(q32), +19, +20, +21 
fadd(14)(q32) revised to der(14)t(14; 18)(q32;? ) and both abnormal chromosome 
10s revised to der(IO)t(10; 18)?. foHowing FISH) 
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Figure 4. Representative karyotype from case L(M)9 
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L010A 
B-Cell low-gmde follicular 
89, XXXX, +X, add(I)(p36), +del(3)(p21) x2, del(6)(q15q21) x3, 
del(9)(p22)t(9; 13)(q2l; ql2), der(9)del(9)(p22)t(9; 13)(q2l; ql2), dup(12)(ql3q22) 
x2, -13, -13, t(I 4; 18)(q32; q2l), -15, -16, add(I 6)(q 12), 
-der(18)t(14; 18)(q32; q2l), add(19)(pll) 
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Finre 4.10 Representative karyotype from case LOIOA 
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LOIOB 
B-cell high-grade centroblastic 
48, XX, +add(X)(p22), add(l)(p36), add(3)(q2l), del(6)(ql5q2l), +7, 
del(9)(p22)t(9; 13)(q2l; ql2), dup(12)(ql3q22), t(14; 18)(q32; q2l), add(19)(ql3.4) 
aA41 
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U191LEVAL-11 Representative karyotype from case L010B 
Y 
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1,011- This case was diagnosed as B-cell low-grade centrocytic lymphoma. 
Cytogenetic analysis was carried out on 28 cells, of which 82% exhibited an 
abnormal karyotype. The most common clone is shown in figure 4.12. Other 
clones showed either an additional abnormality of chromosome I (represented by 
2 cells) or a normal extra copy of chromosome 9 (represented by 4 cells). 
L012- This case was diagnosed as B-cell low-grade lymphocytic lymphorna. 
Cytogenetic analysis was carried out on 28 cells, of which 82% exhibited an 
abnormal karyotype, shown in figure 4.13. 
1,013- This case was diagnosed as B-cell low-grade follicular lymphoma. 
Cytogenetic analysis was carried out on 22 cells, of which 100% exhibited an 
abnonnal karyotype, shown in figure 4.14. 
L014- This case was diagnosed as B-cell low-grade folliCular lymphoma. 
Cytogenetic analysis was carried out on 22 cells, of which 82% exhibited an 
abnormal karyotype. The most common clone is shown in figure 4.15. Another 
clone (represented by 4 cells) did not show trisomy of chromosome 8. 
L015- This case was diagnosed as B-cell low-grade lymphocytic lymphoma. 
Cytogenetic analysis was carried out on 23 cells, of which 100% exhibited an 
abnormal karyotype, shown in figure 4.16. 
L016- This case was diagnosed as B-cell low-grade lymphocytic 
lymphoma. 
Cytogenetic analysis was carried out on 24 cells, of which 
96% exhibited an 
abnormal karyotype, shown in figure 4.17. 
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B-cell low-grade centrocyfic 
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Figure 4,12 Representative karyotype from case LOI I 
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L012 
B-cell low-grade lymphocytic 
48, XY, add(l)(p32), +7, -11, del(14)(q24), del(15)(q24), del(20)(ql3), +marl x2 
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Figure 4.13 Representative karyotype from case L012 
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L013 
B-cell low-grade follicular 
45, X, -X, +l2, -14 
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Figure 4.14 Representative karyotype from case L013 
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L014 
B-cell low-grade follicular 
47, XX, t(6; 8)(p2 I; q24), +8, t(14; I 8)(q32; q2 1) 
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FigUre 4.1E Representative karyotype from case 
L014 
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L015 
B-cell low-grade lymphocytic 
48, XX, add(10)(q22), add(Il)(pl I), t(14; 18)(q32; q2l), +18, 
+der(18)t(14; 18)(q32; q2l), del(22)(q23) 
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.4 
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Representative karyotype from case L015 
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L016 
B-cell low-grade lymphocytic 
47, XX, +12, del(14)(q22) 
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Figure 4.17 Representative karyotype from case L016 
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L017- This case was diagnosed as B-cell high-grade centroblastic lymphorna. 
Cytogenetic analysis was carried out on 31 cells, of which 93% exhibited an 
abnormal karyotype, shown in figure 4.18. 
L018- This case was diagnosed as B-cell low-grade lymphocytic lymphoma. 
Cytogenetic analysis was carried out on 32 cells, all of which exhibited a normal 
karyotype (data not shown). 
1,019- This case was diagnosed as T-cell low-grade T-zone lymphoma. 
Cytogenetic analysis was carried out on 35 cells, of which 94% exhibited an 
abnonnal karyotype, shown in figure 4.19. 
L020- This case was initially diagnosed as B-cell low-grade lymphocytic 
lymphoma. Cytogenetic analysis of the first sample received (L020A) was carried 
out on 27 cells, of which 96% exhibited an abnormal karyotype, shown in figure 
4.20. When two years later a second biopsy was obtained (L020B) This diagnosis 
was again B-cell low-grade lymphocytic lymphoma. Cytogenetic analysis was 
carried out on 17 cells, of which 100% exhibited an abnormal karyotype, shown 
in figure 4.21. 
L021- This case was diagnosed as B-cell high-grade centroblastic lymphoma. 
Cytogenetic analysis was carried out on 27 cells, of which 85% exhibited an 
abnonnal karyotype, shown in figure 4.22. 
L022- This case was diagnosed as B-cell low-grade follicular lymphoma. 
Cytogenetic analysis was carried out on 24 cells, of which 100% exhibited an 
abnormal karyotype, shown in figure 4.23. 
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L017 
B-ceU high-grade centroblastic 
47, XY, +X, add(6)(q23), ins(7;? )(pl3;? ), t(9; 17)(qll; pl 1), +12,43, 
t(14; 18)(q32; q2l), -15, +18 
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Figure 4.18 Representative karyotype from case L017 
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L019 
T-cell low-grade T-zone 
46, XY, -5, -9, add(10)(pl I), add(Il)(q2l), der(16)t(1; 16)(q2l; pll), +2mar 
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Figure 4.19 Representative karyotype from case L019 
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B-cell low-grade lymphocytic 
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Figure 4.20 Representative karyotype from case L020A 
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B-cell low-grade lymphocydc 
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Figure 4.21 Representative karyotype from case L020B 
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L021 
B-cell high-grade centroblastic 
47, XY, add(l)(q2l), add(5)(pl3), 8, -9, -10, -11, del(13)(q3l), add(14)(q24), 
+add(17)(pl2), +22, +4mar 
f add(14)(q24) revised to der(14)t(I 1; 14) and one marker revised to der(I 1) 
following FISHI 
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Figure 4.22 Representative karyotype from case L021 
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L022 
B -cell low-gmde follicular 
50, XX, +X, der(I)t(1; 9)(p32; q12), add(5)(q13) x2, +5der(6)t(6;?; 5)(q13;?; q13), 
-8, +12, add(14)(q32), add(14)(q32), der(15)t(1; 15)(q2l; q22), +18, +mar 
(one add(14)(q32) revised to der(14)t(14; 18)(q32;? ) following FISHI 
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Figure 4.23 Representative karyotype from case L022 
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1,023- This case was diagnosed as B-cell low-grade follicular lymphorna. 
Cytogenetic analysis was carried out on 29 cells, of which 86% exhibited an 
abnormal karyotype, shown in figure 4.24. 
1,024- This case was diagnosed as B-cell high-grade immunoblastic lymphoma. 
Cytogenetic analysis was carried out on 20 cells, of which 100% exhibited an 
abnormal karyotype, shown in figure 4.25. 
L025- This case was diagnosed as B-cell high-grade centroblastic lymphoma. 
Cytogenetic analysis was carried out on 23 cells, of which 78% exhibited an 
abnormal karyotype, shown in figure 4.26. 
L026- This case initially was diagnosed as B-cell low-grade lymphocytic 
lymphoma. Cytogenetic analysis of the first sample received (L026A) was carried 
out on 25 cells, of which 100% exhibited an abnormal karyotype, shown in figure 
4.27. Three years later a second biopsy was obtained (L026B) and again 
diagnosed as B-cell low-grade lymphocytic lymphoma. Cytogenetic analysis was 
carried out on 21 cells, of which 100% exhibited an abnormal karyotype, shown 
in figure 4.28. 
L027- This case was diagnosed as B-cell low-grade follicular lymphoma. 
Cytogenetic analysis was carried out on 19 cells, of which 89% exhibited an 
abnormal karyotype, shown in figure 4.29. 
L028- This case was diagnosed as B-cell high-grade centroblastic lymphoma. 
Cytogenetic analysis was carried out on 29 cells, of which 86% exhibited an 
abnormal karyotype, shown in figure 4.30. 
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L023 
B-cell low-grade follicular 
52-54, XX, +X, dup(l)(q2lq32), add(l)(p32), add(2)(p2l), +3, +5, i(6)(pIO), +7. 
+add(8)(pl 1), +11, t(13; 15)(qlO; qlO), t(14; 18)(q32; q2l), +del(18)(q2l), +21, +2r 
[cp25] 
(del(18)(q2l) revised to der(18)t(14; 18)(q32; q2l) following FISH) 
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Figur 4.24 Representative karyotype from case L023 
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L024 
B-cell high-grade immunoblastic 
46, XY, add(l)(q42), del(2)(q23), t(8; 14)(q24; q32) 
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Figurg 4., 2f Representative karyotype from case 1,024 
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Figure 4.26 Representative karyotype from case L025 
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L026A 
B-cell low-grade lymphocytic 
46, XY, +12, -13, del(14)(q24), add(17)(q25), add(17)(q2l) 
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Figure 4.27 Representative karyotype from case L026A 
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L026B 
B-cell low-grade lymphocytic 
46, XY, +12, -13, del(14)(q24), add(17)(q25), add(17)(q2l) 
31 U 
2 
x db # 
a 
A 
. 9 A £ 
% 
ei 
13 
7 
14 15 
"1 
AA 
hA9z 440 
10 
12 
ix A4 It 
16 17 is 
Ia 
x 
Figure 4.2 Representative karyotype from case L026B 
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B-cell low-grade follicular 
48, XX, +5, i(6)(plO), +12, t(14; 18)(q32; q2l), -18, +mar 
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Figure 4.29 Representative karyotype from case L027 
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L028 
B-ceH high-grade centroblastic 
43-46, X, add(X)(p22), add(I)(p32), +3, add(4)(q21), -6, add(7)(p21), 
add(8)(p2l), -10, -13, add(16)(pl2), -17, add(18)(q23), 
der(20)t(X; 20;? )(ql3; ql3;? ), -22, +2mar [cp25] 
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Figure 4.30 Representative karyotype from case L028 
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L029- This case was diagnosed as B-cell high-grade centroblastic lymphoma. 
Cytogenetic analysis was carried out on 35 cells, of which 100% exhibited an 
abnormal karyotype, shown in figure 4.31. 
L030- This case was diagnosed as B-cell high-grade centroblastic lymphoma. 
Cytogenetic analysis was carried out on 23 cells, of which 100% exhibited an 
abnormal karyotype, shown in figure 4.32 
L031- This case was diagnosed as B-cell low-grade follicular lymphoma. 
Cytogenetic: analysis was carried out on 36 cells, of which 83% exhibited an 
abnormal karyotype. The most common clone (represented by 10 cells) is shown 
in figure 4.33. Three other clones were identified. One (7 cells) showed only an 
add(14)(q32), another (6 cells) displayed an additional add(3)(q27) and the third 
(2 cells) revealed additional abnormalities of chromosomes X, 2, and 20. 
L032- This case was diagnosed as B-cell high-grade centroblastic lymphoma 
Cytogenetic analysis was carried out on 32 cells, of which 50% exhibited an 
abnornial karyotype, shown in figure 4.34. 
L033- This case was diagnosed as T-cell high-grade immunoblastic lymphoma. 
Cytogenetic analysis was carried out on 59 cells, of which 3% exhibited an 
abnormal karyotype (data not shown). However, since none of the aberrant cells 
were found to be clonal, they were not included in the overall analysis of the 
series. 
L034- This case was diagnosed as B-cell low-grade follicular lymphoma. 
Cytogenetic analysis was carried out on 24 cells, of which 87% exhibited an 
abnormal karyotype, shown in figure 4.35. 
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B-cell high-grade centroblastic 
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Fig. urg 4.31 Representative karyotype from case L029 
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B-cell high-grade centroblastic 
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Figure 4.32 Representative karyotype from case L030 
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Figure 4.33 Representative karyotype from case L031 
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L032 
B-cell low-grade follicular 
82-85, Y. XY, -Y, i(l)(qlO), add(l)(p36) x2, add(2)(pl3), +i(3)(plO) x2, 
add(3)(pl3), -4, del(4)(ql2q25), +del(6)(q22q23), del(7)(q22) x2, -8, add(8)(pi 
-9, add(9)(q34), -11, -Il, -11, -12, add(12)(pl3), -13, +add(14)(q22), -15, -15, 
add(16)(ql I) x2, +inv(16)(4llpl2), -17, -17, -18, -18, -19, -21, +3mar [cpl6] 
( add(14) revised to mar and two mar revised to der(l, 8)? following FISH) 
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Fig! grC 4,34 Representative karyotype from case 1,032 
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B-cell low-gradd follicular 
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Figure 4.35 Representative karyotype from case L034 
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L036 
B-cell low-grade follicular 
72.74, XX, +X. +X. +add(I)(p13), +2, +add(3)(q27), +4, +5, +5, 
+6, +add(6)(q23), +7, +7, +8, +9, +add(9)(q34), 
+add(I 1)(q23). +13. +add(14)(q32), t(14; 18)(q32; q2l) x2, +16, -18, -19, +20, 
+21, +dcl(22)(q 11), +1 Imar [cp30] 
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FigUrg 4, M Representative karyotype from case L036 
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Figure 4.37 Representative karyotype from case L037 
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L035- This case was diagnosed as B-cell high-grade immunoblastic lymphorna. 
Cytogenetic analysis was carried out on 24 cells, none of which exhibited an 
abnormal karyotype (data not shown). 
L036- This case was diagnosed as B-cell low-grade follicular lymphoma. 
Cytogenetic analysis was carried out on 33 cells, of which 91% exhibited an 
abnonnal karyotype, shown in figure 4.36 
L037- This case was diagnosed as B-cell low-grade follicular lymphoma. 
Cytogenetic analysis was carried out on 21 cells, of which 81% exhibited an 
abnormal karyotype. The most common clone is shown in figure 4.37. Another 
clone (represented by 7 cells) showed an additional translocation between 
chromosomes 9 and 19. 
4.3) OVERALL ANALYSIS OF THE SERIES 
4.3.1) Introduction 
In order to identify consistent data, the results were pooled. Three of the samples 
were re-bioPsies (cases L01013, L020B and L026B) and information from them 
was not included in the analyses described below, because this might bias the 
frequencies determined when considering the overall data. 
The majority of cases showed a pseudo- or hyper-diploid karyotype. Additionally, 
two samples were near triPloid and four were near tetraploid. Only three cases 
(LO18, L033 and L035) had no clonal abnormalities, although in about half the 
samples a mixture of normal and abnormal cells was observed. 
4.3.2) Numerical analysis 
The X chromosome was gained most frequently (32% of cases), which was 
observed in both males (25%) and females (33%). This was followed in frequency 
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by trisomy of chromosomes 12 (27%), 3 (24%), 7 (16%) and 8 (16%). 
Chromosome loss was far less common, most frequently involving chromosome 
13 (13.5%). With the exception of L028 and L032, which both exhibited highly 
complex karyotypes with several marker chromosomes, loss of a chromosome 11, 
13 or 17 appeared to be mutually exclusive. As a result, a quarter of the samples 
studied showed loss of one of these chromosomes. Figure 4.38 shows the 
percentage of cases in which a gain or loss of each of the chromosomes was 
observed. 
Figure 4.38 Numerical Chromosome Changes in NHL 
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The series contained both high and low grade lymphomas (13 and 24 cases 
respectively), allowing comparison between the karyotypes of these two classes 
of NHL. Cases of loss of chromosomes were relatively few and have therefore not 
been considered; however, numerical gains are summarised in Figure 4.39, which 
shows an interesting difference between high and low grade NHL, since most of 
the chromosome gains appeared to be concentrated in the low-grade samples, 
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although additional chromosomes 3 and X occurred at similar frequencies in both 
groups. 
Figure 4.39 Chromosome Gains in High and Low Grade NHL 
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The series could also be split into two approximately equal sized groups on the 
basis of treatment before biopsy. Again there were few chromosome losses to 
analyse, but numerical gains are summarised in Figure 4.40. The samples from 
patients who had previously been treated exhibited an increased frequency of 
gains of all chromosomes, with the exception of chromosome 12 and to a much 
lesser extent chromosomes 21 and 22. 
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Figure 4.40 Chromosome Gains in Treated and Untreated NHL 
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43-3) Structural analysis 
Figure 4.41 summarises the percentage of cases in which structural abnormalities 
were observed. All chromosomes, with the exception of 21 and Y, were involved 
in structural changes. The most frequently affected chromosome was 14 (70%), 
which in approximately half the samples was involved'in the t(14; 18)(q32; q2l). 
However, I I% of cases contained an add(14)(q32) with no identifiable donor 
chromosome. Chromosome I was affected in 40.5% of cases, with bands p32-36 
and q21 most frequently involved. Abnormal chromosomes 6 were observed in 
35% of cases and most exhibited an altered long arm. When translocation 
breakpoints were included, 27% of all cases exhibited deletion or rearrangements 
of 6q2l-25. Other commonly rearranged chromosomes were 9 (22%) with 
breakpoints at p22, q12 and q21 each occurring in two casesi 17 (22%) with 
17.5% of cases involving the p arm and 3 (19%), with bands p13, q13, q21 and 
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q27 each involved in two cases. A majority of the analysed samples contained 
chromosomes that could not be fully identified. 
Figure 4.41 Structural Chromosome Changes in NHL 
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When the structural rearrangements seen in high and low-grade NHL were 
compared, a similar pattern of changes was revealed (Figure 4.42). However, a 
slightly increased frequency of structural abnormalities was seen in the low-grade 
samples. 
When the structural rearrangements observed in those cases that had received 
treatment was contrasted with untreated samples a broadly similar pattern of 
occurrence was seen (Figure 4.43), although they appeared to be more common in 
the treated group. Low-grade samples in particular showed more structural 
abnormalities after treatment than the high-grade group. 
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Figure 4.42 Strutural Chromosome Changes in High and Low Grade NHL 
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Figure 4.43 Structural Chromosome Changes in Treated and Untreated NHL 
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CHAPTER FIVE 
RESILIS OF FISH STUDIES 
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5.1) INTRODUCTION 
In order to gain further information from the cytogenetic analysis of the NHL 
karyotypes, the FISH technique was used. Amongst the numerical changes 
observed, a significant percentage of cases had shown additional copies of the X 
chromosome, but, since the activation status of those extra chromosomes was not 
known, it was difficult to assess their importance in terms of potential oncogene 
activation. It had been noted that a proportion of the karyotypes contained 
add(14)(q32), in which the additional material could not be identified 
cytogenetically. This was of particular interest, since several oncogenes are 
known to be activated by translocation to the immunoglobulin heavy chain locus 
at 14q32. Structural abnormalities of chromosome 6, particularly of the long arm, 
were very common in the series and this frequently rearranged area was known to 
be the location of several oncogenes. Unusually, one case of NHL was found to 
contain double minutes and a FISH approach was used to characterise these extra 
chromosomal bodies in more detail. Interphase FISH was also applied, both to 
cases from the series and to bone marrow smears from cases of childhood acute 
lymphoblastic leukaemia to investigate the possible uses of the technique on 
archival material. 
5.2 NUMERICAL CHANGES 
5.2.1) Investigation of X activation 
Additional copies of the X-chromosome were observed in almost one third of the 
series. This high frequency was observed in both male and female patients, and in 
both low and high grade disease. It was therefore possible that the presence of 
extra X-chromosomes could be an important causative event in the evolution of 
NIHL. Individuals with sex-chromosome syndromes, such as Klinefelter males 
and super-females, have additional X-chromosomes in all of their cells, but do not 
appear to show any significantly increased predisposition to NHL (Sandberg, 
154 
1980). In the latter cases, however, the additional X-chromosomes are present in 
the inactive state (Lyon, 1972). It was therefore of interest to determine whether 
the activation state of the X-chromosomes in the NHL cases was different to that 
observed in sex-chromosome syndrome individuals. 
The inactive state of the X-chromosome had previously been identified in cells 
with a structure called the Barr body. Unfortunately. it was not possible to 
identify Barr bodies with certainty amongst the clumped heterochromatin in 
interphase lymphoid cells, and therefore two alternative strategies were adopted. 
The first of these involved FISH analysis of the binding of a X-chromosome 
centromere probe to interp hase nuclei to reveal the degree of decondensation of 
the X-chromosome centromeric region. 11is method had previously been shown 
to distinguish active from inactive X-chromosomes in fibroblasts, and had also 
allowed for the identification of X-chromosomes that had been reactivated by 5- 
azacytidine (Dyer et al, 1989). The second approach involved an analysis of the 
methylation state of the X-chromosomes. it was known that the inactive state was 
generally associated with a high degree of methylation but, in this study, the 
M270 probe (Fraser et al, 1989) was used , which was a probe 
for the DXS255 
locus (mapped to Xp 11.22) that was methylated in active X-chromosomes (Boyd 
et al, 1990; Gale et al, 1992). Southern blot analysis of the methylation status of 
this locus in the NHL DNA samples could therefore allow for the inactive and 
active X-chromosomes, to be distinguished. 
In order to determine whether the first approach was possible in material from 
lYmphomas, the technique was first used on cultures of peripheral blood 
lymphocytes. An attempt was made to enrich cultures for different stages of the 
cell cycle, since it was expected that a difference would only be detectable 
between active and inactive X chromosomes at GO/Gl. During S-phase, both X 
chromosomes would be in a similar decondensed conformation to allow DNA 
replication to take place and during G2/M, both X chromosomes would be highly 
condensed, prior to cell division. Differences were noted between cell cycle 
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stages and figure 5.1 illustrates typical GI, S and G2 nuclei. GI cells showed one 
compact and one diffuse signal, S-phase cells showed two diffuse signals and G2 
cells showed two compact signals. 
Signal categorisation was subjective, since differences in both signal size and the 
degree of condensation from cell to cell made direct measurement impracticable. 
Furthermore, the orientation of the centromeres was often not parallel to the plane 
of view which made quantitation of their lengths impossible. 
These findings were then confirmed, by studying interphase nuclei of peripheral 
blood lymphocytes from both a super female with three constitutive X 
chromosomes and from a Kleinfelter male with a sex chromosome complement of 
XXY- As expected, cells from the XXX sample revealed one diffuse and two 
compact signals and the XXY nuclei showed one c ompact and one diffuse 
signal. (figure 5.2) 
The technique was then applied to NHLs from the series that had been previously 
shown to have an aberrant copy number of the X chromosome. The results are 
shown below as table 5.1. 
Examples of three cases that appeared to contain more than one activated X- 
chromosome are shown in figure 5.3. In sample L022 there were three X- 
chromosomes, and FISH analysis revealed one discrete signal with two elongated 
signals (rig. 5.3a). L036 had four X-chromosomes, and FISH analysis revealed 
one discrete and three elongated signals (fig. 5.3b). In L010A there were five X- 
chromosomes, and analysis of the interphase cells revealed one discrete signal but 
four elongated signals (fig. 5.3c). Interestingly, all of these samples had been 
diagnosed as low grade, follicular, NHL. On the basis of the FISH data, the other 
samples in the series appeared to contain additional X-chromosomes that were 
present in the inactive state. 
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Fizuri-M Interphase nuclei of normal peripheral blood lymphocytes, hybridised 
with a centromeric probe for the X-chromosome. 
a) Typical GI nucleus, showing one compact and one diffuse signal. 
b) Tyical S-phase nucleus, showing two diffuse signals. 
0 Typical G2 nucleus, showing two compact signals. 
Compact signals are indicated by arrows and diffuse signals by arrow heads. 
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EWMIMUZ Centromeric probe for the X-chromosome hybridised to interphase 
nuclei from peripheral blood lymphocytes. 
a) Nuclei from a super female (XXX), showing one diffuse and two compact 
signals. 
b) Nuclei from a Kleinfelter male (XXY), showing one compact and one diffuse 
signal. 
Compact signals are indicated by arrows and diffuse signals by arrow heads. 
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Figure 
.3 FISH analysis of X-chromosome centromeres in interphase nuclei 
from a series of NHL cells. The cells were karyotyped and found to contain a) 3 
X-chromosomes (case L022), b) 4 X-chromosomes (case L036), c) 5 X- 
chromosomes (case LOIOA). The arrow indicates the compact signal in the GI /S 
nucleus that represents the inactive X-chromosome. 
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Table 5.1 Analysis of X Activation in NHL 
Methylation analysis 
FISH analysis Active: inactive 
Patient Sex (densitometer reading 
chromosomes ActiveX Inactive X ratios) 
L005 XXX 1 2 1: 2.4 
L010A XXXXX 4 1 1 : 1.3 
L010B XXX 1 2 1: 9.7 
L022 XXX 2 1 1: 7.8 
L023 XXX 1 2 NA 
L032 XXY 1 1 1: 1 
L034 XXX 1 2 1: 7.1 
L036 XXXX 3 1 NA 
L109 X(X) 1/2 1/0 1: 0.5 
NA - tissue not available for analysis; Methylation data taken from Grierson et al, 
1994. 
Methylation of the X-chromosomes was studied by hybridising the M27P probe 
to Southern blots of Msp I/ Kpn 1, and Hpa II / Kpn 1, digested NHL DNA 
samples. This work was carried out by another member of the laboratory 
(Grierson et al, 1994). The hybridisation pattern obtained after Msp I digestion of 
the DNA revealed fragments of approximately 7-10 kb in size. The size 
differences were due to the presence of a VNTR which- was highly polymorphic. 
Therefore in some samples the two alleles were readily resolved (1,022), but in 
others they coincided (LO09). Hpa II digestion of the DNA samples demonstrated 
that one of the alleles was heavily methylated and could not be cut at the Msp I 
Hpa II site, and therefore produced a Kpn I fragment of over 12 kb. The latter 
represented the active X-chromosomes in the sample. The hybridisation patterns 
were scanned by a densitometer to quantify the ratios of the alleles and to assess 
the proportion of X-chromosomes in the active state (table 5.1). This indicated 
that in LOIOA there was more than one X-chromosome present in the active state, 
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which had already been suggested by the FISH analysis. The methylation study 
did not, however, support the observation of the FISH analysis that additional X- 
chromosomes were present in the active state in patient L022 (Fig. 5.3a). It was 
also noteworthy that in some cases (1,0101), L034) the densitometer ratios implied 
that there were many more inactive X-chromosomes present than had actually 
been observed cytogenetically. 
When patient L109 was examined for methylation of the DXS255 locus, there 
appeared to be a significant increase in the hybridisation signal representing the 
activated X-chromosomes This sample was further analysed for LOH of the 
DXS14 locus, which was located close to, and proximal to, the DXS255 locus. 
The region deleted from the abnormal X-chromosome was distal to the positions 
of these loci. These data revealed evidence for loss of one of the X-chromosomes 
in a substantial number of cells in the biopsy sample, as the 2.5kb fragment was 
far more prominent in the NHL biopsy sample than in peripheral blood leukocyte 
DNA from the same patient. Cytogenetic analysis had not previously been carried 
out on case L109. When the chromosomes in this biopsy sample were examined, 
although there were a number of normal cells present, a second clone appeared to 
show monosomy of the X-chromosome in addition to other abnormalities that 
included a marker chromosome and double minutes (figure 5.4). 
However, FISH analysis of this sample had revealed two signals of differing 
degrees of decondensation in each cell (table 5.1). This anomaly was resolved by 
demonstrating, with chromosome painting, that the unidentified marker 
chromosome was in fact a derivative X-chromosome that had lost most of its p 
and q arms (Section 5.2.2). It was not clear, however, whether the one active / one 
inactive X-chromosome combination of signals referred only to the normal cells, 
and whether the combination of two active X-chromosomes represented the 
malignant cells. 
161 
it 11))! 
Ali (i 
' $ " 1 
 0 
4p 
niar 
Figure 5.4 Apparent karyotype of case L109,49, X, -X, +3, i(6p), +8, 
t(14; 18)(q32; q21), +add( 18)(q21), +mar 
5.2-2) Investigation of monosorny X 
Chromosome painting was used to examine abnormal chromosomes whose 
origins were Linclear. In one case (1-109), an apparent monosorny of' the X 
chromosome was investigated (see section 5.2.1). Although loss of' the X 
chromosome had been observed in over a third of* T-cell lcukaernias and 
lyrnphornas (Pui et al, 1988), it was uncommon in B-cell NHL (Mitch-nan et al, 
199] a). An X chromosome paint was therel'Ore used to identil'Y the presence o1'X 
chromosome sequences on other chromosomes. We l'ound that the paint 
hybridised to both the single X chromosome and also to a marker chromosome 
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(rig. 5.5). The latter was apparently a second X chromosome that had lost parts of 
both its p and q arms. 
5.2.3) Interphase analysis 
5.2.3.1) Interphase analysis of NHL 
When studying the cytogenetics of malignancy, there is often difficulty in 
obtaining a sufficient number of metaphases suitable for analysis. In order to 
investigate the possibilities for analysing non-dividing material, FISH was used to 
identify numerical chromosome abnormalities in interphase NHL cells. A series 
of experiments were performed, involving the hybridisation of an alphoid repeat 
sequence, which hybridised to the centromeric region of the X chromosome. In 
lymphocytes from a normal female donor, both of the X chromosomes were 
clearly indicated in both metaphase spreads and interphase nuclei (fig. 5.6), as 
were the three X chromosomes in lymphocytes from a superfemale donor 
(fig. 5.2a). This approach was used to identify the X chromosomes in interphase 
nuclei from NHL cells containing three (fig. 5.3a), four (fig. 5.3b) and five (rig. 
5.3c) X chromosomes. 
5.2.3.2) Interphase analysis of archival material 
In order to explore the potential use of interphase FISH in archival material, a 
series of experiments was performed on bone marrow smears from cases of 
childhood acute lymphoblastic leukaemia (ALL). To evaluate the reliability of 
FISH on aged bone marrow slides, a probe for the centromeric region of the X 
chromosome was applied to a series of bone marrow smears from ALL patients in 
remission, which had been stored from 6 months to 20 years. Centromere probes 
for chromosomes X, 6 and 18 were also hybridised to smears obtained at 
diagnosis, from cases found to have an abnormal karyotype by conventional 
cYtogenetics, to assess the degree of concordance between results obtained by 
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Fig"r 5.5 Metaphase spread from case L109 that had apparently exhibited 
monosomy of the X chromosome, hybridised with a painting probe specific for 
the X-chromosome. Signal is apparent on both the X chromosome (arrow head) 
and on an unidentified marker chromosome (arrow). 
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FISH and routine chromosome analysis. This work was carried out in 
collaboration with the Section of Paediatric Haematology at the Sheffield 
Children's Hospital and also the Centre for Human Genetics in Sheffield, where 
the chromosome analysis was performed. 
Table 5.2 gives patient information, smear type and age and the percentages of 
nuclei with different numbers of X centromere hybridisation signals for the series 
of patients in remission. The hybridisation efficiency ranged from 51-99% with 
an average of 76.7%. The oldest sample showed the lowest efficiency and the 
most recent the highest. A small percentage of nuclei demonstrated extra X 
centromere signals (two in males and three in females), with a mean of 1.86±1.21. 
Figure 5.7 illustrates hybridisation of the X centromere to typical interphase 
nuclei from smears stored for 10 and 15 years. 
Details of the hybridisation of probes specific for the centromeric regions of 
chromosomes X, 6 and 18 to bone marrow smears from children with ALL are 
given in table 5.3. In this series of samples a hybridisation efficiency of between 
76.5 and 100% was obtained, with the unfixed frozen material showing very few 
nuclei without signals. A trisomic clone was defined as being present in an ALL 
bone marrow smear when the percentage of nuclei displaying three signals was 
greater than the mean %± twice the standard deviation of cells showing an extra 
signal in the remission samples (Anastasi et al, 1991). When this criterion was 
applied to the ALL smears, all cases clearly demonstrated the presence of extra 
copies of those chromosomes previously identified by conventional cytogenetics 
as aneusomic. Results from the unfixed material showed a closer correspondence 
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figiLre 5.6 FISH analysis of the X chromosome in peripheral blood lymphocytes 
by the use of a centromeric alphoid repeat probe in metaphase and interphase 
cells. 
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Figure .7 Hybridisation of X centromere probes to interphase nuclei from 
Romanowsky stained bone marrow smears. 
a) 10 year old bone marrow smear from a female patient with ALL in remission. 
Two signals are clearly visible in most cells. 
b) 15 year old bone marrow smear from a male patient with ALL in remission. 
One signal is present in a number of cells. 
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Table 5.2 FISH with an X Centromere Probe applied to Stored Bone 
Marrow Smears taken from Patients with ALL in Remission 
Case No Age (Y) 
/Sex 
Age of 
smear 
(M) 
Type of 
smear 
% of cells with number of signals 
0123 
I 5/M 6 RM 26 72 2 0 
2 8/M 6 RM 49 49.5 1.5 0 
3 8/F 6 RM 22.5 11 65 1.5 
4 4/F 12 RM 5 14 81 0 
5 2/F 36 RM 23.5 18 56 2.5 
6 9/F 240 RM 49 15 36 0 
7 15/F 120 RM 16 16 66 2 
8 3/M 60 RM 21 74.5 4.5 0 
9 5/F I RM 1 6 90 3 
UF 3 10 85 2 
10 6/M 180 RM 40.5 58 1.5 0 
RM: - Romanowsky stained, UF: - unfixed 
to the proportion of abnormal cells found cytogenetically, than did results from 
Romanowsky stained slides. 
In case 15 , the data confirmed the identity of a marker chromosome thought to be 
derived from chromosome 6 and revealed the possible presence of a small clone 
containing three chromosome 6 centromeres. 
5.3) STRUCTURAL CHANGES 
5.3.1) IjIvestigation of add(14)(q) chromosomes 
Although the long arm of chromosome 14 was the most common region of 
rearrangements in the series, it was not always possible to determine the origin of 
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material translocated onto chromosome 14. These cases were initially investigated 
using chromosomes 14 and 18 paints since chromosome 18 is the most common 
translocation partner for chromosome 14 in NHL. If this first approach proved 
uninformative, paints for chromosome 14 and either chromosome 3,8,10,11 or 
19 were then applied because, as discussed above (Section 1.3.2), all of these 
chromosomes carry oncogenes which are activated in translocations with 
chromosome 14. 
Patient L023. An example of a typical t(14; 18)(q32; q2l) was observed in the 
malignant cells of the biopsy sample (fig. 5.8), which had been diagnosed as low 
grade follicular NHL. The chromosome 14 paint hybridised to the normal 
chromosome 14 and to the der(14), however, the region of chromosome 14 that 
was translocated to form the der(18) was too small to detect by painting. The 
hybridisation of the chromosome 18 paint to these cells clearly demonstrated the 
presence of three chromosomes 18, two of which were der(l8q), as well as 
chromosome 18 material that had been translocated to the q arm of the der(14) 
chromosome (fig. 5.9a). 
Patient L009. The karyotype was pseudotriploid and in addition to a 
t(14; 18)(q32; q2l) also contained a normal chromosome 14, a der(14) (fig. 5-8) 
and two chromosomes 18. This biopsy had been diagnosed as low grade follicular 
N'HL- The chromosome 14 paint hybridised to all three chromosomes 14, but the 
chromosome 18 paint hybridised to both der(14), the chromosomes 18 and to two 
der(IO) chromosomes (fig. 5.9b). 
Patient L022. This karyotype contained two der(14)t(14;? )(q32;? ) (fig. 5.8) with 
three apparently normal chromosomes 18. The biopsy was diagnosed as low 
grade follicular NHL. Dual painting with chromosome 14 and 18 paints 
demonstrated that both der(14) hybridised to the chromosome 14 paint, but only 
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Figure 5.8 Partial karyotypes of non-Hodgkin's lymphomas showing the normal 
and derivative chromosomes 14. Giernsa-banding of the malignant cell 
metaphases was carried out as described in the Materials and Methods. The 
normal chromosomes 14 are shown on the left in each case and the apparent 
translocation breakpoints on the der(14) indicated by arrowheads. 
a) L023; b) L009; L022; d) L03 1; e) LO 11; f) L006 - the del(I 4q) is on the left 
and the der(14) on the right; g) L02) 1; h) L032. 
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Figure 5.9 Analysis of non-Hodgkin's lymphoma metaphases by dual 
, chromosome painting. In all experiments the chromosome 14 paint is shown in 
red and the other paint in green. The chromosomes were counterstained using 
DAPI (blue). 
a) L023 - chromosomes 14 and 18 paints were used. The der(14) is indicated by 
the arrow. 
b) L009 - chromosomes 14 and 18 paints were used. The der(14) are indicated by 
the white arrows and the der(10) chromosomes by the yellow arrows. 
c) L022 - chromosomes 14 and 18 paints were used. The der(14) which 
hybridized to the chromosome 18 paint is indicated by the white arrow and the 
der(14) that did not hybridize with the chromosome 18 paint is indicated by the 
yellow arrow. 
d) L031 - chromosomes 14 and 3 paints were used. The der(14) chromosome is 
indicated by the arrow. 
e) LOI 1- chromosomes 14 and 3 paints were used. The der(14) is indicated by 
the white arrow. 
f) L006 - chromosomes 14 and 3 paints were used. The der(14) is indicated by the 
white arrow. 
g) L021 -"chromosomes 14 and II paints were used. The der(14) is indicated 
by 
the white arrow and the marker by the yellow arrow. 
h) L032 - chromosomes 14 and 18 paints were used. The four normal 
chromosomes 14 are in red, the two normal chromosomes 18 in green and two of 
the markers also in green. 
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one der(14) hybridised with the chromosome 18 paint; which also hybridised to 
the three chromosomes 18 (fig. 5.9c). The unknown material that had been 
translocated to the q arm of the other der(14) did not hybridise with paints for 
either chromosome 3 or 19 and cytogenetically did not resemble chromosome II 
material. No further analysis was possible on this sample, which had become 
depleted. 
Patient L031. Several different clones of cells were identified in this sample, 
which had been diagnosed as low grade follicular NHL. The only common 
abnormality in all clones was the presence of a der(14)t(14;? )(q32;? ), which was 
not typical of the product of the t(14; 18) (fig. 5.8). The paints for chromosomes 
14 and 18 only hybridised to their respective chromosomes. Therefore paints 
from chromosomes 14 and 3 were used, as a der(3)t(3;? )(q27;? ) had been 
observed in one of the clones. In this case the chromosome 14 paint hybridised 
only to the normal and der(14) chromosomes and the chromosome 3 paint only to 
the normal and der(3) chromosomes (fig. 5.9d). Similar results were obtained by 
dual painting with chromosome paints for 14 and 8,14 and 10,14 and 11 and 14 
and 19 where in each case the paints hybridised only to their respective 
chromosomes. As a result, the origins of the material that had been translocated to 
the q arm of this der(14) were not identified. 
Patient L011. Several malignant cell clones were identified in this biopsy, which 
had been diagnosed as low grade centrocytic NHL (though within a few months 
of this biopsy the patient relapsed with high grade centroblastic NHL). The only 
consistent abnormalities observed in all of the clones was a der(14), which was 
not typical of the product of the t(14; 18) (fig. 5.8), and extra chromosomes 8 and 
18, which were apparently normal. Dual painting with chromosome 14 and 18 
paints, demonstrated that they hybridised to their respective chromosomes. 
Chromosome 14 and 3 paints were then used and this time the material 
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translocated to the q arm of the der(14) was shown to be from chromosome 3. 
The two chromosomes 3 appeared to be cytogenetically normal and hybridised 
with the chromosome 3 paint, but not with the chromosome 14 paint (fig. 5.9e). 
Patient L006. Two abnormal chromosomes 14 were observed, one of which was 
a del(14q) and the other a der(14) (fig. 5.8) similar to the one observed in LOI I. 
The diagnosis for this biopsy was high grade centroblastic NHL. The 
chromosome 14 and 18 paints hybridised only with their respective 
chromosomes. Therefore chromosome 14 and 3 paints were used and this time 
the material that had been translocated to the q arm of the der(14) was identified 
as originating from chromosome 3 (fig. 5.9f). 
Patient L021. A der(14)t(14;? )(q24;? ) (fig. 5.8) and a number of marker 
chromosomes were observed in this biopsy, which had been diagnosed as high 
grade centroblastic NHL. The paints for chromosomes 14 and 18 hybridised with 
their respective chromosomes. Similarly paints for chromosomes 14 and 3,14 
and 8, and 14 and 19 all hybridised with their respective chromosomes. However, 
when the chromosomes were dual painted with chromosome 14 and II paints, the 
chromosome 11 paint hybridised to a region that hadapparently been inserted 
into the q arm of the der(14), in a manner which was not suspected from the 
Giemsa banding. This paint also hybridised to the normal chromosome II and to 
a marker chromosome (fig. 5.9g). 
Patient L032. The karyotype was pseudotetraploid and contained four normal 
chromosomes 14 and an apparent der(14)t(14;? )(q22;? ) (fig. 5.8) with two 
chromosomes 18 and three marker chromosomes. The diagnosis for this biopsy 
was low grade follicular NHL. Dual painting with chromosome 14 and 18 paints 
demonstrated that the paints hybridised to their respective chromosomes, but the 
chromosome 18 paint also hybridised to two of the markers (fig. 5.9h). The 
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surprising result was that only the four normal chromosomes 14 hybridised with the 
chromosome 14 paint and the larger abnormal chromosome that had been identified 
as a der(14) by Giernsa-banding did not in fact contain chromosome 14 material. This 
observation was consistent in all ten cells analysed. 
5.3.2) Investigation of abnormalities of chromosome 6. 
Abnormalities of chromosome 6 were studied by two methods. In the first approach, a 
chromosome 6 paint was hybridised to NHL metaphases obtained from cases 
displaying an aberrant chromosome 6, in order to reveal either any translocated 6 
material or the presence of non 6 chromatin (which would be visible as counterstain) 
in rearrangements of chromosome 6 detected by conventional cytogenetics. The 
second strategy involved refining the previously mapped position of the MYB proto- 
oncogene on the long arm of chromosome 6, using metaphase spreads from normal 
PBLS. The MYB probe was then hybridised to NHL metaphases to determine whether 
the locus of the gene was involved in any sub-microscopic rearrangements. 
5.3.2.1) Painting of chromosome 6 
Chromosome painting of cases L007, L010A, L017, L022, L023, L032, L034 and 
L036 failed to reveal any unexpected absence of chromosome 6 material from 
previously noted abnormal chromosomes 6. Furthermore, in only one case (L036), 
did any other chromosome display signal from the 6 paint, which in this instance was 
considered to indicate the presence of 6 material in one of the marker chromosomes 
revealed by conventional cytogenetics. Figure 5.10 shows examples of chromosome 
painting in cases L036, L034 and L032. 
5.3.2.2) FISH analysis of the MYB proto-oncogene 
The MYB probe was mapped to metaphase spreads according to the methods 
described in Section 3.7. Four separate experiments provided 13 metaphases, in 
which both FISH and post banding results were of sufficient quality to derive 
I 
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'Fi9zMLM Analysis of NHL metaphases with chromosome 6 painting. 
a) L036; arrows indicate apparently normal chromosomes 6. A marker containing 
chromosome 6 material is indicated by an arrowhead. 
b) L034; arrowheads indicate add(6) chromosomes. 
0 L032; arrows indicate apparently normal chromosomes 6. An arrowhead 
indicates a del(6) chromosome. 
176 
clear mapping data. Table 5.4 displays the raw data (in millimetres) obtained from 
projected slides of the preparations, the Fractional Length (derived from cen-q 
ter/probe-q ter on the FISH preparations), the measurement (derived with the FL) 
for probe-q ter on the post banded chromosomes and the specific band identified 
by application of the measurement. 
Table 5.4 Mapping of the MYB Proto-oncogene onto Metaphase 
Chromosomes 
EIM POST BANDING 
Cen-Ute r probe:! ater- Fl cen-qter probe-qter 'band 
157 48 3.3 146 45 6q23.2 
113 38 3.0 102 34 6q23.1 
149 47 3.2 147 46 6q23.2 
68 22 3.1 66 21 6q23.3 
94 29 3.2 93 29 6q23.2 
67 23 2.9 67 23 6q23.2 
87 27 3.2 84 26 6q23.2 
62 18 3.4 60 18 6q23.1 
77 28 2.8 75 27 6q23.1 
89 25 3.6 95 26 6q23.3 
129 47 2.7 125 46 6q23.2 
95 30 3.2 96 30 6q23.3 
Figure 5.11 illustrates probe hybridisation and post banding in a typical mapping 
metaphase. In all scored cells, the MYB probe was mapped to band 6q23, with 
over 50% of the metaphases showing hybridisation to 6q23.2. 
The MYB probe was then applied to metaphases obtained from NHLs, in order to 
investigate any occult rearrangements involving the 6q23 locus. Acceptable FISH 
results were obtained in two cases (LOIOA and L017). Metaphases from these 
cases, hybridised with both the MYB probe and the p308 chromosome 6 
centromere probe, are shown in figures 5.12. L010A showed three pairs of signals 
on at least three of the four chromosomes 6 present, implying that submicroscopic 
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Figure 5.11 FISH analysis of the MYB gene on normal and NHL metaphases. a) 
Mapping of the MYB proto-oncogene to chromosome 6q23. FISH localization of 
the MYB proto-oncogene on a metaphase spread from normal human lymphocytes 
(indicated by the arrow). A chromosome 6 centromeric probe was also used to aid 
identification. 
b) Post-banding of the metaphase spread shown in a). 
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Figure 5.12 FISH analysis of the MYB gene on NHL metaphase spreads. The 
arrows indicate the positions of the MYB hybridization signals on the visible parts 
of the chromosomes 6. A chromosome 6 centromeric probe was also used to aid 
identification. 
a) Case LO I OA Ib) Case L017 
179 
amplification and subsequent reintegration of the 6q23 region had taken place. In 
contrast, L017 revealed only a single pair of signals on each of the two 
chromosomes 6. However, on one chromosome, the signals were present at an 
aberrant, more proximal locus on the long arm. This suggested a previously 
unsuspected chromosomal rearrangement involving the 6q23 region had occurred 
5.3.4) Analysis of double minutes in NHL 
Double minutes are rarely found in NHL and none were observed in the series of 
samples reported in Chapter four. However, when more than 30 abnormal cells 
were examined from an additional node biopsy from a case (1,109) with a 
diagnosis of follicular low grade NHL (see Section 5.2.1), unexpectedly, all were 
found to contain double minutes (dmin). The number of dmin ranged between 5- 
20, with a median of 10 dmin per cell. The identification of these 
extrachromosomal bodies as dmin was based on their morphology (fig. 5.13a) and 
the fact that they were negative by C-banding (fig. 5.13b). As part of the 
characterisation of abnormalities in these cells, an X chromosome paint had been 
hybridised to the metaphases. (see Section 5.2.2). 'Ibis unexpectedly revealed that 
the dmin were composed of X chromosome material (fig. 5.13c). In parallel 
studies an X chromosome centromere probe was observed to hybridise to both the 
X chromosome centromeres and to all of the dmin (fig. 5.13d). As a negative 
control, a centromere probe for another chromosome (in. this case chromosome 6) 
was used and it was observed to hybridise only to the chromosomes 6 and not to 
the dmin. It was thus demonstrated that the dmin in these cells were derived from 
an X chromosome and that they contained sequences that were specific for the 
centromeric region. 
Further FISH analysis of the case demonstrated that a pan-centromere probe 
hybridised not only to the centromeres of all chromosomes, but to each of the 
dmin (fig. 5.14a). The hybridisation of this probe was therefore examined in cells 
from a neuroblastoma biopsy sample which contained many (usually >20) dmin 
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Figure 5.13 Cytogenetic and FISH analysis of cells from a NHL node biopsy. a) 
G-banded metaphase, b) C-banded metaphase. 
Cells hybridized with an X chromosome paint 0 or an X chromosome centromere 
probe d). Examples of dmin are indicated by arrowheads. 
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Eigurc 5.14 FISH analysis of the presence of centromere-associated DNA 
sequences in drain in malignant cells. NHL cell hybridized with the pan- 
centromere probe (a). Neuroblastoma cell stained with propidium iodide (b) and 
hybridized with the pan-centromere probe (c). Soft tissue sarcoma cell stained 
with propidium iodide (d) and hybridized with the pan-centromere probe (e). 
Acute myeloid leukaemia cells from patients AML-6528 and AML-5926 stained 
with propidium iodide (f and h, respectively) and hybridized with the pan- 
centromere probe (g and i, respectively). Examples of dmin are indicated by 
arrowheads. 
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per cell (fig. 5.14b). In this case there was no evidence of hybridisation to the 
dmin (fig. 5.14c). As it was known that the dmin in these tumour cells are 
associated with amplification of the N-MYC gene from chromosome 2 (Kohl et 
al, 1983), a chromosome 2-specific centromere probe was also hybridised to the 
metaphase spreads. Even under conditions of low stringency there was still no 
evidence of hybridisation of this centromere probe to the dmin. Cells from a soft 
tissue sarcoma biopsy sample, which contained approximately 20 dmin per cell 
(fig. 5.14d), were also hybridised with the pan-centromere probe and similarly 
failed to reveal hybridisation to the dmin (fig. 5.14e). Acute myeloid leukaemia 
cells from two patients were also examined. These cells were observed to contain 
a variable number of dmin, but in both cases there were always <20 dmin per cell 
(fig. 5.13f, h). It was found that approximately 25% of the dmin in these cells 
hybridised with the pan-centromere probe (fig. 5.14g, i). Although this might 
indicate that the dmin were not homogeneous in the AML cells, the failure to 
detect signal in some of the dmin might also have been due to the generally 
fainter hybridisation signals observed in these cells. In both of these figures, 
examples of dmin are indicated by five arrows, two of'which indicate dmin that 
contained centromere-associated DNA and three arrows that indicate dmin which 
did not contain centromere- associated DNA. The hybridisation data thus 
demonstrated the existence of dmin containing centromere-associated DNA 
sequences in the malignant cells of lymphoma / leukaemias, but not in cells from 
those solid tumours examined. 
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CHAPTER SIX 
DISCUSSION 
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6.1) CYTOGENETICS 
6-1.1) General considerations 
Cytogenetic analysis was performed on a series of 40 NHL node biopsies 
obtained from U. K. patients. This group was composed of both low- and high- 
grade NHL samples and approximately equal numbers of untreated and 
previously treated patients. 
A considerable number of series detailing NHL karyotypes have been published 
over the last decade (Kaneko et al, 1983; Kristofferson et al, 1987; Yunis et al, 
1987; Levine et al, 1988; Cabanillas et al, 1989; Yunis et a], 1989; Schouten et al, 
1990a; Offit et al, 1991b; Tilly et al, 1994). These studies have shown wide 
variation, both in terms of the percentage of successful analyses achieved and the 
number of analysed cases which showed only a normal karyotype. 
The 40 karyotypes reported in this thesis were the result of culturing forty three 
lymph node biopsies, a success rate of 93%. This compares very favourably with 
other studies in the literature, which report success rates from 65% (Kaneko et al, 
1983) to 84% (Juneja et al, 1990). Several aspects of the culture system (Section 
2.2.2.1) may well contribute to the high percentage of analysable metaphases. 
Firstly, three separate cultures were set up for each specimen, increasing the 
chances of overall success, since it was not unusual for one of the cultures to fail. 
Further, no attempt was made to produce pro-metaphase chromosomes by 
manipulating the culture conditions. Lymph node tissue was disaggregated in pre- 
warmed media by a combined cutting and pressing action, using curved scissors. 
This technique generated a suspension containing low numbers of cells from the 
capsule and infra-structure of the node. Finally, the culture media contained 
human serum, in contrast to the foetal calf serum used in other studies (Koduru et 
al, 1987; Juneja et al, 1990). 
Only three out of 40 samples (7.5%) in this series revealed an exclusively normal 
karyotype. Other studies have reported findings of 14% (Kristofferson et al, 
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1987), 20% (Offit et al, 1991a) and 24% (Koduru et al, 1987) cytogenetically 
normal cases. It is of course possible that normal karyotypes apparently obtained 
from tumour cells contain sub-microscopic or other abnormalities, which are not 
detectable by conventional cytogenetics. Alternatively, normal rather than tumour 
cells may have cultured. The lower incidence of normal karyotypes in this series 
may be a reflection of short culture times, no use of mitogens and a greater 
number of (malignant) lymphocytes in the initial culture system, due to the 
disaggregation procedure described above. 
6.1-2) Numerical changes 
Among the many numerical abnormalities, a particularly interesting finding was 
the much greater prevalence of numerical gains in the low-grade NHL samples. 
Twice as many of these samples exhibited trisomies of several chromosomes, 
when compared to those in the high-grade group. Furthermore, trisomies of 
almost all the chromosomes were observed in low-grade samples, whereas only 
seven of the chromosomes were involved in trisomies in the high-grade group. 
This observation does not appear to have been previously documented. It may be 
an indication of a more general breakdown in the machinery of cell replication in 
low-grade disease or is perhaps an example of the regional variation found in 
neoplasia-associated chromosome aberrations (Fifth International Workshop on 
Chromosomes in Leukaemia-Lymphoma, 1987; Johansson et al, 1991). However, 
further analysis of the data showed that trisomies were more common in low- 
grade disease samples from patients who had been previously treated than in 
similarly treated high-grade samples. The effect of the treatment may therefore 
have been greater on the chromosomes in low-grade than in high-grade NHL. 
The most common numerical chromosome change observed was the presence of 
an additional chromosome X, present at a higher frequency than in previously 
reported series, in which the frequency varied between 3 and 22.5% (Offit et al, 
1991a; Yunis et al, 1987; Fleischman et al, 1989). The significance of an extra X 
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chromosome is unclear, although in some NHL cases trisomy X has been reported 
as the only identifiable anomaly (Mitelman et al, 1991), suggesting that the gain 
of a copy of this chromosome may be a primary abnormality in NHL. Studies of 
other malignancies have indicated that additional X chromosomes are present in 
the active state in neoplastic cells (Dutrillaux et al, 1986; Wang et al, 1990) and 
the results of the study of X chromosome activation status in NHL cells from this 
series are discussed below in section 6.2.1.1. 
Trisomies involving chromosomes 3 and 12 were observed at frequencies similar 
to those previously reported in other series (Offit et al, 1991a; Yunis et al, 1987; 
Fleischman et al, 1989; Fifth International Workshop on Chromosomes in 
Leukaemia-Lymphoma, 1987). The data presented in this thesis do not support 
suggestions that +3 is associated with high-grade lymphomas (Schouten et al, 
1990a; Fleischman et al, 1989), or that +12 is associated either with lymphocytic 
(Mitelman et al, 1990) or diffuse large cell lymphoma (Cabanillas et al, 1988; 
Offit et al, 1991a). Trisomy 12 was twice as common in low-grade when 
compared to high-grade NHL in this series, but was not particularly associated 
with the lymphocytic subtype. Notably among the chromosome gains, +12 was 
more frequent in patients who had not been treated; in spite of the fact that low- 
and high-grade samples were evenly distributed between the treated and untreated 
groups. This may reflect clonal selection against trisomy 12, driven by 
chemotherapy. It is also possible that the relatively higher frequency of trisomy 
12 in low-grade NHL could be a manifestation of the different treatment regimes 
used in the management of these cases; since low-grade NHL tend to be treated 
over many years while high-grade cases recieve more agressive, shorter term 
therapy. 
Loss of a whole chromosome was not a frequent occurrence in the series. 
However, when loss of chromosomes 11,13, or 17 was observed, usually only 
one of these chromosomes was lost in any particular sample. This is noteworthy, 
because studies in a variety of malignancies have demonstrated the presence of 
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turnour suppressor genes on these chromosomes. Chromosome 13 carries the RB- 
I gene (Lundberg et al, 1987; Bookstein et al, 1988), chromosome 17 the p53 
gene (Baker et al, 1989) and chromosome II the WT-I gene (van Heyningen et al, 
1985). Loss of one of these chromosomes occurs in one quarter of the cases in 
this study and suggests that molecular biology studies of these tumour suppressor 
genes may be informative. However, loss of chromosome 13 probably involves a 
tumour suppressor gene other than RB-1, since an extensive analysis of RB-1 in 
this series failed to identify any abnormalities (Grierson et al, 1995). A possible 
candidate TSG may exist at the DBM (Disrupted in B-cell Malignancy) locus, 
recently identified within l3q14 (the site of RB-1) in chronic lymphocytic 
leukaernias (Brown et al, 1993). 
6.1.3) Structural changes 
The most common chromosome abnormality detected in the series was the 
t(14; 18)(q32; q2l), with frequencies of 59% in follicular low grade and 17% in 
high-grade NHL. These findings are in agreement with the results of some 
previously published studies (Offit et al, 1991b; Schouten et al, 1990a), but 
somewhat lower than those of others (Yunis et al, 1987; Fleischman et al, 1989). 
It may be that these differences are a reflection of variations in culture techniques 
or ascertainment procedures between different laboratories This translocation 
appears to be the mechanism by which the BCL-2 gene is activated (Tsujimoto et 
al, 1985) and is likely to be of central importance in the aetiology of follicular low 
grade NHL, 
-since 
the BCL-2 gene product acts to prevent apoptotic cell death 
(Reed, 1994), thus allowing the expansion of subpopulations of cells capable of 
subsequent progression to malignancy. However, in a series of high-grade NHL 
with no previous history of low-grade disease BCL-2 rearrangements were 
uncommon (Lee K et al, 1993), suggesting further genetic changes are required 
for high grade malignancy. 
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Chromosome 6 was often observed to have all or part of its q arm deleted. if 
translocation breakpoints are included then 27% of all cases exhibited deletion or 
rearrangements of 6q2l-25. Similar findings have been previously documented 
(Offit et al, 1991b; Fleischman et al, 1989; Fifth International Workshop on 
Chromosomes in Leukaemia-Lymphoma, 1987). There was no evidence to 
support the suggestions that these abnormalities were primarily associated either 
with previous treatment (Cabanillas et al, 1988) or immunoblastic lymphoma 
(Schouten et al, 1990b). In fact the data suggested a more common association of 
6q abnormalities with low grade disease. 
Recurrent breakpoints on other chromosomes were suggestive of known 
oncogene involvement. lp32-36 (L-MYC) (Little et al, 1983), l7p13 (p53) (Baker 
et al, 1989), 3q27 (BCL-6) (Ye et al, 1993) and l9q13 (BCL-3) (McKeithan et al, 
1987) were all noted in several cases. However, the I Iq 13 locus, the site of BCL- 
1, was involved in only one case; in spite of being reported at high frequencies in 
other series (Fifth International Workshop on Chromosomes in Leukaemia- 
Lymphoma, 1987; Offit et al, 199 1 a). Again, this may be an example of regional 
variation. No 1Oq24 (LYT-10) (Neri et al, 1991) breakpoints were observed but, 
given a series of this size, the absence of a relatively uncommon rearrangement 
was not surprising. However, two cases showed rearrangements involving 2p23 
(ALK) (Morris et al, 1994), but without a 5q35 translocation partner. The 
t(2; 5)(p23; q35) is found only in Ki-1 lymphoma and would thus be a highly 
unexpected finding, but the presence of this breakpoint is provocative. 
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6.2) MOLECULAR CYTOGENETICS 
6.2.1) Numerical studies 
6.2.1.1) Activation of chromosome X 
This part of the study attempted to examine the activation status of X- 
chromosomes in NHL cells. With other cell types it should have been a 
straightforward matter to count Barr bodies, but in lymphoid cells these were very 
difficult to distinguish. The adopted strategy of combining FISH analysis of X- 
chromosome centromeres in interphase nuclei with Southern blot analysis of the 
methylation status of the DXS255 locus provided complementary evidence for the 
presence of additional active X-chromosomes, in spite of the limitations inherent 
in both these techniques. 
A major advantage of the FISH approach was in allowing the NHL cells in the 
sample to be distinguished from normal cells, by virtue of abnormal numbers of 
signals. The main disadvantage was the inherent lack of a reliable method of 
quantification, due to the uncertain position in the cell cycle of individual nuclei 
and additionally to differences in signal size from cell to cell. 
The methylation studies examined the DXS255 locus which, although not 
expressed, was differentially methylated on active or inactive X-chromosomes, 
(Boyd and Fraser, 1990). The locus was usually informative because it contained 
a VNTR sequence that was highly polymorphic. In the NEL series, analysis of 
this locus indicated that in one of the cases there were additional X-chromosomes 
present in the active state. In other cases this was not so certain, and in fact L022 
provided no evidence that this was the case even though the FISH analysis had 
indicated otherwise. A possible explanation for the contradiction between the two 
approaches applied to L022 might be due to differential hypermethylation of the 
Msp I/ Hpa II sites in the DXS255 locus in this sample. Hypermethylation of the 
locus has been reported in a number of cell types (Gale et al, 1992; Hendriks et al, 
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1991). It has been assumed that there was no allele specific difference in the 
hyperinethylation which might produce differences in the intensities of the 
hybridisation signals, but if this was not the case then it could account for the data 
obtained for L022, and also question the reliability of the data from samples 
LOIOB and LOA where the proportion of inactive X-chromosomes appeared to 
be far greater than that determined cytogenetically. The presence of normal cells 
in the biopsy samples might also have complicated the situation, especially as the 
inactivation of the X-chromosome could be a random event in these cells. 
Patient L109 was particularly interesting because the malignant cells contained 
one normal and one abnormal X-chromosome, and both of these chromosomes 
appeared to be present in the active state. It was also noted that there was clear 
evidence of LOH of the X-chromosome in this sample. It would appear therefore 
that the inactive X-chromosome had been lost from this clone, duplication of the 
active chromosome then occurred, and finally one of the activated chromosomes 
suffered deletion of part of its p and q arms. This is therefore an interesting 
example of how the probable evolution of part of the malignant karyotype can be 
inferred by a combination of FISH and Southern blot analysis. 
Although there are a number of reservations concerning the approaches used 
here, they have provided evidence that additional X-chromosomes might exist in 
the active state in some NHL cases. Since, under normal circumstances, only 
single copies of most genes present on the X-chromosome are available for 
transcription, this raises the interesting possibility that a subversion of the gene 
dosage effect may contribute to neoplastic development. Although there are few 
studies of this phenomenon in the literature, additional active X-chromosomes 
have been reported in colorectal cancers (Muleris et al, 1990) and in two human 
mammary carcinoma cell lines (Wang et 4 1990). Furthermore, it has also been 
suggested that one or more oncogenes, might be located on the X-chromosome. A 
recent study analysed structural abnormalities of the X-chromosome in 280 cases 
of NHL, and has identified Xp22 and Xq28 as likely regions for the location of 
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such a gene (Goyns et al, 1993). More specifically, a putative oncogene has 
recently been isolated from a T-cell leukaemia and mapped to Xq28 (Thick et al, 
1992). Together these observations suggest a possible role for the X-chromosome 
in the evolution of some cases of NHL. 
6.2.1.2) Interphase cytogenetics 
NHL 
It has often been difficult to obtain metaphase spreads from tumour cells of either 
sufficient quality or quantity for use in conventional cytogenetics. Alpha satellite 
probes have now been used successfully to enumerate chromosome copy number 
in a range of solid tumours (Devilee et al, 1988; Nederloff et al, 1989; Arnoldus 
et al, 1991) and haernatological malignancies (Anastasi et al, 1992). It proved 
possible to clearly identify numerical chromosomal abnormalities in interphase 
NHL cells from the series, allowing both chromosome counting and the 
possibility of determining relative numbers of normal and abnormal cells in a 
particular lymphoma sample. 
Bone marrow smears 
DNA probes specific for the centromeric regions of a range of human 
chromosomes were hybridised to a series of archival bone marrow smears taken 
from children with ALL at diagnosis and in remission. Signals were observed in 
all cases examined, although a proportion of cells in most samples failed to 
exhibit detectable hybridisation. 
In the remission series, the hybridisation efficiency observed and the accuracy of 
the technique in identifying normal male and female cells was related to the age 
of the material, with the oldest performing least well and the freshest the best. In 
previous work applying FISH to bone marrow smears, the age of the material has 
ranged from a few weeks (Anastasi et al, 1991) to several years (Lee W et al, 
192 
1993), the latter on unstained slides. Interestingly, those authors found no 
relationship between the storage time of the material and the extent to which 
hybridisation was successful. However, in the series of diagnostic smears, the 
unfixed frozen material gave far more consistent results when compared to those 
slides where coverslip removal and destaining had been required. 
Numerical chromosomal abnormalities were detected in all of the ALL samples, 
with the proportion of cells displaying aneuploidy varying considerably from case 
to case. This reflected a mixed clonality within the samples, previously 
demonstrated by chromosome analysis, although there was not an exact 
correspondence between conventional and interphase cytogenetics. This 
discordance may be due in part to a low efficiency of hybridisation, particularly 
on the Romanowsky stained material, but it is also likely that the FISH technique, 
which is not limited to dividing cells, is reflecting the relative proportions of 
different clones more accurately, as other workers have found(Anastasi et al, 
1992). 
These findings indicate that it is possible to obtain accurate information on 
chromosome abnormalities from routine bone marrow smears after many years in 
storage, including stained and mounted slides from patients who were diagnosed 
before chromosome techniques were widely available (Seabright, 1971). 
6.2.2) Structural studies 
6.2.2.1) Abnormalities of chromosome 14 
In this study, der(14) chromosomes were analysed from a series of NHL and 
demonstrated the efficacy of chromosome painting as a means of identifying the 
origins of abnormal chromosomes. Although this technique is very powerful it 
does, however, have its limitations. The hybridisation of chromosome paints 
involves the use of competitor DNA which has the effect of reducing the 
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efficiency of hybridisation of the paints compared to that of unique sequence 
probes. Furthermore 
the chromosome paints may not be entirely representative of all regions of a 
chromosome and thus might produce variable signal intensities between different 
regions (Rosenberg et al, 1992). Factors such as these may therefore contribute to 
difficulties in visualising small regions that have been translocated. A good 
example of this concerns the small region of chromosome 14 (14q32-14qter) that 
is translocated to the 18q- derivative chromosome as a result of the t(14; 18) 
reciprocal translocation which, as shown here and elsewhere(Bajalica et al, 1993), 
has consistently been difficult to visualise. Nevertheless chromosome painting has 
been used to determine the origins of derivative chromosomes observed in both 
malignant (Brothman and Patel, 1992; Smit et al, 1991; Xu and Wang, 1994) and 
non-malignant cells (Magnani et al, 1993; Ohta et al, 1993). 
In the present study, chromosome painting has allowed us to identify material that 
had been translocated to form part of the der(14) chromosomes observed in 
several NHL. Ibis not only allowed for the identification of regions that could not 
be characterised by Giemsa-banding, but interestingly also revealed abnormalities 
that had not been suspected. For example in L021, the der(14) was shown not to 
be due to a simple translocation but rather to be the result of insertion of 
chromosome II material into the q arm of chromosome 14. Furthermore, in L032 
an abnormal chromosome that had been identified as a der(14) on the basis of its 
Giemsa-banding pattern was found not to be composed of chromosome 14 
material. These observations are important for a number of reasons, not least of 
which is that they provide a more accurate picture of chromosome abnormalities 
present in malignant cells and hence may result in a reassessment of the accepted 
frequencies of particular chromosome abnormalities. 
It is possible that the additional information obtained by the application of FISH 
techniques could also provide an insight into the evolution of malignant cell 
karyotypes. In LO 11 there were two normal chromosomes 3 and a der(14) which 
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was demonstrated to contain chromosome 3 material. These observations are 
consistent with a model in which a t(3; 14)(q27; q32) translocation had occurred, 
followed by loss of the resulting 3q- chromosome from the cell and duplication of 
the remaining normal chromosome 3. The application of other chromosome 
paints to a range of NHL might therefore allow for common sets of events to be 
identified that are associated with the evolution and progression of NHL. 
A more accurate analysis of the abnormal chromosomes provided by FISH 
techniques could also lead to the identification of reliable prognostic markers. For 
example, LO 11 and L006 both contained der(14) chromosomes typical of the 
t(3; 14)(q27; q32) translocation but without the presence of the reciprocal der(3). 
Chromosome painting demonstrated, however, that the der(14) chromosomes was 
the result of the t(3; 14) translocation. This translocation is associated with 
rearrangement of the BCL-6 gene and high grade centroblastic NHL (Ye et al, 
1993) and it was therefore of interest that although L01 I had been diagnosed with 
low grade disease, within a few months of biopsy, this had transformed to high 
grade centroblastic NHL. 
The cloning of breakpoint regions involving the immunoglobulin heavy chain 
gene locus on 14q32 has been a remarkably successful approach for identifying 
novel genes that are associated with the evolution of NHL (Tsujimoto et al, 
1984a, b; Motokura et al, 1991; Ohno et al, 1990; Ye et al, 1993; Neri et al, 
1991). The identification of der(14;? )(q32:? ) chromosomes that are different to 
those that have previously been used in these cloning experiments, should 
therefore allow for the identification of NHL cases which exhibit translocations 
involving the recombination of other novel oncogenes near to the 
immunoglobulin locus. The application of chromosome painting would therefore 
enable a more efficient search to be made for such oncogenes and in this series 
both L022 and L031 might be examples worth further investigation. 
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6.2.2.2) Abnormalities of chromosome 6 
Aberrations involving the long arm of chromosome 6 are common in NHL 
(Schouten et al, 1990b) and have also been reported in a variety of other 
haernatologic and solid malignancies (Hatashi et al, 1990; Millikin et al, 1991; 
Morita et al, 1991; Stenman et al, 1989; Gaidano et al, 1992). In NHL, these 6q 
abnormalities have been inconsistently correlated with both clinical features and 
prognosis (Cabanillas et al, 1988; Schouten et al, 1990b); therefore chromosome 
painting and single gene localisation by FISH were utilised in an attempt to 
investigate the 6q abnormalities found in this series. 
Although painting with sequences specific for chromosome 6 failed to reveal any 
hidden interstitial rearrangements and only one example of translocated material, 
additional aberrations cannot be completely ruled out, since it is not always 
possible to detect small fragments of a chromosome by this method (Bajalica et 
al, 1993). 
The MYB gene was mapped to 6q23, refining its previous location of 6q22-23 
(Barletta et al, 1987), although it should be noted that other workers have since 
mapped MYB (also by FISH) to 6q24 (Gaidano et al, 1992). The same probe was 
then applied to NHL metaphases with abnormalities of 6q and in at least one of 
these cases, unsuspected rearrangements of chromosome 6 were identified in the 
NHL cells by the prrsence of aberrant MYB hybridisation signals. Recent work 
has identified various regions of common deletion on 6q in NHL (Offit et al, 
1993; Menasce et al, 1994). The former paper attempts to define distinct clinico- 
pathologic subsets based on these regions, as ascertained by conventional 
cytogenetics. The occurrence of occult rearrangements,. such as those detected in 
the work presented in this thesis, may go some way to elucidating the difficulties 
of assigning 6q abnormalities to specific clinical or pathological groups. 
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6.2.2.3) Analysis of double minutes 
C-banding of chromosomes is known to reveal heterochromatic regions found in 
all centromeres and in certain pericentromeric regions (Sumner, 1982), However, 
the centromere-associated DNA-containing dmin described here were negative 
for C-banding. This raised the possibility that the centromere-associated DNA in 
these dmin exists in an abnormal conformational state, or that it may have been 
altered in some other way. 
The dmin are generally regarded as containing a number of amplicons or gene 
amplification units (Kaufman et al, 1979; Cowell, 1982), that may have arisen by 
a variety of mechanisms (Carroll et al., 1988; Wahl et al., 1989; Von Hoff et al., 
1990; Roelofs et al., 1993). The dmin described here could only be demonstrated 
to contain centromere-associated DNA sequences because the intensity of the 
hybridisation signals, coupled with the small size of the dmin, prevented any non- 
centromeric regions from being observed. It was therefore unclear whether these 
dmin represented only amplicons of non-coding centromeric alphoid repeats or 
contained also other sequences. If the latter was the case, then it suggested that a 
mechanism could exist for the formation of dmin which allowed for the 
integration of disparate DNA sequences, as has been described in a gastric cancer 
cell line (Bar-Am et al., 1992). 
It has been proposed that the presence of dmin in tumour cells, with their 
associated amplification of oncogenes (Brodeur et al., 1984; Dolf et al., 1991) or 
drug resistance genes (Hahn et al., 1992), could be an indicator of poor prognosis 
(Schwab and Amler, 1990; Nielson et al., 1993). However, if dmin are not always 
associated with gross gene amplification, then this might suggest that dmin should 
be reassessed as prognostic markers in malignant disease. A comprehensive study 
of the frequency of centromere-associated DNA positive dmin and their 
correlation with prognosis would be of value. 
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6.3) CONCLUSIONS 
By comparison with other NHL series, this study of 40 specimens is small; in the 
largest series to date, Offit and colleagues reported on 434 specimens in 1991. 
However, with the notable exceptions of finding both a high incidence of 
additional copies of the X chromosome and a low incidence of lIql3 
abnormalities, the results reported here are very much in agreement with those of 
Offit et al. This suggests that smaller studies may well be informative if the data 
is gathered in a consistent manner. Cytogenetics has to date proved a powerful 
tool for the analysis of genetic change in NHL. As the number of analysed cases 
in the literature increases, both the identification of new consistent breakpoints, 
which may be the site of potential oncogenes and the forging of firm associations 
between specific abnormalities, diagnosis and particularly prognosis become 
more likely. Probably the most effective approach in the search for chromosomal 
indicators of prognosis is the analysis of sequential samples from individual 
cases. At the time of writing, only three studies of this nature have been reported 
(Sanger et al, 1987; Levine et al, 1990; Whang-Peng et al, 1995). However, most 
recent series of NHL karyotypes contain examples of cases that have been 
sequentially sampled, including the data in this thesis and a logical next step 
would be to collate all the available information, in an attempt to identify those 
acquired abnormalities associated with transformation from low- to high-grade 
NHL. 
The question of regional variation in the incidence of particular chromosome 
abnormalities (Johansson et al, 1991) will be less straightforward to resolve, 
especially since the overwhelming majority of cases are reported from the USA. 
Apart from adding another variable to the already complex task of deriving firm 
clinical/pathological associations, this geographic heterogeneity may be important 
in attempts to define the aetiological effects of different genetic or environmental 
factors on NHL. 
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The above questions can only be resolved satisfactorily if chromosome 
abnormalities can be tabulated correctly. The results of the work under discussion 
in this thesis make it clear that although conventional cytogenetics can be a 
powerful tool for the investigation of genetic change in NHL and other 
malignancies, several areas of potential inaccuracy exist. In the study of 
metaphase cells it is not always possible to identify every chromosome. 
Furthermore, unsuspected chromosomal rearrangements, which are not detectable 
by G-banding, may be present. An additional confounding factor may also arise 
from the exclusive study of dividing cells, since other clones may exist in the 
interphase population. 
The application of FISH techniques has gone some way towards resolving the 
difficulty in obtaining an accurate picture of karyotypic change in cancer cells. 
Chromosome painting is now used almost routinely to elucidate complex or 
obscure cytogenetic abnormalities. Indeed, in order to incorporate the new 
information gained from painting into the standard nomenclature, a new system 
for scoring structural aberrations detected by chromosome painting has recently 
been proposed (Tucker et al, 1995). The use of interphase cytogenetics has 
revealed an enormous potential for detecting both numerical and structural 
chromosome abnormalities in tumour cells. Data concerning the frequency of 
polysomy 12 and monosomy 18 in NHL, obtained by the application of 
interphase cytogenetics, have recently been published (Younes et al, 1994a; 
1994b) and the report of deletion of the RBI gene in interphase nuclei of chronic 
lymphocytic leukaemia cells (Stilgenbauer et al, 1993) serves as an example of 
the sensitivity of this approach in haematological malignancy. 
There is considerable future potential for the application of a combined 
cytogenetic / FISH approach to the study of genetic alterations in NHL. It is 
envisaged that in addition to applying the techniques described above to a 
continuing series of NHL biopsies, the use of FISH technology will be further 
extended. Ratio painting (Dauwcrse et al, 1992) will be applied to lymphoma 
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metaphases to enable a more complete characterisation to be carried out and NHL 
DNA will be used in CGH (Kallioniemi et al, 1992; du Manoir et al, 1993) 
experiments, in order to identify occult regions of amplification or deletion. The 
investigation of genetic change in malignancy at the chromosomal level has now 
been greatly enhanced and extended by the application of FISH techniques. The 
capability of examining the complete genome, albeit at low resolution, remains 
vital to an overall understanding of the genetics of cancer. 
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